Professor Michael Proinsias Farrell
Tabs
Publications related to this Person
Books
Darke S; Lappin J; Farrell M, 2021, The pocket guide to drugs and health, Silverback, London
Darke S; Lappin J; Farrell M, 2019, The Clinician's Guide to Illicit Drugs and Health, Silverback Publishing, Great Britain, https://www.silverbackpublishing.org/products/the-clinicians-guide-to-illicit-drugs-and-health
Teesson M; Hall W; Proudfoot H; Degenhardt LJ, 2012, Addictions, 4, Psychology Press Ltd, East Essex, UK, http://www.psypress.com/addictions-9780415583008
Baker A; Velleman R, (ed.), 2007, Clinical Handbook of Co-existing Mental Health and Drug and Alcohol Problems, Routledge, http://dx.doi.org/10.4324/9780203028513
Teesson M; Degenhardt LJ; Hall WD, 2002, Addictions, 4, Psychology Press, Sussex, UK
Book Chapters
Farrell M; Larance B; Breen C, 2020, 'Opioids', in Geddes JR; Andreasen NC; Goodwin GM (ed.), New Oxford Textbook of Psychiatry, Oxford University Press, pp. 507 - 518, http://dx.doi.org/10.1093/med/9780198713005.003.0051
Glass IB; Farrell M; Hajek P, 2016, 'Tell me about the client: History-taking and formulating the case', in The International Handbook of Addiction Behaviour, pp. 191 - 203, http://dx.doi.org/10.4324/9781315542355
Farrell M, 2016, 'Physical complications of drug abuse', in The International Handbook of Addiction Behaviour, pp. 120 - 125, http://dx.doi.org/10.4324/9781315542355
Withall AL; Draper B; Johnco C, 2015, 'There's a tear in my beer: issues for the older patient with alcohol and substance abuse', in Haber P; Day C; Farrell M (ed.), Addiction Medicine: Principles and Practice, IP Communications, Melbourne, pp. 398 - 406
Berends L, 2014, 'Pathways of care', in Haber P; Day C; Farrell M (ed.), A short textbook of addiction medicine
Farrell M; Singleton N; Strang J, 2013, 'Drugs and prisons: A high risk and high burden environment', in Drug Use in Prisons, pp. 203 - 214, http://dx.doi.org/10.4324/9781315079998-17
Darker CD; Sweeney BP; Barry JM; Farrell MF, 2012, 'Psychosocial interventions for benzodiazepine harmful use, abuse or dependence', in Darker CD (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd009652
Wodak AD; Ryan J; Griffiths P; van Beek I; Barratt M; Lenton S; Dolan K; Rodas AA; Noller G; Farrell M, 2012, 'Policy and practice in harm reduction in Australasia', in Pates R; Riley D (ed.), Harm Reduction in Substance Use and High-Risk Behaviour, edn. 1, Wiley-Blackwell, Chichester, UK, pp. 405 - 424, http://www.wiley.com/WileyCDA/WileyTitle/productCd-1118343352.html
Mayet S; Farrell M; Mani SG, 2010, 'Opioid agonist maintenance for opioid dependent patients in prison', in Mayet S (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd008221
Hall W; Farrell M, 2008, 'Drug use and drug dependence', in Essential Psychiatry, Fourth Edition, pp. 230 - 249, http://dx.doi.org/10.1017/CBO9780511544125.012
Knapp WP; Soares BGO; Farrel M; Lima MS, 2007, 'Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders.', in , pp. CD003023, http://dx.doi.org/10.1002/14651858.CD003023.pub2
Flannery W; Farrell M, 2005, 'Forensic psychiatry and forensic psychology', in Encyclopedia of Forensic and Legal Medicine, pp. 405 - 416, http://dx.doi.org/10.1016/B0-12-369399-3/00167-1
Strang J; Ruben S; Farrell M; Witton J; Keaney F; Gossop M, 2004, 'The history of prescribing heroin and other injectable drugs as addiction treatment in the UK', in Heroin Addiction and The British System, pp. 1 - 16, http://dx.doi.org/10.4324/9780203643358
Farrell M; Raistrick D, 2004, 'The coming of age of oral methadone maintenance treatment in the UK in the 1990s', in Heroin Addiction and The British System, pp. 104 - 118, http://dx.doi.org/10.4324/9780203643358
Mayet S; Farrell M; Ferri M; Davoli M; Amato L, 2003, 'Psychosocial treatment for opiate abuse and dependence', in , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd004330
Gowing L; Farrell M; Bornemann R; Ali R, 2003, 'Substitution treatment of injecting opioid users for preventing transmission of HIV infection', in , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd004145
Farrell M; Hall W, 2003, 'Methadone and opioid-related deaths', in Methadone Matters, CRC Press, pp. 155 - 165, http://dx.doi.org/10.1201/b14312-19
Grace V; Worth H; Simmons L, 2003, 'Introduction', in Baudrillard West of the Dateline, edn. 12, Dunmore Press, Palmerston North, pp. 421 - 422, http://dx.doi.org/10.1053/j.mppsy.2006.09.008
Soares BGO; Lima MS; Farrell M, 2001, 'Psychosocial treatments for psychostimulants dependence', in Soares BGDO (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd003023
Silva de Lima M; Soares B; Farrell M, 2001, 'Psychosocial interventions for alcohol use disorders', in Silva de Lima M (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd003027
Strang J; Farrell M; Unnithan S, 1993, 'Treatment of Cocaine Abuse: Exploring the Condition and Selecting the Response', in Cocaine and Crack, Palgrave Macmillan UK, pp. 146 - 172, http://dx.doi.org/10.1007/978-1-349-22773-0_8
Journal articles
Howard BC; McRobbie H; Petrie D; Barker D; Mendelsohn C; Anderson J; Borland R; Naughton F; Tutka P; Zwar N; Boland VC; Aiken A; Shakeshaft A; Gartner C; Richmond RL; Hall W; Mattick RP; Farrell M; Courtney RJ, 2022, 'Effectiveness, safety and cost-effectiveness of vaporized nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: a study protocol for a randomized controlled trial', Trials, vol. 23, pp. 777, http://dx.doi.org/10.1186/s13063-022-06644-8
Farrell M, 2022, 'From harm to hope or is it from harmful to hopeless?', International Journal of Drug Policy, vol. 109, http://dx.doi.org/10.1016/j.drugpo.2022.103845
Acheson LS; Ezard N; Lintzeris N; Dunlop A; Brett J; Rodgers C; Gill A; Christmass M; McKetin R; Farrell M; Shoptaw S; Siefried KJ, 2022, 'Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal', PLoS ONE, vol. 17, pp. e0275371, http://dx.doi.org/10.1371/journal.pone.0275371
Treloar C; Lancaster K; Gendera S; Rhodes T; Shahbazi J; Byrne M; Degenhardt L; Farrell M, 2022, 'Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot', International Journal of Drug Policy, vol. 107, pp. 103788, http://dx.doi.org/10.1016/j.drugpo.2022.103788
Bharat C; Gisev N; Barbieri S; Dobbins T; Larney S; Farrell M; Degenhardt L, 2022, 'Trends in opioid analgesic utilisation among people with a history of opioid dependence', Drug and Alcohol Dependence, vol. 238, pp. 109548 - 109548, http://dx.doi.org/10.1016/j.drugalcdep.2022.109548
Bharat C; Gisev N; Barbieri S; Dobbins T; Larney S; Farrell M; Degenhardt L, 2022, 'The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.', International Journal of Population Data Science, vol. 7, http://dx.doi.org/10.23889/ijpds.v7i3.1954
Dudley A; Sweeney K; Looby S; Farrell M; McGovern E, 2022, 'Teaching NeuroImage: Cerebral Amyloid Angiopathy-Related Inflammation: An Interesting Evolution of Imaging Findings.', Neurology, vol. 99, pp. 216 - 217, http://dx.doi.org/10.1212/WNL.0000000000200833
Fearon C; Howley R; Looby S; Byrne A; Heffernan J; Heeney C; Beausang A; Cryan J; Farrell M; O'Dowd S; Brett F, 2022, 'Establishing a committee for antemortem reviews of suspect Creutzfeldt-Jakob disease cases in Ireland.', Ir J Med Sci, http://dx.doi.org/10.1007/s11845-022-03070-2
Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2022, 'Characteristics of fatal tapentadol-related toxicity in Australia', Drug and Alcohol Review, vol. 41, pp. 1071 - 1077, http://dx.doi.org/10.1111/dar.13462
Colledge-Frisby S; Jones N; Larney S; Peacock A; Lewer D; Brothers TD; Hickman M; Farrell M; Degenhardt L, 2022, 'The impact of opioid agonist treatment on hospitalisations for injecting-related diseases among an opioid dependent population: A retrospective data linkage study', Drug and Alcohol Dependence, vol. 236, pp. 109494 - 109494, http://dx.doi.org/10.1016/j.drugalcdep.2022.109494
Brothers TD; Lewer D; Jones N; Colledge-Frisby S; Farrell M; Hickman M; Webster D; Hayward A; Degenhardt L, 2022, 'Opioid agonist treatment and risk of death or rehospitalization following injection drug use–associated bacterial and fungal infections: A cohort study in New South Wales, Australia', PLoS Medicine, vol. 19, pp. e1004049, http://dx.doi.org/10.1371/journal.pmed.1004049
Hall W; Farrell M, 2022, 'Aldous Huxley's The Doors of Perception', Addiction, vol. 117, pp. 1811 - 1815, http://dx.doi.org/10.1111/add.15713
Nielsen S; Picco L; Murnion B; Winters B; Matheson J; Graham M; Campbell G; Parvaresh L; Khor KE; Betz-Stablein B; Farrell M; Lintzeris N; Le Foll B, 2022, 'Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies', Neuropsychopharmacology, vol. 47, pp. 1315 - 1330, http://dx.doi.org/10.1038/s41386-022-01322-4
Chaillon A; Bharat C; Stone J; Jones N; Degenhardt L; Larney S; Farrell M; Vickerman P; Hickman M; Martin NK; Bórquez A, 2022, 'Modeling the population-level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia', Addiction, vol. 117, pp. 1338 - 1352, http://dx.doi.org/10.1111/add.15736
Zahra E; Chen R; Nielsen S; Tran AD; Santo T; Degenhardt L; Farrell M; Byrne J; Ali R; Larance B, 2022, 'Examining the cost and impact of dosing fees among clients in opioid agonist treatment: Results from a cross-sectional survey of Australian treatment clients', Drug and Alcohol Review, vol. 41, pp. 841 - 850, http://dx.doi.org/10.1111/dar.13437
Krausz M; Westenberg JN; Tsang V; Suen J; Ignaszewski MJ; Mathew N; Azar P; Cabanis M; Elsner J; Vogel M; Spijkerman R; Orsolini L; Vo D; Moore E; Moe J; Strasser J; Köck P; Marian C; Dürsteler KM; Backmund M; Röhrig J; Post M; Haltmayer H; Wladika W; Trabi T; Muller C; Rechberger G; Teesson M; Farrell M; Christie G; Merry S; Mamdouh M; Alinksy R; Levy S; Fishman M; Rosenthal R; Jang K; Choi F, 2022, 'Towards an International Consensus on the Prevention, Treatment, and Management of High-Risk Substance Use and Overdose among Youth', Medicina (Lithuania), vol. 58, http://dx.doi.org/10.3390/medicina58040539
Darke S; Peacock A; Duflou J; Farrell M; Lappin J, 2022, 'Characteristics of fatal ‘novel’ synthetic opioid toxicity in Australia', Drug and Alcohol Dependence, vol. 232, http://dx.doi.org/10.1016/j.drugalcdep.2022.109292
Warfield SC; Bharat C; Bossarte RM; DePhilippis D; Farrell M; Hoover M; Larney S; Marshalek P; McKetin R; Degenhardt L, 2022, 'Trends in comorbid opioid and stimulant use disorders among Veterans receiving care from the Veterans Health Administration, 2005–2019', Drug and Alcohol Dependence, vol. 232, http://dx.doi.org/10.1016/j.drugalcdep.2022.109310
Weatherburn D; Darke S; Zahra E; Farrell M, 2022, 'Who would try (or use more) cannabis if it were legal?', Drug and Alcohol Review, vol. 41, pp. 386 - 395, http://dx.doi.org/10.1111/dar.13360
Farrell M; Shahbazi J; Byrne M; Grebely J; Lintzeris N; Chambers M; Larance B; Ali R; Nielsen S; Dunlop A; Dore GJ; McDonough M; Montebello M; Nicholas T; Weiss R; Rodgers C; Cook J; Degenhardt L, 2022, 'Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence', International Journal of Drug Policy, vol. 100, pp. 103492 - 103492, http://dx.doi.org/10.1016/j.drugpo.2021.103492
Darke S; Peacock A; Duflou J; Farrell M; Lappin J, 2022, 'Characteristics of fatal ‘novel’ benzodiazepine toxicity in Australia', Forensic Science International, vol. 331, pp. 111140, http://dx.doi.org/10.1016/j.forsciint.2021.111140
Bosworth RJ; Borschmann R; Altice FL; Kinner SA; Dolan K; Farrell M, 2022, 'HIV/AIDS, hepatitis and tuberculosis-related mortality among incarcerated people: a global scoping review', International Journal of Prisoner Health, vol. 18, pp. 66 - 82, http://dx.doi.org/10.1108/IJPH-02-2021-0018
Mammen K; Mills L; Deacon RM; Bruno R; Dunlop A; Holmes J; Luksza J; Shakeshaft A; Farrell M; Lintzeris N, 2022, 'Determining clinical cutoff scores for the Australian Treatment Outcomes Profile psychological health, physical health and quality of life questions', Drug and Alcohol Review, vol. 41, pp. 106 - 113, http://dx.doi.org/10.1111/dar.13346
Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2022, 'Characteristics of fatal gabapentinoid-related poisoning in Australia, 2000–2020', Clinical Toxicology, vol. 60, pp. 304 - 310, http://dx.doi.org/10.1080/15563650.2021.1965159
Tran AD; Chen R; Nielsen S; Zahra E; Degenhardt L; Santo T; Farrell M; Larance B, 2022, 'Economic analysis of out-of-pocket costs among people in opioid agonist treatment: A cross-sectional survey in three Australian jurisdictions', International Journal of Drug Policy, vol. 99, pp. 103472, http://dx.doi.org/10.1016/j.drugpo.2021.103472
Wong RXY; Farrell M; Degenhardt L; Memedovic S; Harvey SB; Petrie K, 2022, 'Substance use among vocational trainees in Australia: differences between medical specialties', Internal Medicine Journal, http://dx.doi.org/10.1111/imj.15729
Acheson LS; Williams BH; Farrell M; McKetin R; Ezard N; Siefried KJ, 2022, 'Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta-analysis of randomised controlled trials', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.13511
Yuen WS; Leung J; Man N; Chiu V; Gisev N; Livingston M; Degenhardt L; Farrell M; Pearson SA; Dobbins T; Dunlop A; Mattick RP; Peacock A, 2022, 'Age at first alcohol-related hospital separation or emergency department presentation and rate of re-admission: A retrospective data linkage cohort of young Australians', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.13529
Darke S; Duflou J; Peacock A; Chrzanowska A; Farrell M; Lappin J, 2022, 'Rates, characteristics and toxicology of cocaine-related deaths in Australia, 2000–2021', Addiction, http://dx.doi.org/10.1111/add.16055
Yuen WS; Peacock A; Man N; Callinan S; Slade T; Farrell M; Mattick R; Livingston M, 2022, 'Age, period and cohort effects on alcohol-related risky behaviours in Australia from 2001 to 2016', Addiction, vol. 41, http://dx.doi.org/10.1111/add.16061
Acheson LS; Ezard N; Lintzeris N; Dunlop A; Brett J; Rodgers C; Gill A; Christmass M; McKetin R; Farrell M; Shoptaw S; Siefried KJ, 2022, 'Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trial', Drug and Alcohol Dependence, pp. 109692 - 109692, http://dx.doi.org/10.1016/j.drugalcdep.2022.109692
Darke S; Banister S; Farrell M; Duflou J; Lappin J, 2021, '‘Synthetic cannabis’: A dangerous misnomer', International Journal of Drug Policy, vol. 98, http://dx.doi.org/10.1016/j.drugpo.2021.103396
Chrzanowska A; Man N; Darke S; Degenhardt L; Farrell M; Moran L; Peacock A, 2021, 'Unintentional and intentional drug poisoning deaths, Australia, 2012–2016: Drug pattern profile and demographic characteristics', Drug and Alcohol Dependence, vol. 229, pp. 109112 - 109112, http://dx.doi.org/10.1016/j.drugalcdep.2021.109112
Yuen WS; Bruno R; Chan GCK; McCambridge J; Slade T; Clare PJ; Aiken A; Kypri K; Hutchinson D; McBride N; Boland V; Upton E; Farrell M; Mattick RP; Peacock A, 2021, 'The experience of physiological and psychosocial alcohol-related harms across adolescence and its association with alcohol use disorder in early adulthood: A prospective cohort study', Alcoholism: Clinical and Experimental Research, vol. 45, pp. 2518 - 2527, http://dx.doi.org/10.1111/acer.14726
Courtney RJ; Tutka P; Farrell M, 2021, 'The Effect of Cytisine vs Varenicline on Smoking Cessation - Reply', JAMA - Journal of the American Medical Association, vol. 326, pp. 1872 - 1873, http://dx.doi.org/10.1001/jama.2021.16064
Quinn B; Ward B; Agius PA; Jenkinson R; Hickman M; Sutton K; Hall C; McKetin R; Farrell M; Cossar R; Dietze PM, 2021, 'A prospective cohort of people who use methamphetamine in Melbourne and non-metropolitan Victoria, Australia: Baseline characteristics and correlates of methamphetamine dependence', Drug and Alcohol Review, vol. 40, pp. 1239 - 1248, http://dx.doi.org/10.1111/dar.13194
McKetin R; Sutherland R; Peacock A; Farrell M; Degenhardt L, 2021, 'Patterns of smoking and injecting methamphetamine and their association with health and social outcomes', Drug and Alcohol Review, vol. 40, pp. 1256 - 1265, http://dx.doi.org/10.1111/dar.13364
Hall W; Farrell M, 2021, 'What can we learn from the history of research on psychedelic drugs in the addictions?', Addiction, vol. 116, pp. 2936 - 2938, http://dx.doi.org/10.1111/add.15560
Bharat C; Degenhardt L; Dobbins T; Larney S; Farrell M; Barbieri S, 2021, 'Using administrative data to predict cessation risk and identify novel predictors among new entrants to opioid agonist treatment', Drug and Alcohol Dependence, vol. 228, http://dx.doi.org/10.1016/j.drugalcdep.2021.109091
Lewer D; Eastwood B; White M; Brothers TD; McCusker M; Copeland C; Farrell M; Petersen I, 2021, 'Fatal opioid overdoses during and shortly after hospital admissions in England: A casecrossover study', PLoS Medicine, vol. 18, http://dx.doi.org/10.1371/journal.pmed.1003759
Man N; Chrzanowska A; Price O; Bruno R; Dietze PM; Sisson SA; Degenhardt L; Salom C; Morris L; Farrell M; Peacock A, 2021, 'Trends in cocaine use, markets and harms in Australia, 2003–2019', Drug and Alcohol Review, vol. 40, pp. 946 - 956, http://dx.doi.org/10.1111/dar.13252
Santo T; Clark B; Hickman M; Grebely J; Campbell G; Sordo L; Chen A; Tran LT; Bharat C; Padmanathan P; Cousins G; Dupouy J; Kelty E; Muga R; Nosyk B; Min J; Pavarin R; Farrell M; Degenhardt L, 2021, 'Association of Opioid Agonist Treatment with All-Cause Mortality and Specific Causes of Death among People with Opioid Dependence: A Systematic Review and Meta-analysis', JAMA Psychiatry, vol. 78, pp. 979 - 993, http://dx.doi.org/10.1001/jamapsychiatry.2021.0976
Nielsen S; Gisev N; Leung J; Clare P; Bruno R; Lintzeris N; Larance B; Blyth F; Hall W; Cohen M; Degenhardt L; Farrell M; Campbell G, 2021, 'Clinical correlates and outcomes associated with pregabalin use among people prescribed opioids for chronic non-cancer pain: A five-year prospective cohort study', British Journal of Clinical Pharmacology, vol. 87, pp. 3092 - 3104, http://dx.doi.org/10.1111/bcp.14715
Yuen WS; Chan G; Bruno R; Clare PJ; Aiken A; Mattick R; Farrell M; Kypri K; Slade T; Hutchinson D; McBride N; McCambridge J; Boland V; Peacock A, 2021, 'Trajectories of alcohol-induced blackouts in adolescence: early risk factors and alcohol use disorder outcomes in early adulthood', Addiction, vol. 116, pp. 2039 - 2048, http://dx.doi.org/10.1111/add.15415
Courtney RJ; McRobbie H; Tutka P; Weaver NA; Petrie D; Mendelsohn CP; Shakeshaft A; Talukder S; Macdonald C; Thomas D; Kwan BCH; Walker N; Gartner C; Mattick RP; Paul C; Ferguson SG; Zwar NA; Richmond RL; Doran CM; Boland VC; Hall W; West R; Farrell M, 2021, 'Effect of Cytisine vs Varenicline on Smoking Cessation: A Randomized Clinical Trial', JAMA - Journal of the American Medical Association, vol. 326, pp. 56 - 64, http://dx.doi.org/10.1001/jama.2021.7621
Nielsen S; Sanfilippo P; Belackova V; Day C; Silins E; Lintzeris N; Bruno R; Grebely J; Lancaster K; Ali R; Bell J; Dietze P; Degenhardt L; Farrell M; Larance B, 2021, 'Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: findings from a cross-sectional study in three Australian cities', Addiction, vol. 116, pp. 1482 - 1494, http://dx.doi.org/10.1111/add.15297
Deacon RM; Mammen K; Bruno R; Mills L; Dunlop A; Holmes J; Jefferies M; Hall M; Shakeshaft A; Farrell M; Graham R; Lintzeris N, 2021, 'Assessing the concurrent validity, inter-rater reliability and test–re-test reliability of the Australian Treatment Outcomes Profile (ATOP) in alcohol and opioid treatment populations', Addiction, vol. 116, pp. 1245 - 1255, http://dx.doi.org/10.1111/add.15331
Degenhardt L; Hungerford P; Nielsen S; Bruno R; Larance B; Clare PJ; Dobbins T; Hall W; Cohen M; Blyth F; Lintzeris N; Farrell M; Campbell G, 2021, 'Pharmaceutical Opioid Use Patterns and Indicators of Extramedical Use and Harm in Adults with Chronic Noncancer Pain, 2012-2018', JAMA Network Open, vol. 4, pp. e213059, http://dx.doi.org/10.1001/jamanetworkopen.2021.3059
McKetin R; Farrell M, 2021, 'When the evidence is not enough: is it time to rethink trial design?', Addiction, vol. 116, pp. 711 - 712, http://dx.doi.org/10.1111/add.15273
Cutts JC; Quinn B; Seed CR; Kotsiou G; Pearson R; Scott N; Wilson DP; Harrod ME; Maher L; Caris S; Thompson AJ; Farrell M; Pink J; Hellard ME, 2021, 'A Systematic Review of Interventions Used to Increase Blood Donor Compliance with Deferral Criteria', Transfusion Medicine and Hemotherapy, vol. 48, pp. 118 - 129, http://dx.doi.org/10.1159/000509027
Maher L, 2021, 'A Systematic Review of Interventions Used to Increase Blood Donor Compliance with Deferral Criteria', Transfusion Medicine and Hemotherapy, http://dx.doi.org/10.1159/000509027
Delaney C; Farrell M; Doherty CP; Brennan K; O'Keeffe E; Greene C; Byrne K; Kelly E; Birmingham N; Hickey P; Cronin S; Savvides SN; Doyle SL; Campbell M, 2021, 'Attenuated CSF-1R signalling drives cerebrovascular pathology.', EMBO Mol Med, vol. 13, pp. e12889, http://dx.doi.org/10.15252/emmm.202012889
Darke S; Duflou J; Farrell M; Peacock A; Lappin J, 2021, 'Characteristics and circumstances of death related to the self-administration of ketamine', Addiction, vol. 116, pp. 339 - 345, http://dx.doi.org/10.1111/add.15154
Jones NR; Nielsen S; Farrell M; Ali R; Gill A; Larney S; Degenhardt L, 2021, 'Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001–2018: Implications for treatment systems and potential impact on client outcomes', Drug and Alcohol Dependence, vol. 219, pp. 108464, http://dx.doi.org/10.1016/j.drugalcdep.2020.108464
Darke S; Duflou J; Larance B; Farrell M; Lappin J, 2021, 'Characteristics and circumstances of death related to buprenorphine toxicity in Australia', Drug and Alcohol Dependence, vol. 218, http://dx.doi.org/10.1016/j.drugalcdep.2020.108360
Donlon E; Lynch R; Murphy OC; Farrell M; Noel J; Keogan M; O'Connell M; Lynch T, 2021, 'Braak's Unfinished Hypothesis: A Clinicopathological Case Report of α-Synuclein Peripheral Neuropathy Preceding Parkinsonism by 20 Years.', Mov Disord Clin Pract, vol. 8, pp. 1129 - 1133, http://dx.doi.org/10.1002/mdc3.13321
Fearon C; Lees AJ; McKinley JJ; McCarthy A; Smyth S; Farrell M; Lynch T, 2021, 'On the Emergence of Tremor in Prodromal Parkinson's Disease.', J Parkinsons Dis, vol. 11, pp. 261 - 269, http://dx.doi.org/10.3233/JPD-202322
Harford DA; Delaney C; O'Callaghan J; Hudson N; Connolly R; Doyle S; Farrell M; Doherty CP; Cahill M; Campbell M, 2021, 'Decreased CSF1R Signaling and the Accumulation of Reticular Pseudo-Drusen?', Ophthalmic Surg Lasers Imaging Retina, vol. 52, pp. 666 - 671, http://dx.doi.org/10.3928/23258160-20211101-01
Healy V; O'Halloran PJ; Husien MB; Bolger C; Farrell M, 2020, 'Intermixed arteriovenous malformation and hemangioblastoma: case report and literature review.', CNS Oncol, vol. 9, pp. CNS66, http://dx.doi.org/10.2217/cns-2020-0021
Wang Y; Liu M; Lu Q; Farrell M; Lappin JM; Shi J; Lu L; Bao Y, 2020, 'Global prevalence and burden of HIV-associated neurocognitive disorder: A meta-analysis', Neurology, vol. 95, pp. E2610 - E2621, http://dx.doi.org/10.1212/WNL.0000000000010752
Darke S; Peacock A; Duflou J; Farrell M; Lappin J, 2020, 'Characteristics and circumstances of death related to gamma hydroxybutyrate (GHB)', Clinical Toxicology, vol. 58, pp. 1028 - 1033, http://dx.doi.org/10.1080/15563650.2020.1726378
McKetin R; Boden JM; Foulds JA; Najman JM; Ali R; Degenhardt L; Baker AL; Ross J; Farrell M; Weatherburn D, 2020, 'The contribution of methamphetamine use to crime: Evidence from Australian longitudinal data', Drug and Alcohol Dependence, vol. 216, http://dx.doi.org/10.1016/j.drugalcdep.2020.108262
Campbell G; Noghrehchi F; Nielsen S; Clare P; Bruno R; Lintzeris N; Cohen M; Blyth F; Hall W; Larance B; Hungerford P; Dobbins T; Farrell M; Degenhardt L, 2020, 'Risk factors for indicators of opioid-related harms amongst people living with chronic non-cancer pain: Findings from a 5-year prospective cohort study', EClinicalMedicine, vol. 28, pp. 100592 - 100592, http://dx.doi.org/10.1016/j.eclinm.2020.100592
Campbell G; Darke S; Degenhardt L; Townsend H; Carter G; Draper B; Farrell M; Duflou J; Lappin J, 2020, 'Prevalence and Characteristics Associated with Chronic Noncancer Pain in Suicide Decedents: A National Study', Suicide and Life-Threatening Behavior, vol. 50, pp. 778 - 791, http://dx.doi.org/10.1111/sltb.12627
Cepeda JA; Vickerman P; Bruneau J; Zang G; Borquez A; Farrell M; Degenhardt L; Martin NK, 2020, 'Estimating the contribution of stimulant injection to HIV and HCV epidemics among people who inject drugs and implications for harm reduction: A modeling analysis', Drug and Alcohol Dependence, vol. 213, pp. 108135 - 108135, http://dx.doi.org/10.1016/j.drugalcdep.2020.108135
Larance B; Byrne M; Lintzeris N; Nielsen S; Grebely J; Degenhardt L; Shahbazi J; Shanahan M; Lancaster K; Dore G; Ali R; Farrell M, 2020, 'Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: Protocol for the CoLAB study', BMJ Open, vol. 10, pp. e034389, http://dx.doi.org/10.1136/bmjopen-2019-034389
Guillaumier A; Skelton E; Shakeshaft A; Farrell M; Tzelepis F; Walsberger S; D'Este C; Paul C; Dunlop A; Stirling R; Fowlie C; Kelly P; Oldmeadow C; Palazzi K; Bonevski B, 2020, 'Effect of increasing the delivery of smoking cessation care in alcohol and other drug treatment centres: a cluster-randomized controlled trial', Addiction, vol. 115, pp. 1345 - 1355, http://dx.doi.org/10.1111/add.14911
Larance B; Degenhardt L; Grebely J; Nielsen S; Bruno R; Dietze P; Lancaster K; Larney S; Santo T; Shanahan M; Memedovic S; Ali R; Farrell M, 2020, 'Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia', Addiction, vol. 115, pp. 1295 - 1305, http://dx.doi.org/10.1111/add.14941
Bórquez A; Rich K; Farrell M; Degenhardt L; McKetin R; Tran LT; Cepeda J; Silva-Santisteban A; Konda K; Cáceres CF; Kelly S; Altice FL; Martin NK, 2020, 'Integrating HIV pre-exposure prophylaxis and harm reduction among men who have sex with men and transgender women to address intersecting harms associated with stimulant use: a modelling study', Journal of the International AIDS Society, vol. 23, pp. e25495, http://dx.doi.org/10.1002/jia2.25495
Darke S; Duflou J; Farrell M; Peacock A; Lappin J, 2020, 'Characteristics and circumstances of synthetic cannabinoid-related death', Clinical Toxicology, vol. 58, pp. 368 - 374, http://dx.doi.org/10.1080/15563650.2019.1647344
Quinn B; Pearson R; Cutts J; Seed C; Scott N; Hoad V; Dietze P; Wilson D; Maher L; Thompson A; Farrell M; Harrod M; Caris S; Pink J; Kotsiou G; Hellard M, 2020, 'Blood donation amongst people who inject drugs in Australia: research supporting policy change', Vox Sanguinis, vol. 115, pp. 162 - 170, http://dx.doi.org/10.1111/vox.12891
Farrell M; Robertson R, 2020, 'Commentary on Ho et al. (2020): Managing people with HIV and drug problems is complex and multi-faceted', Addiction, vol. 115, pp. 653 - 654, http://dx.doi.org/10.1111/add.14950
Colledge S; Larney S; Peacock A; Leung J; Hickman M; Grebely J; Farrell M; Degenhardt L, 2020, 'Depression, post-traumatic stress disorder, suicidality and self-harm among people who inject drugs: A systematic review and meta-analysis', Drug and Alcohol Dependence, vol. 207, http://dx.doi.org/10.1016/j.drugalcdep.2019.107793
Black N; Campbell G; Tran LT; Farrell M; Hall W; Degenhardt L, 2020, 'Cannabinoids for the treatment of mental disorders – Author's reply', The Lancet Psychiatry, vol. 7, pp. 127 - 128, http://dx.doi.org/10.1016/S2215-0366(19)30526-7
O'Keeffe E; Kelly E; Liu Y; Giordano C; Wallace E; Hynes M; Tiernan S; Meagher A; Greene C; Hughes S; Burke T; Kealy J; Doyle N; Hay A; Farrell M; Grant GA; Friedman A; Veksler R; Molloy MG; Meaney JF; Pender N; Camarillo D; Doherty CP; Campbell M, 2020, 'Dynamic Blood-Brain Barrier Regulation in Mild Traumatic Brain Injury.', J Neurotrauma, vol. 37, pp. 347 - 356, http://dx.doi.org/10.1089/neu.2019.6483
Jacka B; Larance B; Copeland J; Burns L; Farrell M; Jackson E; Degenhardt L, 2020, 'Health care engagement behaviors of men who use performance- and image-enhancing drugs in Australia', Substance Abuse, vol. 41, pp. 139 - 145, http://dx.doi.org/10.1080/08897077.2019.1635954
Nielsen S; Picco L; Campbell G; Lintzeris N; Larance B; Farrell M; Degenhardt L; Bruno R, 2020, 'Development of a brief patient-administered screening tool for prescription opioid dependence for primary care settings', Pain Medicine (United States), vol. 21, pp. E79 - E88, http://dx.doi.org/10.1093/pm/pnz213
Peacock A; Gisev N; Memedovic S; Larance B; Brown J; Cairns R; Buckley N; Farrell M; Degenhardt L, 2020, 'Opioid use and harms associated with a sustained-release tapentadol formulation: A post-marketing surveillance study.', Drug Alcohol Depend, vol. 206, pp. 107697, http://dx.doi.org/10.1016/j.drugalcdep.2019.107697
Fischer B; Daldegan-Bueno D; Bell R; Boden JM; Bullen C; Farrell M; Hall W; Newcombe D, 2020, 'The Lower-Risk Cannabis Use Guidelines (LRCUG): A ready-made targeted prevention tool for cannabis in New Zealand.', Public Health Pract (Oxf), vol. 1, pp. 100046, http://dx.doi.org/10.1016/j.puhip.2020.100046
O'Halloran PJ; Amoo M; Johnson D; Corr P; Nolan D; Farrell M; Caird J, 2020, 'Sports & exercise related traumatic brain injury in the Republic of Ireland - The neurosurgical perspective.', J Clin Neurosci, vol. 81, pp. 416 - 420, http://dx.doi.org/10.1016/j.jocn.2020.10.015
Paramanandam V; Olszewska DA; Shakya B; Chalissery AJ; O'Connell M; Farrell M; Lynch T, 2020, 'Reply to Comment on: A 57-Year-Old Woman With Progressive Left Hand Clumsiness and Falls.', Mov Disord Clin Pract, vol. 7, pp. 581 - 582, http://dx.doi.org/10.1002/mdc3.12964
Fearon C; Loftus T; Byrne AL; Heffernan J; Cooney M; Heeney C; Walsh A; Lorigan J; Beausang A; Cryan J; Farrell M; Brett F, 2020, 'Impact of the 2016 World Health Organization Classification of Tumours of the Central Nervous System: an Irish experience.', Ir J Med Sci, vol. 189, pp. 799 - 803, http://dx.doi.org/10.1007/s11845-019-02144-y
Ma J; Bao YP; Wang RJ; Su MF; Liu MX; Li JQ; Degenhardt L; Farrell M; Blow FC; Ilgen M; Shi J; Lu L, 2019, 'Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis', Molecular Psychiatry, vol. 24, pp. 1868 - 1883, http://dx.doi.org/10.1038/s41380-018-0094-5
Gisev N; Nielsen S; Campbell G; Santo T; Mant A; Bruno R; Cohen M; Hall WD; Larance B; Lintzeris N; Farrell M; Degenhardt L, 2019, 'Antidepressant Use among People Prescribed Opioids for Chronic Noncancer Pain', Pain Medicine (United States), vol. 20, pp. 2450 - 2458, http://dx.doi.org/10.1093/pm/pnz009
Black N; Stockings E; Campbell G; Tran LT; Zagic D; Hall WD; Farrell M; Degenhardt L, 2019, 'Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis', The Lancet Psychiatry, vol. 6, pp. 995 - 1010, http://dx.doi.org/10.1016/S2215-0366(19)30401-8
Peacock A; Bruno R; Gisev N; Degenhardt L; Hall W; Sedefov R; White J; Thomas KV; Farrell M; Griffiths P, 2019, 'New psychoactive substances: challenges for drug surveillance, control, and public health responses', The Lancet, vol. 394, pp. 1668 - 1684, http://dx.doi.org/10.1016/S0140-6736(19)32231-7
Farrell M; Martin NK; Stockings E; Bórquez A; Cepeda JA; Degenhardt L; Ali R; Tran LT; Rehm J; Torrens M; Shoptaw S; McKetin R, 2019, 'Responding to global stimulant use: challenges and opportunities', The Lancet, vol. 394, pp. 1652 - 1667, http://dx.doi.org/10.1016/S0140-6736(19)32230-5
Darke S; Farrell M; Duflou J; Larance B; Lappin J, 2019, 'Circumstances of death of opioid users being treated with naltrexone', Addiction, vol. 114, pp. 2000 - 2007, http://dx.doi.org/10.1111/add.14729
Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2019, 'Characteristics and circumstances of death related to new psychoactive stimulants and hallucinogens in Australia', Drug and Alcohol Dependence, vol. 204, pp. 107556, http://dx.doi.org/10.1016/j.drugalcdep.2019.107556
McKetin R; Leung J; Stockings E; Huo Y; Foulds J; Lappin JM; Cumming C; Arunogiri S; Young JT; Sara G; Farrell M; Degenhardt L, 2019, 'Mental health outcomes associated with of the use of amphetamines: A systematic review and meta-analysis', EClinicalMedicine, vol. 16, pp. 81 - 97, http://dx.doi.org/10.1016/j.eclinm.2019.09.014
Degenhardt L; Wolfe D; Hall W; Hickman M; Chang J; Bruneau J; Farrell M; Griffiths P, 2019, 'Strategies to reduce drug-related harm: responding to the evidence base', The Lancet, vol. 394, pp. 1490 - 1493, http://dx.doi.org/10.1016/S0140-6736(19)32232-9
Stockings E; Tran LT; Santo T; Peacock A; Larney S; Santomauro D; Farrell M; Degenhardt L, 2019, 'Mortality among people with regular or problematic use of amphetamines: a systematic review and meta-analysis', Addiction, vol. 114, pp. 1738 - 1750, http://dx.doi.org/10.1111/add.14706
Darke S; Duflou J; Kaye S; Farrell M; Lappin J, 2019, 'Psychostimulant Use and Fatal Stroke in Young Adults', Journal of Forensic Sciences, vol. 64, pp. 1421 - 1426, http://dx.doi.org/10.1111/1556-4029.14056
Gisev N; Bharat C; Larney S; Dobbins T; Weatherburn D; Hickman M; Farrell M; Degenhardt L, 2019, 'The effect of entry and retention in opioid agonist treatment on contact with the criminal justice system among opioid-dependent people: a retrospective cohort study', The Lancet Public Health, vol. 4, pp. e334 - e342, http://dx.doi.org/10.1016/S2468-2667(19)30060-X
Darke S; Duflou J; Kaye S; Farrell M; Lappin J, 2019, 'Body mass index and fatal stroke in young adults: A national study', Journal of Forensic and Legal Medicine, vol. 63, pp. 1 - 6, http://dx.doi.org/10.1016/j.jflm.2019.02.003
Peacock A; Larance B; Bruno R; Pearson SA; Buckley NA; Farrell M; Degenhardt L, 2019, 'Post-marketing studies of pharmaceutical opioid abuse-deterrent formulations: a framework for research design and reporting', Addiction, vol. 114, pp. 389 - 399, http://dx.doi.org/10.1111/add.14380
Peacock A; Larance B; Bruno R; Pearson SA; Buckley NA; Farrell M; Degenhardt L, 2019, 'Effectiveness and framing of pharmaceutical opioid abuse-deterrent formulations', Addiction, vol. 114, pp. 404 - 405, http://dx.doi.org/10.1111/add.14556
Boland VC; Mattick RP; Siahpush M; Barker D; Doran CM; Martire KA; Bonevski B; McRobbie H; Borland R; Farrell M; West R; Courtney RJ, 2019, 'Factors associated with Quitline and pharmacotherapy utilisation among low-socioeconomic status smokers', Addictive Behaviors, vol. 89, pp. 113 - 120, http://dx.doi.org/10.1016/j.addbeh.2018.09.029
Grebely J; Larney S; Peacock A; Colledge S; Leung J; Hickman M; Vickerman P; Blach S; Cunningham EB; Dumchev K; Lynskey M; Stone J; Trickey A; Razavi H; Mattick RP; Farrell M; Dore GJ; Degenhardt L, 2019, 'Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs', Addiction, vol. 114, pp. 150 - 166, http://dx.doi.org/10.1111/add.14393
Thomas D; Farrell M; McRobbie H; Tutka P; Petrie D; West R; Siahpush M; Gartner C; Walker N; Mendelsohn CP; Hall W; Paul C; Zwar N; Ferguson SG; Boland VC; Richmond R; Doran CM; Shakeshaft A; Mattick RP; Courtney RJ, 2019, 'The effectiveness, safety and cost-effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non-inferiority trial', Addiction, http://dx.doi.org/10.1111/add.14541
Kearney H; Price T; Cryan J; Beausang A; Looby S; Brett FM; Farrell M, 2019, 'Acute multiple sclerosis lesion pathology does not predict subsequent clinical course-a biopsy study.', Ir J Med Sci, vol. 188, pp. 1427 - 1434, http://dx.doi.org/10.1007/s11845-019-01983-z
Paramanandam V; Olszewska DA; Shakya B; Chalissery AJ; O'Connell M; Farrell M; Lynch T, 2019, 'A 57-Year-Old Woman With Progressive Left Hand Clumsiness and Falls.', Mov Disord Clin Pract, vol. 6, pp. 656 - 660, http://dx.doi.org/10.1002/mdc3.12825
Duffy S; McCarthy R; Farrell M; Thomas S; Brennan P; Power S; O'Hare A; Morris L; Rainsford E; MacCarthy E; Thornton J; Gilvarry M, 2019, 'Per-Pass Analysis of Thrombus Composition in Patients With Acute Ischemic Stroke Undergoing Mechanical Thrombectomy.', Stroke, vol. 50, pp. 1156 - 1163, http://dx.doi.org/10.1161/STROKEAHA.118.023419
Mohammed W; Farrell M; Bolger C, 2019, 'Spinal Cord Ependymoma - Surgical Management and Outcome.', J Neurosci Rural Pract, vol. 10, pp. 316 - 320, http://dx.doi.org/10.4103/jnrp.jnrp_267_18
Darke S; Farrell M, 2018, 'Burroughs’ ‘Letter from a master addict to dangerous drugs’: a forgotten classic', Addiction, vol. 113, pp. 2305 - 2308, http://dx.doi.org/10.1111/add.14391
Lucke J; Jensen C; Dunn M; Chan G; Forlini C; Kaye S; Partridge B; Farrell M; Racine E; Hall W, 2018, 'Non-medical prescription stimulant use to improve academic performance among Australian university students: Prevalence and correlates of use', BMC Public Health, vol. 18, pp. 1270, http://dx.doi.org/10.1186/s12889-018-6212-0
Budohoski K; Clerkin J; Millward C; O’Halloran P; Waqar M; Looby S; Young A; Guilfoyle M; Fitzroll D; Devadass A; Allinson K; Farrell M; Javadpour M; Jenkinson M; Santarius T; Kirollos R, 2018, 'MNGI-10. PREDICTORS OF EARLY PROGRESSION OF SURGICALLY TREATED ATYPICAL MENINGIOMAS', Neuro-Oncology, vol. 20, pp. vi150 - vi150, http://dx.doi.org/10.1093/neuonc/noy148.626
Peacock A; Leung J; Larney S; Colledge S; Hickman M; Rehm J; Giovino GA; West R; Hall W; Griffiths P; Ali R; Gowing L; Marsden J; Ferrari AJ; Grebely J; Farrell M; Degenhardt L, 2018, 'Global statistics on alcohol, tobacco and illicit drug use: 2017 status report', Addiction, vol. 113, pp. 1905 - 1926, http://dx.doi.org/10.1111/add.14234
Thomas T; Farrell M; McRobbie H; Tutka P; Petrie D; West R; Siahpush M; Gartner C; Walker N; Mendelsohn C; Hall W; Paul C; Zwar N; Ferguson S; Veronica B; Richmond R; Doran C; Shakeshaft A; Mattick R; Courtney R, 2018, 'The effectiveness, safety and cost-effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non-inferiority trial', Addiction, http://dx.doi.org/10.1111/add.14541
Hall WD; Farrell M, 2018, 'The challenges in providing safe, effective, affordable cannabis-based medicines for unapproved indications', Medical Journal of Australia, vol. 209, pp. 209 - 210, http://dx.doi.org/10.5694/MJA18.00445
Hobden B; Bryant J; Carey M; Baker AL; Farrell M; Oldmeadow C; Mattick RP; Shakeshaft A; Sanson-Fisher R, 2018, 'Finding the optimal treatment model: A systematic review of treatment for co-occurring alcohol misuse and depression', Australian and New Zealand Journal of Psychiatry, vol. 52, pp. 737 - 750, http://dx.doi.org/10.1177/0004867418758922
Stockings E; Zagic D; Campbell G; Weier M; Hall WD; Nielsen S; Herkes GK; Farrell M; Degenhardt L, 2018, 'Evidence for cannabis and cannabinoids for epilepsy: A systematic review of controlled and observational evidence', Journal of Neurology, Neurosurgery and Psychiatry, vol. 89, pp. 741 - 753, http://dx.doi.org/10.1136/jnnp-2017-317168
Campbell G; Hall WD; Peacock A; Lintzeris N; Bruno R; Larance B; Nielsen S; Cohen M; Chan G; Mattick RP; Blyth F; Shanahan M; Dobbins T; Farrell M; Degenhardt L, 2018, 'Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study', The Lancet Public Health, vol. 3, pp. e341 - e350, http://dx.doi.org/10.1016/S2468-2667(18)30110-5
Hall WD; Farrell M, 2018, 'Reducing the opioid overdose death toll in North America', PLoS Medicine, vol. 15, http://dx.doi.org/10.1371/journal.pmed.1002626
Lappin JM; Darke S; Farrell M, 2018, 'Methamphetamine use and future risk for Parkinson's disease: Evidence and clinical implications', Drug and Alcohol Dependence, vol. 187, pp. 134 - 140, http://dx.doi.org/10.1016/j.drugalcdep.2018.02.032
Stockings E; Shakeshaft A; Farrell M, 2018, 'Community Approaches for Reducing Alcohol-Related Harms: an Overview of Intervention Strategies, Efficacy, and Considerations for Future Research', Current Addiction Reports, vol. 5, pp. 274 - 286, http://dx.doi.org/10.1007/s40429-018-0210-2
Hall W; Farrell M, 2018, 'Prisoners and risk of injury after release', The Lancet Public Health, vol. 3, pp. e209 - e210, http://dx.doi.org/10.1016/S2468-2667(18)30073-2
Capper D; Jones DTW; Sill M; Hovestadt V; Schrimpf D; Sturm D; Koelsche C; Sahm F; Chavez L; Reuss DE; Kratz A; Wefers AK; Huang K; Pajtler KW; Schweizer L; Stichel D; Olar A; Engel NW; Lindenberg K; Harter PN; Braczynski AK; Plate KH; Dohmen H; Garvalov BK; Coras R; Hölsken A; Hewer E; Bewerunge-Hudler M; Schick M; Fischer R; Beschorner R; Schittenhelm J; Staszewski O; Wani K; Varlet P; Pages M; Temming P; Lohmann D; Selt F; Witt H; Milde T; Witt O; Aronica E; Giangaspero F; Rushing E; Scheurlen W; Geisenberger C; Rodriguez FJ; Becker A; Preusser M; Haberler C; Bjerkvig R; Cryan J; Farrell M; Deckert M; Hench J; Frank S; Serrano J; Kannan K; Tsirigos A; Brück W; Hofer S; Brehmer S; Seiz-Rosenhagen M; Hänggi D; Hans V; Rozsnoki S; Hansford JR; Kohlhof P; Kristensen BW; Lechner M; Lopes B; Mawrin C; Ketter R; Kulozik A; Khatib Z; Heppner F; Koch A; Jouvet A; Keohane C; Mühleisen H; Mueller W; Pohl U; Prinz M; Benner A; Zapatka M; Gottardo NG; Driever PH; Kramm CM; Müller HL; Rutkowski S; von Hoff K; Frühwald MC; Gnekow A; Fleischhack G; Tippelt S; Calaminus G; Monoranu C-M; Perry A; Jones C; Jacques TS; Radlwimmer B; Gessi M; Pietsch T; Schramm J; Schackert G; Westphal M; Reifenberger G; Wesseling P; Weller M; Collins VP; Blümcke I; Bendszus M; Debus J; Huang A; Jabado N; Northcott PA; Paulus W; Gajjar A; Robinson GW; Taylor MD; Jaunmuktane Z; Ryzhova M; Platten M; Unterberg A; Wick W; Karajannis MA; Mittelbronn M; Acker T; Hartmann C; Aldape K; Schüller U; Buslei R; Lichter P; Kool M; Herold-Mende C; Ellison DW; Hasselblatt M; Snuderl M; Brandner S; Korshunov A; von Deimling A; Pfister SM, 2018, 'DNA methylation-based classification of central nervous system tumours.', Nature, vol. 555, pp. 469 - 474, http://dx.doi.org/10.1038/nature26000
Nielsen S; Larney S; Farrell M, 2018, 'Commentary on McDonald et al. (2018): Intranasal naloxone—from the laboratory to the real world', Addiction, vol. 113, pp. 494 - 495, http://dx.doi.org/10.1111/add.14087
Peacock A; Larance B; Farrell M; Cairns R; Buckley N; Degenhardt L, 2018, 'Opioid use and harms associated with a sustained-release tapentadol formulation: A postmarketing study protocol', BMJ Open, vol. 8, http://dx.doi.org/10.1136/bmjopen-2017-020006
Larance B; Dobbins T; Peacock A; Ali R; Bruno R; Lintzeris N; Farrell M; Degenhardt L, 2018, 'The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) study', The Lancet Psychiatry, vol. 5, pp. 155 - 166, http://dx.doi.org/10.1016/S2215-0366(18)30003-8
Nielsen S; Germanos R; Weier M; Pollard J; Degenhardt L; Hall W; Buckley N; Farrell M, 2018, 'The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews', Current Neurology and Neuroscience Reports, vol. 18, http://dx.doi.org/10.1007/s11910-018-0814-x
Stockings E; Campbell G; Hall WD; Nielsen S; Zagic D; Rahman R; Murnion B; Farrell M; Weier M; Degenhardt L, 2018, 'Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: A systematic review and meta-analysis of controlled and observational studies', Pain, vol. 159, pp. 1932 - 1954, http://dx.doi.org/10.1097/j.pain.0000000000001293
Rumpf HJ; Achab S; Billieux J; Bowden-Jones H; Carragher N; Demetrovics Z; Higuchi S; King DL; Mann K; Potenza M; Saunders JB; Abbott M; Ambekar A; Aricak OT; Assanangkornchai S; Bahar N; Borges G; Brand M; Mei-Lo Chan E; Chung T; Derevensky J; El Kashef A; Farrell M; Fineberg NA; Gandin C; Gentile DA; Griffiths MD; Goudriaan AE; Grall-Bronnec M; Hao W; Hodgins DC; Ip P; Király O; Lee HK; Kuss D; Lemmens JS; Long J; Lopez-Fernandez O; Mihara S; Petry NM; Pontes HM; Rahimi-Movaghar A; Rehbein F; Rehm J; Scafato E; Sharma M; Spritzer D; Stein DJ; Tam P; Weinstein A; Wittchen HU; Wölfling K; Zullino D; Poznyak V, 2018, 'Including gaming disorder in the ICD-11: The need to do so from a clinical and public health perspective: Commentary on: A weak scientific basis for gaming disorder: Let us err on the side of caution (van Rooij et al., 2018)', Journal of Behavioral Addictions, vol. 7, pp. 556 - 561, http://dx.doi.org/10.1556/2006.7.2018.59
Lappin JM; Darke S; Duflou J; Kaye S; Farrell M, 2018, 'Fatal stroke in pregnancy and the puerperium: Case series', Stroke, vol. 49, pp. 3050 - 3053, http://dx.doi.org/10.1161/STROKEAHA.118.023274
McGlacken-Byrne SM; Gorman KM; Lagan NK; Robinson I; Farrell M; King MD, 2018, 'Identification of Leptomeningeal Medulloblastoma with Contrast-Enhanced Magnetic Resonance Imaging: A Devastating Differential of Acute Disseminated Encephomyelitis.', J Paediatr Child Health, vol. 54, pp. 929 - 930, http://dx.doi.org/10.1111/jpc.14094
Hanley BP; Walsh S; O'Leary DP; MacNally SP; Power C; Farrell M; Hill A, 2018, 'Reply Letter to the Editor.', Breast J, vol. 24, pp. 1141, http://dx.doi.org/10.1111/tbj.13107
Budohoski KP; Clerkin J; Millward CP; O'Halloran PJ; Waqar M; Looby S; Young AMH; Guilfoyle MR; Fitzroll D; Devadass A; Allinson K; Farrell M; Javadpour M; Jenkinson MD; Santarius T; Kirollos RW, 2018, 'Predictors of early progression of surgically treated atypical meningiomas.', Acta Neurochir (Wien), vol. 160, pp. 1813 - 1822, http://dx.doi.org/10.1007/s00701-018-3593-x
De Looze C; Beausang A; Cryan J; Loftus T; Buckley PG; Farrell M; Looby S; Reilly R; Brett F; Kearney H, 2018, 'Machine learning: a useful radiological adjunct in determination of a newly diagnosed glioma's grade and IDH status.', J Neurooncol, vol. 139, pp. 491 - 499, http://dx.doi.org/10.1007/s11060-018-2895-4
Hanley BP; Walsh SM; O'Leary DP; MacNally SP; Power C; Farrell M; Hill AD, 2018, 'The significance of receptor status discordance between breast cancer primary and brain metastasis.', Breast J, vol. 24, pp. 683 - 685, http://dx.doi.org/10.1111/tbj.13028
Pilson K; Farrell M; Lynch B; Devaney D, 2018, 'A Case of Juvenile Onset Neuronal Intranuclear Inclusion Disease With a Negative Antemortem Skin Biopsy.', Pediatr Dev Pathol, vol. 21, pp. 494 - 496, http://dx.doi.org/10.1177/1093526617724293
Zia-Ul-Hussnain HM; Farrell M; Looby S; Tormey W; Javadpour M; Mcconkey S; Thompson CJ, 2018, 'Pituitary tuberculoma: a rare cause of sellar mass.', Ir J Med Sci, vol. 187, pp. 461 - 464, http://dx.doi.org/10.1007/s11845-017-1654-4
Larney S; Farrell M, 2017, 'Prisoner suicide: a multilevel problem', The Lancet Psychiatry, vol. 4, pp. 894 - 895, http://dx.doi.org/10.1016/S2215-0366(17)30435-2
Mc Govern EM; Killian O; Narasimham S; Quinlivan B; Butler JB; Beck R; Beiser I; Williams LW; Killeen RP; Farrell M; O'Riordan S; Reilly RB; Hutchinson M, 2017, 'Disrupted superior collicular activity may reveal cervical dystonia disease pathomechanisms.', Sci Rep, vol. 7, pp. 16753, http://dx.doi.org/10.1038/s41598-017-17074-x
Quinn B; Seed C; Keller A; Maher L; Wilson D; Farrell M; Caris S; Williams J; Madden A; Thompson A; Pink J; Hellard ME, 2017, 'Re-examining blood donor deferral criteria relating to injecting drug use', International Journal of Drug Policy, vol. 48, pp. 9 - 17, http://dx.doi.org/10.1016/j.drugpo.2017.05.058
Martire KA; clare P; courtney R; bonevski B; boland V; borland R; Doran C; Farrell M; hall W; Iredale J; siahpush M; mattick R, 2017, 'Smoking and Finances: Baseline Characteristics of Low Income Daily Smokers in the FISCALS Cohort', International Journal for Equity in Health, vol. 16, http://dx.doi.org/10.1186/s12939-017-0643-6
Lappin JM; Darke S; Farrell M, 2017, 'Stroke and methamphetamine use in young adults: a review', Journal of Neurology Neuropsychiatry and Psychiatry, vol. 88, pp. 1079 - 1091, http://dx.doi.org/10.1136/jnnp-2017-316071
Bonevski B; Borland R; Paul CL; Richmond RL; Farrell M; Baker A; Gartner CE; Lawn S; Thomas DP; Walker N, 2017, 'No smoker left behind: It’s time to tackle tobacco in Australian priority populations', Medical Journal of Australia, vol. 207, pp. 141 - 142, http://dx.doi.org/10.5694/mja16.01425
Marsden J; Stillwell G; Jones H; Cooper A; Eastwood B; Farrell M; Lowden T; Maddalena N; Metcalfe C; Shaw J; Hickman M, 2017, 'Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England', Addiction, vol. 112, pp. 1408 - 1418, http://dx.doi.org/10.1111/add.13779
Nielsen S; Sabioni P; Trigo JM; Ware MA; Betz-Stablein BD; Murnion B; Lintzeris N; Khor KE; Farrell M; Smith A; Le Foll B, 2017, 'Opioid-sparing effect of cannabinoids: A systematic review and meta-analysis', Neuropsychopharmacology, vol. 42, pp. 1752 - 1765, http://dx.doi.org/10.1038/npp.2017.51
Lappin JM; Sara GE; Farrell M, 2017, 'Methamphetamine-related psychosis: an opportunity for assertive intervention and prevention', Addiction, vol. 112, pp. 927 - 928, http://dx.doi.org/10.1111/add.13663
Stockings E; Farrell M, 2017, 'Drinking-reduction goals offer potential to widen the options for measuring and treating alcohol dependence', The Lancet Psychiatry, vol. 4, pp. 430 - 431, http://dx.doi.org/10.1016/S2215-0366(17)30187-6
Saunders JB; Degenhardt L; Farrell M, 2017, 'Excessive gambling and gaming: addictive disorders?', The Lancet Psychiatry, vol. 4, pp. 433 - 435, http://dx.doi.org/10.1016/S2215-0366(17)30210-9
Kenny C; Healy GM; Redmond CE; Farrell M; Connaghan G; McGuigan C; Killeen RP, 2017, 'FDG PET diagnosis of primary intracranial lymphoma: radiology-pathology correlation.', QJM, vol. 110, pp. 317 - 318, http://dx.doi.org/10.1093/qjmed/hcx054
Degenhardt L; Sara G; McKetin R; Roxburgh A; Dobbins T; Farrell M; Burns L; Hall WD, 2017, 'Crystalline methamphetamine use and methamphetamine-related harms in Australia', Drug and Alcohol Review, vol. 36, pp. 160 - 170, http://dx.doi.org/10.1111/dar.12426
Darke S; Larney S; Farrell M, 2017, 'Yes, people can die from opiate withdrawal', Addiction, vol. 112, pp. 199 - 200, http://dx.doi.org/10.1111/add.13512
Campbell G; Bruno R; Cohen M; Hall W; Nielsen S; Lintzeris N; Larance B; Mattick RP; Farrell M; Degenhardt L, 2017, 'Defining problematic pharmaceutical opioid use among people prescribed opioids for chronic non-cancer pain: Different measures, same patients?', DRUG AND ALCOHOL DEPENDENCE, vol. 171, pp. E33 - E33, http://dx.doi.org/10.1016/j.drugalcdep.2016.08.103
Courtney RJ; Clare P; Boland V; Martire KA; Bonevski B; Hall W; Siahpush M; Borland R; Doran CM; West R; Farrell M; Mattick RP, 2017, 'Predictors of retention in a randomised trial of smoking cessation in low-socioeconomic status Australian smokers', Addictive Behaviors, vol. 64, pp. 13 - 20, http://dx.doi.org/10.1016/j.addbeh.2016.07.019
Van Buskirk J; Griffiths P; Farrell M; Degenhardt L, 2017, 'Trends in new psychoactive substances from surface and “dark” net monitoring', The Lancet Psychiatry, vol. 4, pp. 16 - 18, http://dx.doi.org/10.1016/S2215-0366(16)30405-9
Saunders JB; Hao W; Long J; King DL; Mann K; Fauth-Bühler M; Rumpf HJ; Bowden-Jones H; Rahimi-Movaghar A; Chung T; Chan E; Bahar N; Achab S; Lee HK; Potenza M; Petry N; Spritzer D; Ambekar A; Derevensky J; Griffiths MD; Pontes HM; Kuss D; Higuchi S; Mihara S; Assangangkornchai S; Sharma M; El Kashef A; Ip P; Farrell M; Scafato E; Carragher N; Poznyak V, 2017, 'Gaming disorder: Its delineation as an important condition for diagnosis, management, and prevention', Journal of Behavioral Addictions, vol. 6, pp. 271 - 279, http://dx.doi.org/10.1556/2006.6.2017.039
Ritter A; Hoang VP; Cao VL; Shanahan M; Shukla N; Perez P; Farrell M, 2017, 'Modelling heroin careers over 40 years: Social costs', Drug and Alcohol Dependence, vol. 171, pp. e177 - e177, http://dx.doi.org/10.1016/j.drugalcdep.2016.08.486
Farrelly L; Rosato-Siri MV; Föcking M; Codagnone M; Reines A; Dicker P; Wynne K; Farrell M; Cannon M; Cagney G; Pasquini JM; Cotter DR, 2017, 'The Effects of Prenatal Iron Deficiency and Risperidone Treatment on the Rat Frontal Cortex: A Proteomic Analysis.', Proteomics, vol. 17, http://dx.doi.org/10.1002/pmic.201600407
Jenkinson MD; Javadpour M; Haylock BJ; Young B; Bulbeck H; Farrell M; Preusser M; Hughes D; Gamble C; Weber D, 2017, 'P12.10 The ROAM / EORTC 1308 trial: Radiation versus observation following surgical resection of atypical meningioma - study update', Neuro-Oncology, vol. 19, pp. iii97 - iii97, http://dx.doi.org/10.1093/neuonc/nox036.368
Stillwell G; Jones H; Shaw J; Farrell M; Marsden J, 2017, 'An evaluation of opioid substitution treatment in prison on risk of mortality in period immediately after prison: Does leaving prison on OST reduce the risk of death?', Drug and Alcohol Dependence, vol. 171, pp. e197 - e197, http://dx.doi.org/10.1016/j.drugalcdep.2016.08.538
McGovern EM; Foley M; Looby S; Connolly S; Farrell M; Healy DG, 2017, 'Pseudomonoballismus in a Deafferented Arm Following Combined Medullary and Cerebellar Lesions of the Proprioceptive Pathways.', Mov Disord Clin Pract, vol. 4, pp. 455 - 457, http://dx.doi.org/10.1002/mdc3.12417
Fisher A; Rahman H; Farrell M; Hennessy M, 2017, 'Progressive Fatal Myelopathy Secondary to Isolated Spinal Cord Vasculitis.', Front Neurol, vol. 8, pp. 705, http://dx.doi.org/10.3389/fneur.2017.00705
Candy S; Ma I; McMahon JM; Farrell M; Mychasiuk R, 2017, 'Staying in the game: a pilot study examining the efficacy of protective headgear in an animal model of mild traumatic brain injury (mTBI).', Brain Inj, vol. 31, pp. 1521 - 1529, http://dx.doi.org/10.1080/02699052.2017.1363407
Kamel K; Farrell M; O'Brien C, 2017, 'Mitochondrial dysfunction in ocular disease: Focus on glaucoma.', Mitochondrion, vol. 35, pp. 44 - 53, http://dx.doi.org/10.1016/j.mito.2017.05.004
Duffy S; Farrell M; McArdle K; Thornton J; Vale D; Rainsford E; Morris L; Liebeskind DS; MacCarthy E; Gilvarry M, 2017, 'Novel methodology to replicate clot analogs with diverse composition in acute ischemic stroke.', J Neurointerv Surg, vol. 9, pp. 486 - 491, http://dx.doi.org/10.1136/neurintsurg-2016-012308
Sweeney KJ; Reynolds M; Farrell M; Bolger C, 2017, 'Gross total resection rates of grade II/III intramedullary ependymomas using the surgical strategy of en-bloc resection without intra-operative neurophysiological monitoring.', Br J Neurosurg, vol. 31, pp. 364 - 368, http://dx.doi.org/10.1080/02688697.2016.1270419
Gorman KM; Aird JJ; Conroy J; Devaney D; Farrell M; King MD, 2017, 'Symmetrical thalamic calcification: A trio whole exome sequencing negative series.', Brain Dev, vol. 39, pp. 426 - 430, http://dx.doi.org/10.1016/j.braindev.2016.12.001
Nielsen S; Menon N; Larney S; Farrell M; Degenhardt L, 2016, 'Community pharmacist knowledge, attitudes and confidence regarding naloxone for overdose reversal', Addiction, vol. 111, pp. 2177 - 2186, http://dx.doi.org/10.1111/add.13517
Lappin JM; Roxburgh A; Kaye S; Chalmers J; Sara G; Dobbins T; Burns L; Farrell M, 2016, 'Increased prevalence of self-reported psychotic illness predicted by crystal methamphetamine use: Evidence from a high-risk population', International Journal of Drug Policy, vol. 38, pp. 16 - 20, http://dx.doi.org/10.1016/j.drugpo.2016.10.018
Marsden J; Stillwell G; Jones H; Cooper A; Eastwood B; Farrell M; Lowden T; Maddalena N; Metcalf C; Shaw J; Hickman M, 2016, 'Does exposure to opioid substitution treatment at prison release reduce the risk of death? A prospective, observational study in England', LANCET, vol. 388, pp. 11 - 11, http://dx.doi.org/10.1016/s0140-6736(16)32247-4
Darke S; Farrell M, 2016, 'Commentary on Singh et al. (2016): Still searching for the answer', Addiction, vol. 111, pp. 1347, http://dx.doi.org/10.1111/add.13369
Gethin A; Trimingham T; Chang T; Farrell M; Ross J, 2016, 'Coping with problematic drug use in the family: An evaluation of the Stepping Stones program', Drug and Alcohol Review, vol. 35, pp. 470 - 476, http://dx.doi.org/10.1111/dar.12327
Campbell G; Bruno R; Lintzeris N; Cohen M; Nielsen S; Hall W; Larance B; Mattick RP; Blyth F; Farrell M; Degenhardt L, 2016, 'Defining problematic pharmaceutical opioid use among people prescribed opioids for chronic noncancer pain: Do different measures identify the same patients?', Pain, vol. 157, pp. 1489 - 1498, http://dx.doi.org/10.1097/j.pain.0000000000000548
Bonevski B; Guillaumier A; Shakeshaft A; Farrell M; Tzelepis F; Walsberger S; D'Este C; Paul C; Dunlop A; Searles A; Kelly P; Fry R; Stirling R; Fowlie C; Skelton E, 2016, 'An organisational change intervention for increasing the delivery of smoking cessation support in addiction treatment centres: Study protocol for a randomized controlled trial', Trials, vol. 17, http://dx.doi.org/10.1186/s13063-016-1401-6
Gowing L; Farrell M; Ali R; White JM, 2016, 'Alpha
Darke S; Farrell M, 2016, 'Which medications are suitable for agonist drug maintenance?', Addiction, vol. 111, pp. 767 - 774, http://dx.doi.org/10.1111/add.13158
Darke S; Farrell M, 2016, 'Response to commentaries on 'Which medications are suitable for agonist drug maintenance'', Addiction, vol. 111, pp. 781 - 782, http://dx.doi.org/10.1111/add.13359
Hoang VP; Shanahan M; Shukla N; Perez P; Farrell M; Ritter A, 2016, 'A systematic review of modelling approaches in economic evaluations of health interventions for drug and alcohol problems', BMC Health Services Research, vol. 16, http://dx.doi.org/10.1186/s12913-016-1368-8
Campbell G; Bruno R; Darke S; Shand F; Hall W; Farrell M; Degenhardt L, 2016, 'Prevalence and correlates of suicidal thoughts and suicide attempts in people prescribed pharmaceutical opioids for chronic pain', Clinical Journal of Pain, vol. 32, pp. 292 - 301, http://dx.doi.org/10.1097/AJP.0000000000000283
Larney S; Degenhardt L; Farrell M, 2016, 'Response to Bird et al.: The importance of post-release engagement in treatment in estimating impacts on post-release deaths', Addiction, vol. 111, pp. 560 - 561, http://dx.doi.org/10.1111/add.13208
Larney S; Farrell M, 2016, 'Commentary on Binswanger et al. (2016): Multiple opportunities exist to improve the health and wellbeing of people released from prisons', Addiction, vol. 111, pp. 511 - 512, http://dx.doi.org/10.1111/add.13245
Farrell M, 2016, 'Swift and certain approaches to reduce alcohol reoffending', The Lancet Psychiatry, vol. 3, pp. 189 - 190, http://dx.doi.org/10.1016/S2215-0366(15)00519-2
Wilson AJ; Bonevski B; Dunlop A; Shakeshaft A; Tzelepis F; Walsberger S; Farrell M; Kelly PJ; Guillaumier A, 2016, ''The lesser of two evils': A qualitative study of staff and client experiences and beliefs about addressing tobacco in addiction treatment settings', Drug and Alcohol Review, vol. 35, pp. 92 - 101, http://dx.doi.org/10.1111/dar.12322
Darke S; Farrell M, 2016, 'The twenty-first century opioid epidemic: What is happening and what can be done?', The Addictions Newsletter, vol. Spring, pp. 18 - 20, http://www.apa.org/divisions/div50/Newsletters/tan-spring-2016.pdf
Ritter A; Schukla N; Shanahan M; Hoang P; Cao L; Perez P; Farrell M, 2016, 'Building a Microsimulation Model of Heroin Use Careers in Australia', The International Journal of Microsimulation, vol. 9, pp. 140 - 176, http://www.microsimulation.org/IJM/V9_3/6_IJM_2016_21_Ritter_edit_final.pdf
Jack E; Kay E; Cummings R; Buckley P; Brett F; Farrell M; Cryan J, 2016, 'LG-07BRAFV600 MUTATION TESTING IN GLIOMA IN MODERN CLINICAL PRACTICE', Neuro-Oncology, vol. 18, pp. iii79.5 - iii80, http://dx.doi.org/10.1093/neuonc/now075.07
Doherty CP; O'Keefe E; Wallace E; Loftus T; Keaney J; Kealy J; Humphries MM; Molloy MG; Meaney JF; Farrell M; Campbell M, 2016, 'Blood-Brain Barrier Dysfunction as a Hallmark Pathology in Chronic Traumatic Encephalopathy.', J Neuropathol Exp Neurol, vol. 75, pp. 656 - 662, http://dx.doi.org/10.1093/jnen/nlw036
Yap SM; Farrell M; Cryan J; Smyth S, 2016, 'An irish case of limb-girdle muscular dystrophy 2I with structural eye involvement.', Muscle Nerve, vol. 54, pp. 509 - 510, http://dx.doi.org/10.1002/mus.25059
Jenkinson MD; Waqar M; Farah JO; Farrell M; Barbagallo GMV; McManus R; Looby S; Hussey D; Fitzpatrick D; Certo F; Javadpour M, 2016, 'Early adjuvant radiotherapy in the treatment of atypical meningioma.', J Clin Neurosci, vol. 28, pp. 87 - 92, http://dx.doi.org/10.1016/j.jocn.2015.09.021
Glynn N; Hannon AM; Farrell M; Brett F; Javadpour M; Agha A, 2016, 'Variable Thyroid-Stimulating Hormone Dynamics in ‘Silent’ Thyrotroph Adenomas', AACE Clinical Case Reports, vol. 2, pp. e155 - e160, http://dx.doi.org/10.4158/ep15841.cr
McEvoy SH; Farrell M; Brett F; Looby S, 2016, 'Haemangioma, an uncommon cause of an extradural or intradural extramedullary mass: case series with radiological pathological correlation.', Insights Imaging, vol. 7, pp. 87 - 98, http://dx.doi.org/10.1007/s13244-015-0432-y
Rutledge S; Chalissery A; O'Connor R; Mahon S; Connolly S; Farrell M; Crowley P; MacSweeney F; Tubridy N, 2016, 'Anti-NMDA-receptor antibody-mediated cortical blindness: a case report.', QJM, vol. 109, pp. 127 - 128, http://dx.doi.org/10.1093/qjmed/hcv151
Stewart W; McNamara PH; Lawlor B; Hutchinson S; Farrell M, 2016, 'Chronic traumatic encephalopathy: a potential late and under recognized consequence of rugby union?', QJM, vol. 109, pp. 11 - 15, http://dx.doi.org/10.1093/qjmed/hcv070
Curtin D; Costigan D; McCarthy C; Jansen M; Farrell M; Reid V; O'Rourke K, 2016, 'Novel antibody associations in immune-mediated necrotising myopathy without inflammation.', Ir J Med Sci, vol. 185, pp. 941 - 943, http://dx.doi.org/10.1007/s11845-014-1207-z
Reynolds MR; Boland MR; Arias EJ; Farrell M; Javadpour M; Caird J, 2016, 'Intraparenchymal meningioma within the basal ganglia of a child: A case report.', Br J Neurosurg, vol. 30, pp. 360 - 362, http://dx.doi.org/10.3109/02688697.2015.1096910
Mayet S; Farrell M; Mani SG, 2015, 'Opioid agonist maintenance for opioid dependent patients in prison', Cochrane Database of Systematic Reviews, vol. 2015, http://dx.doi.org/10.1002/14651858.CD008221.pub2
Jenkinson MD; Javadpour M; Haylock BJ; Young B; Gillard H; Vinten J; Bulbeck H; Das K; Farrell M; Looby S; Hickey H; Preusser M; Mallucci CL; Hughes D; Gamble C; Weber DC, 2015, 'The ROAM/EORTC-1308 trial: Radiation versus Observation following surgical resection of Atypical Meningioma: study protocol for a randomised controlled trial.', Trials, vol. 16, pp. 519, http://dx.doi.org/10.1186/s13063-015-1040-3
Hoban B; Larance B; Gisev N; Nielsen S; Cohen M; Bruno R; Shand F; Lintzeris N; Hall W; Farrell M; Degenhardt L, 2015, 'The use of paracetamol (acetaminophen) among a community sample of people with chronic non-cancer pain prescribed opioids', International Journal of Clinical Practice, vol. 69, pp. 1366 - 1376, http://dx.doi.org/10.1111/ijcp.12716
Nielsen S; Larance B; Lintzeris N; Holliday S; Vanderhaven M; Hordern A; Dunlop A; Haber PS; Murnion B; Silsbury C; Johnson J; Demirkol A; Sadler C; Phung N; Campbell G; Farrell M; Cohen M; Bruno R; Hardy M; Brown A; Houseman J; Degenhardt L, 2015, 'LONGER TERM OUTCOMES FOR PHARMACEUTICAL OPIOID DEPENDENCE: 12 MONTH FINDINGS FROM AN IN-TREATMENT COHORT', DRUG AND ALCOHOL REVIEW, vol. 34, pp. 48 - 48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000367694000129&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Larney S; Degenhardt L; Mattick RP; Farrell M, 2015, 'Variation in mortality risk of people released from prison', The Lancet Psychiatry, vol. 2, pp. 681, http://dx.doi.org/10.1016/S2215-0366(15)00235-7
Farrell M; Marsden J; Strang J, 2015, 'Griffith Edwards, the Addiction Research Unit and research on the criminal justice system', Addiction, vol. 110, pp. 54 - 58, http://dx.doi.org/10.1111/add.12910
Farrell M; Hall W, 2015, 'Heroin-assisted treatment: Has a controversial treatment come of age?', British Journal of Psychiatry, vol. 207, pp. 3 - 4, http://dx.doi.org/10.1192/bjp.bp.114.160986
Smith K; Mattick RP; Bruno R; Nielsen S; Cohen M; Campbell G; Larance B; Farrell M; Degenhardt L, 2015, 'Factors associated with the development of depression in chronic non-cancer pain patients following the onset of opioid treatment for pain', Journal of Affective Disorders, vol. 184, pp. 72 - 80, http://dx.doi.org/10.1016/j.jad.2015.05.049
Noctor E; Gupta S; Brown T; Farrell M; Javadpour M; Costigan C; Agha A, 2015, 'Paediatric cyclical Cushing's disease due to corticotroph cell hyperplasia.', BMC Endocr Disord, vol. 15, pp. 27, http://dx.doi.org/10.1186/s12902-015-0024-3
Degenhardt L; Bruno R; Ali R; Lintzeris N; Farrell M; Larance B, 2015, 'The introduction of a potentially abuse deterrent oxycodone formulation: Early findings from the Australian National Opioid Medications Abuse Deterrence (NOMAD) study', Drug and Alcohol Dependence, vol. 151, pp. 56 - 67, http://dx.doi.org/10.1016/j.drugalcdep.2015.02.038
Davoli M; Amato L; Clark N; Farrell M; Hickman M; Hill S; Magrini N; Poznyak V; Schünemann HJ, 2015, 'The role of Cochrane reviews in informing international guidelines: A case study of using the grading of recommendations, assessment, development and evaluation system to develop World Health Organization guidelines for the psychosocially assisted pharmacological treatment of opioid dependence', Addiction, vol. 110, pp. 891 - 898, http://dx.doi.org/10.1111/add.12788
Darker CD; Sweeney BP; Barry JM; Farrell MF; Donnelly-Swift E, 2015, 'Psychosocial interventions for benzodiazepine harmful use, abuse or dependence', Cochrane Database of Systematic Reviews, vol. 2015, http://dx.doi.org/10.1002/14651858.CD009652.pub2
Minozzi S; Cinquini M; Amato L; Davoli M; Farrell MF; Pani PP; Vecchi S, 2015, 'Anticonvulsants for cocaine dependence', Cochrane Database of Systematic Reviews, vol. 2015, http://dx.doi.org/10.1002/14651858.CD006754.pub4
Knapp WP; Soares BG; Farrell MF; Silva de Lima M, 2015, 'Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders', Cochrane Database of Systematic Reviews, vol. 2015, http://dx.doi.org/10.1002/14651858.CD003023.pub3
Minozzi S; Amato L; Davoli M; Farrell MF; Lima Reisser AARL; Pani PP; Silva de Lima M; Soares BGO; Vecchi S, 2015, 'Anticonvulsants for cocaine dependence', Cochrane Database of Systematic Reviews, vol. 2015, http://dx.doi.org/10.1002/14651858.CD006754.pub3
Farrell M, 2015, 'Demons: Our Changing Attitudes to Alcohol, Tobacco, and Drugs', DRUG AND ALCOHOL REVIEW, vol. 34, pp. 231 - 231, http://dx.doi.org/10.1111/dar.12186
Degenhardt L; Lintzeris N; Campbell G; Bruno R; Cohen M; Farrell M; Hall WD, 2015, 'Experience of adjunctive cannabis use for chronic non-cancer pain: Findings from the Pain and Opioids IN Treatment (POINT) study', Drug and Alcohol Dependence, vol. 147, pp. 144 - 150, http://dx.doi.org/10.1016/j.drugalcdep.2014.11.031
Degenhardt L; Larance B; Bruno R; Lintzeris N; Ali R; Farrell M, 2015, 'Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: The National Opioid Medications Abuse Deterrence (NOMAD) study protocol', Addiction, vol. 110, pp. 226 - 237, http://dx.doi.org/10.1111/add.12746
Degenhardt L; Larney S; Kimber J; Farrell M; Hall W, 2015, 'Excess mortality among opioid-using patients treated with oral naltrexone in Australia', Drug and Alcohol Review, vol. 34, pp. 90 - 96, http://dx.doi.org/10.1111/dar.12205
Hayhurst KP; Leitner M; Davies L; Flentje R; Millar T; Jones A; King C; Donmall M; Farrell M; Faze S; Harris R; Hickman M; Lennox C; Mayet S; Senior J; Shaw J, 2015, 'The effectiveness and cost-effectiveness of diversion and aftercare programmes for offenders using class a drugs: A systematic review and economic evaluation', Health Technology Assessment, vol. 19, pp. 1 - 198, http://dx.doi.org/10.3310/hta19060
Farrell M, 2015, 'Kommentar zum Editorial von Peter Anderson "Reframing the governance of addictions", SUCHT, 60, 2014, 309-311', SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice, vol. 61, pp. 109 - 110, http://dx.doi.org/10.1024/0939-5911.a000358
Degenhardt L; Larance B; Peacock A; Farrell M, 2015, 'Reducing extramedical use and harms of pharmaceutical opioids: The potential role of abuse-deterrent formulations', The Lancet Psychiatry, vol. 2, pp. 957 - 959, http://dx.doi.org/10.1016/S2215-0366(15)00331-4
Degenhardt L; Larney S; Kimber J; Gisev N; Farrell M; Dobbins T; Weatherburn DJ; Gibson A; Mattick R; Butler T; Burns L, 2015, 'The impact of opioid substitution therapy on mortality post-release from prison', Drug and Alcohol Dependence, vol. 146, pp. e260 - e260, http://dx.doi.org/10.1016/j.drugalcdep.2014.09.173
Larney S; Gisev N; Farrell M; Dobbins T; Burns L; Gibson A; Kimber J; Degenhardt L, 2015, 'Opioid substitution therapy as a strategy to reduce deaths in prison: Retrospective cohort study', Drug and Alcohol Dependence, vol. 146, pp. e168 - e168, http://dx.doi.org/10.1016/j.drugalcdep.2014.09.373
Nielsen S; Bruno R; Campbell G; Cohen M; Farrell M; Hall W; Hoban B; Larance B; Lintzeris N; Mattick R; Degenhardt L, 2015, 'Benzodiazepine use among a sample of chronic pain patients prescribed opioids', Drug and Alcohol Dependence, vol. 146, pp. e52 - e52, http://dx.doi.org/10.1016/j.drugalcdep.2014.09.512
O'Toole O; Murphy O; O'Dwyer J; Lonergan R; Keogh B; Tubridy N; Lynch T; Farrell M, 2015, 'Paraneoplastic dentate ganglionopathy: clinical and neuroimmunologic studies.', Clin Neuropathol, vol. 34, pp. 34 - 39, http://dx.doi.org/10.5414/NP300754
Brown P; Farrell M, 2015, 'A practical approach to avoiding iatrogenic Creutzfeldt-Jakob disease (CJD) from invasive instruments.', Infect Control Hosp Epidemiol, vol. 36, pp. 844 - 848, http://dx.doi.org/10.1017/ice.2015.53
Reynolds MR; Crilly SM; Sweeney KJ; Farrell M; Rawluk D, 2015, 'Metastatic pancreatic neuroendocrine tumor to the central nervous system in a patient with von Hippel-Lindau disease: A case report and literature review.', Br J Neurosurg, vol. 29, pp. 291 - 293, http://dx.doi.org/10.3109/02688697.2014.957650
Lefter S; Hardiman O; McLaughlin RL; Murphy SM; Farrell M; Ryan AM, 2015, 'A novel MYH7 Leu1453pro mutation resulting in Laing distal myopathy in an Irish family.', Neuromuscul Disord, vol. 25, pp. 155 - 160, http://dx.doi.org/10.1016/j.nmd.2014.09.007
McCarthy A; Lonergan R; Olszewska DA; O'Dowd S; Cummins G; Magennis B; Fallon EM; Pender N; Huey ED; Cosentino S; O'Rourke K; Kelly BD; O'Connell M; Delon I; Farrell M; Spillantini MG; Rowland LP; Fahn S; Craig P; Hutton M; Lynch T, 2015, 'Closing the tau loop: the missing tau mutation.', Brain, vol. 138, pp. 3100 - 3109, http://dx.doi.org/10.1093/brain/awv234
Reynolds MR; Sweeney KJ; Crilly SM; Farrell M; Jaffe ES; Javadpour M, 2015, 'Rapid, de novo development of isolated intracranial rosai-dorfman disease: A case report.', Br J Neurosurg, vol. 29, pp. 82 - 84, http://dx.doi.org/10.3109/02688697.2014.950634
Gorman KM; Farrell M; Madigan C; King MD; Shahwan A, 2015, 'Rasmussen's encephalitis, should absence of seizures influence or delay treatment?', Childs Nerv Syst, vol. 31, pp. 2009 - 2010, http://dx.doi.org/10.1007/s00381-015-2917-x
Brown P; Farrell M, 2015, 'A new practical diagnostic test for Creutzfeldt-Jakob disease.', Infect Control Hosp Epidemiol, vol. 36, pp. 849, http://dx.doi.org/10.1017/ice.2015.109
McElnea EM; Hughes E; McGoldrick A; McCann A; Quill B; Docherty N; Irnaten M; Farrell M; Clark AF; O'Brien CJ; Wallace DM, 2014, 'Lipofuscin accumulation and autophagy in glaucomatous human lamina cribrosa cells.', BMC Ophthalmol, vol. 14, pp. 153, http://dx.doi.org/10.1186/1471-2415-14-153
Bonevski B; Wilson A; Dunlop A; Shakeshaft A; Tzelepis F; Walsberger S; Farrell M; Kelly P; Guillaumier A; Skelton E, 2014, 'SMOKING CESSATION IN DRUG AND ALCOHOL TREATMENT SETTINGS: A QUALITATIVE STUDY OF STAFF AND CLIENT BARRIERS AND FACILITATORS', DRUG AND ALCOHOL REVIEW, vol. 33, pp. 16 - 17, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Courtney RJ; Bradford D; Martire KA; Bonevski B; Borland R; Doran C; Hall W; Farrell M; Siahpush M; Sanson-Fisher R; West R; Mattick RP, 2014, 'A randomized clinical trial of a financial education intervention with nicotine replacement therapy (NRT) for low socio-economic status Australian smokers: a study protocol', Addiction (Abingdon, England), vol. 109, pp. 1602 - 1611, http://dx.doi.org/10.1111/add.12669
Degenhardt L; Larney S; Kimber J; Gisev N; Farrell M; Dobbins T; Weatherburn DJ; Gibson A; Mattick R; Butler T; Burns L, 2014, 'The Impact of Opioid Substitution Therapy on Mortality Post-Release from Prison: A Retrospective Data Linkage Study', PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 23, pp. 346 - 346, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342763600643&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Courtney RJ; Bradford D; Martire KA; Bonevski B; Borland R; Doran C; Hall W; Farrell M; Siahpush M; Sanson-Fisher R; West R; Mattick RP, 2014, 'A randomized clinical trial of a financial education intervention with nicotine replacement therapy (NRT) for low socio-economic status Australian smokers: a study protocol', Addiction (Abingdon, England), vol. 109, pp. 1602 - 1611, http://dx.doi.org/10.1111/add.12669
Farrell M, 2014, 'Drug legalisation', BMJ (Online), vol. 349, http://dx.doi.org/10.1136/bmj.g5233
O'Brien M; Cryan J; Brett F; Howley R; Farrell M, 2014, 'Ten years on: Genetic screening for mitochondrial disease in Ireland', CLINICAL NEUROPATHOLOGY, vol. 33, pp. 279 - 283, http://dx.doi.org/10.5414/NP300722
Mulligan L; Ryan E; O'Brien M; Looby S; Heffernan J; O'Sullivan J; Clarke M; Buckley P; O'Brien D; Farrell M; Brett FM, 2014, 'Genetic features of oligodendrogliomas and presence of seizures', CLINICAL NEUROPATHOLOGY, vol. 33, pp. 292 - 298, http://dx.doi.org/10.5414/NP300727
Farrell M; Buchbinder R; Hall W, 2014, 'Should doctors prescribe cannabinoids?', BMJ (Online), vol. 348, http://dx.doi.org/10.1136/bmj.g2737
Mayet S; Farrell MF; Ferri M; Amato L; Davoli M, 2014, 'Psychosocial treatment for opiate abuse and dependence', Cochrane Database of Systematic Reviews, vol. 2014, http://dx.doi.org/10.1002/14651858.CD004330.pub3
Van Buskirk J; Roxburgh A; Farrell M; Burns L, 2014, 'The closure of the Silk Road: What has this meant for online drug trading?', Addiction, vol. 109, pp. 517 - 518, http://dx.doi.org/10.1111/add.12422
Gowing L; Farrell MF; Ali R; White JM, 2014, 'Alpha
Campbell G; Mattick R; Bruno R; Larance B; Nielsen S; Cohen M; Lintzeris N; Shand F; Hall WD; Hoban B; Kehler C; Farrell M; Degenhardt L, 2014, 'Cohort protocol paper: The pain and opioids in treatment (POINT) study', BMC Pharmacology and Toxicology, vol. 15, http://dx.doi.org/10.1186/2050-6511-15-17
Degenhardt L; Hall WD; Farrell M; Whiteford HA, 2014, 'Illicit drug dependence across the globe: Results from the global burden of disease 2010 study', Psychiatric Times, vol. 31
Larney S; Gowing L; Mattick RP; Farrell M; Hall W; Degenhardt L, 2014, 'A systematic review and meta-analysis of naltrexone implants for the treatment of opioid dependence', Drug and Alcohol Review, vol. 33, pp. 115 - 128, http://dx.doi.org/10.1111/dar.12095
Darke S; Farrell M, 2014, 'Would legalizing illicit opioids reduce overdose fatalities? Implications from a natural experiment', Addiction, vol. 109, pp. 1237 - 1242, http://dx.doi.org/10.1111/add.12456
Degenhardt L; Larney S; Kimber J; Gisev N; Farrell M; Dobbins T; Weatherburn DJ; Gibson A; Mattick R; Butler T; Burns L, 2014, 'The impact of opioid substitution therapy on mortality post-release from prison: Retrospective data linkage study', Addiction, vol. 109, pp. 1306 - 1317, http://dx.doi.org/10.1111/add.12536
Larney S; Gisev N; Farrell M; Dobbins T; Burns L; Gibson A; Kimber J; Degenhardt L, 2014, 'Opioid substitution therapy as a strategy to reduce deaths in prison: Retrospective cohort study', BMJ Open, vol. 4, http://dx.doi.org/10.1136/bmjopen-2013-004666
Rai D; Hall W; Bebbington P; Skapinakis P; Hassiotis A; Weich S; Meltzer H; Moran P; Brugha T; Strydom A; Farrell M, 2014, 'Estimated verbal IQ and the odds of problem gambling: A population-based study', Psychological Medicine, vol. 44, pp. 1739 - 1749, http://dx.doi.org/10.1017/S0033291713002195
Hall W; Farrell M; Carter A, 2014, 'Compulsory treatment of addiction in the patient's best interests: More rigorous evaluations are essential', Drug and Alcohol Review, vol. 33, pp. 268 - 271, http://dx.doi.org/10.1111/dar.12122
Smyth EG; Farrell M; Healy DG; Finn C; O'Brien D; O'Brien DF; Howley R; Turner P; Humphreys H, 2014, 'Managing the consequences of neurosurgical intervention in a patient with previously undiagnosed Creutzfeldt-Jakob disease.', Infect Control Hosp Epidemiol, vol. 35, pp. 907 - 908, http://dx.doi.org/10.1086/676879
Molloy A; Williams L; Farrell M; O'Riordan S, 2014, 'Hereditary Diffuse Leucoencephalopathy and Spheroids Resulting From a Mutation in CSF1R: A Rare Cause of Parkinsonism.', Mov Disord Clin Pract, vol. 1, pp. 132 - 133, http://dx.doi.org/10.1002/mdc3.12033
McKinley J; O'Connell M; Farrell M; Lynch T, 2014, 'Normal dopamine transporter imaging does not exclude multiple system atrophy.', Parkinsonism Relat Disord, vol. 20, pp. 933 - 934, http://dx.doi.org/10.1016/j.parkreldis.2014.04.022
Thavanesan N; Gillies M; Farrell M; Green AL; Aziz T, 2014, 'Deep brain stimulation in multiple system atrophy mimicking idiopathic Parkinson's disease.', Case Rep Neurol, vol. 6, pp. 232 - 237, http://dx.doi.org/10.1159/000368571
Beggan C; Towers M; Farrell M; Jaber K, 2014, 'Spinal diastematomyelia: a means of identification of charred remains.', J Forensic Leg Med, vol. 21, pp. 5 - 8, http://dx.doi.org/10.1016/j.jflm.2013.10.011
Uwineza A; Gill H; Buckley P; Owens C; Capra M; O'Sullivan C; McDermott M; Brett F; Farrell M; Pears J; O'Sullivan MJ, 2014, 'Rhabdoid tumor: the Irish experience 1986-2013.', Cancer Genet, vol. 207, pp. 398 - 402, http://dx.doi.org/10.1016/j.cancergen.2014.05.015
Van Buskirk J; Roxburgh A; Bruno R; Sindicich N; Farrell M; Burns L, 2013, 'MONITORING ILLICIT DRUG USE IN THE INTERNET AGE', DRUG AND ALCOHOL REVIEW, vol. 32, pp. 69 - 69, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326649400212&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Dunn M; Cooper A; Farrell M, 2013, 'PERFORMANCE AND IMAGE ENHANCING DRUG USERS: THE FORGOTTEN INJECTORS?', DRUG AND ALCOHOL REVIEW, vol. 32, pp. 34 - 34, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326649400109&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Lima CT; Farrell M; Prince M, 2013, 'Job strain, hazardous drinking, and alcohol-related disorders among Brazilian bank workers', Journal of Studies on Alcohol and Drugs, vol. 74, pp. 212 - 222, http://dx.doi.org/10.15288/jsad.2013.74.212
Meltzer H; Bebbington P; Brugha T; Farrell M; Jenkins R, 2013, 'The relationship between personal debt and specific common mental disorders', European Journal of Public Health, vol. 23, pp. 108 - 113, http://dx.doi.org/10.1093/eurpub/cks021
Doherty KM; Silveira-Moriyama L; Parkkinen L; Healy DG; Farrell M; Mencacci NE; Ahmed Z; Brett FM; Hardy J; Quinn N; Counihan TJ; Lynch T; Fox ZV; Revesz T; Lees AJ; Holton JL, 2013, 'Parkin disease: a clinicopathologic entity?', JAMA Neurol, vol. 70, pp. 571 - 579, http://dx.doi.org/10.1001/jamaneurol.2013.172
Doherty KM; Moriyama LS; Parkkinen L; Healy DG; Farrell M; Mencacci NE; Ahmed Z; Brett FM; Hardy J; Quinn N; Counihan TJ; Lynch T; Fox ZV; Revesz T; Lees AJ; Holton JL, 2013, 'PARKIN DISEASE–A CLINICOPATHOLOGICAL ENTITY?', Journal of Neurology, Neurosurgery & Psychiatry, vol. 84, pp. e2.35 - e2, http://dx.doi.org/10.1136/jnnp-2013-306573.13
Farrell M, 2013, 'Relapsing-remitting and primary progressive MS have the same cause(s)--the neuropathologist's view: commentary.', Mult Scler, vol. 19, pp. 270, http://dx.doi.org/10.1177/1352458513477232
McCarthy A; Farrell M; Hedley-Whyte T; McGuone D; Kavanagh E; McNally S; Keogan M; Horgan N; Lynch T; O'Rourke K, 2013, 'Granulomatosis with polyangiitis masquerading as giant cell arteritis.', J Neurol, vol. 260, pp. 1661 - 1663, http://dx.doi.org/10.1007/s00415-013-6913-3
O'Halloran PJ; Farrell M; Caird J; Capra M; O'Brien D, 2013, 'Paediatric spinal glioblastoma: case report and review of therapeutic strategies.', Childs Nerv Syst, vol. 29, pp. 367 - 374, http://dx.doi.org/10.1007/s00381-013-2023-x
Lonergan R; Carthy F; Alexander M; Roberts K; Farrell M; Lynch T, 2013, 'PICK ‘N’ MIX: NEUROPATHOLOGICAL DETECTION OF PERI–TUMOUR TAUOPATHY', Journal of Neurology, Neurosurgery & Psychiatry, vol. 84, pp. e2.206 - e2, http://dx.doi.org/10.1136/jnnp-2013-306573.85
Roxburgh A; Burns L; Drummer OH; Pilgrim J; Farrell M; Degenhardt L, 2012, 'TRENDS IN FENTANYL PRESCRIPTIONS AND FENTANYL-RELATED MORTALITY IN AUSTRALIA', DRUG AND ALCOHOL REVIEW, vol. 31, pp. 18 - 18, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000311236700060&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Farrell M; Hall W, 2012, 'Griffith Edwards OBITUARY', BRITISH MEDICAL JOURNAL, vol. 345, http://dx.doi.org/10.1136/bmj.e7234
Hickman M; Degenhardt L; Farrell M; Hall W, 2012, 'Commentary on kelty & hulse (2012): Is the comparison of mortality between patients prescribed implanted or oral naltrexone an unbiased and unconfounded comparison?', Addiction, vol. 107, pp. 1825 - 1826, http://dx.doi.org/10.1111/j.1360-0443.2012.03966.x
Farrell M; Wodak A; Gowing L, 2012, 'Maintenance drugs to treat opioid dependence', BMJ (Online), vol. 344, http://dx.doi.org/10.1136/bmj.e2823
Iyer PM; Moroney J; Mullins G; Farrell M; Delanty N, 2012, 'Status of memory loss.', BMJ Case Rep, vol. 2012, http://dx.doi.org/10.1136/bcr.11.2011.5267
Kinsella P; Howley R; Doolan P; Clarke C; Madden SF; Clynes M; Farrell M; Amberger-Murphy V, 2012, 'Characterization and response of newly developed high-grade glioma cultures to the tyrosine kinase inhibitors, erlotinib, gefitinib and imatinib.', Exp Cell Res, vol. 318, pp. 641 - 652, http://dx.doi.org/10.1016/j.yexcr.2012.01.014
Hedrich D; Alves P; Farrell M; Stöver H; Møller L; Mayet S, 2012, 'The effectiveness of opioid maintenance treatment in prison settings: A systematic review', Addiction, vol. 107, pp. 501 - 517, http://dx.doi.org/10.1111/j.1360-0443.2011.03676.x
Hedrich D; Farrell M, 2012, 'Opioid maintenance in European prisons: Is the treatment gap closing?', Addiction, vol. 107, pp. 461 - 463, http://dx.doi.org/10.1111/j.1360-0443.2011.03694.x
Readdick CA; Farrell MP; Koepke LA, 2012, 'Irish voices: Families in a globalizing economy', Journal of Family Issues, vol. 33, pp. 3 - 9, http://dx.doi.org/10.1177/0192513X11420953
Hedrich D; Alves P; Farrell M; Stover H; Moller L; Mayet S, 2012, 'The effectiveness of opioid maintenance treatment in prison settings: a systematic review', Addiction, vol. 107, pp. 501 - 517, http://dx.doi.org/10.1111/j.1360-0443.2011.03676.x/pdf
Hedrich D; Farrell M, 2012, 'Opioid maintenance in European prisons: Is the treatment gap closing?', Addiction, vol. 107, pp. 461 - 463, http://dx.doi.org/10.1111/j.1360-0443.2011.03694.x/pdf
Farrell M; Wodak A; Gowing L, 2012, 'Maintenance drugs to treat opioid dependence', BMJ, vol. 344, pp. e2823 - e2823, http://www.bmj.com/highwire/filestream/584745/field_highwire_article_pdf/0.pdf
Hickman M; Degenhardt LJ; Farrell M; Hall W, 2012, 'Commentary on Kelty & Hulse (2012): Is the comparison of mortality between patients prescribed implanted or oral naltrexone an unbiased and unconfounded comparison?', Addiction, vol. 107, pp. 1825 - 1826, http://dx.doi.org/10.1111/j.1360-0443.2012.03966.x/pdf
Farrell M; Hall W, 2012, 'Griffith Edwards: Key contributor to the study and science of addiction: Obituaries', BMJ, vol. 345, pp. 1 - 2, http://www.bmj.com/highwire/filestream/611554/field_highwire_article_pdf/0/bmj.e7234
Haroon M; Molloy E; Farrell M; Alraqi S, 2012, 'Central nervous system vasculitis: all that glitters is not gold.', J Rheumatol, vol. 39, pp. 662 - 663, http://dx.doi.org/10.3899/jrheum.111141
Crowley RK; Al-Derazi Y; Lynch K; Rawluk D; Thompson CJ; Farrell M; Agha A, 2012, 'Acromegaly associated with gangliocytoma.', Ir J Med Sci, vol. 181, pp. 353 - 355, http://dx.doi.org/10.1007/s11845-009-0433-2
O'Brien D; Lim CH; Farrell M; O'Marcaigh A; Rawluk D; Fitzpatrick F; Smyth E, 2012, 'Invasive intracerebral fungal infection in a leukaemic patient.', Br J Neurosurg, vol. 26, pp. 423 - 425, http://dx.doi.org/10.3109/02688697.2011.633638
Klyubin I; Mably A; Minogue A; Hu N; Farrell M; Walsh D; Rowan M, 2012, 'P4‐034: Alzheimer's disease human brain beta‐amyloid‐containing extracts inhibit hippocampal long‐term potentiation in rats in vivo : Relationship between soluble and insoluble preparations', Alzheimer's & Dementia, vol. 8, pp. p648 - p648, http://dx.doi.org/10.1016/j.jalz.2012.05.1735
Stevens NT; Greene CM; O'Gara JP; Bayston R; Sattar MTA; Farrell M; Humphreys H, 2012, 'Ventriculoperitoneal shunt-related infections caused by Staphylococcus epidermidis: pathogenesis and implications for treatment.', Br J Neurosurg, vol. 26, pp. 792 - 797, http://dx.doi.org/10.3109/02688697.2011.651514
McKiernan RC; Jimenez-Mateos EM; Bray I; Engel T; Brennan GP; Sano T; Michalak Z; Moran C; Delanty N; Farrell M; O'Brien D; Meller R; Simon RP; Stallings RL; Henshall DC, 2012, 'Reduced mature microRNA levels in association with dicer loss in human temporal lobe epilepsy with hippocampal sclerosis.', PLoS One, vol. 7, pp. e35921, http://dx.doi.org/10.1371/journal.pone.0035921
Slade T; Teesson M; Carragher N; Farrell M, 2011, 'Commentary on Agrawal etal. (2011): Assessing the impact of changes to diagnostic criteria on the estimated prevalence of alcohol use disorders in general population surveys', Addiction, vol. 106, pp. 1944 - 1945, http://dx.doi.org/10.1111/j.1360-0443.2011.03597.x
Farrell M, 2011, 'PRESENTATION 1-TREATMENT OPTIONS: AGONIST REPLACEMENT AND ANTAGONIST RELAPSE PREVENTION - NOT ONLY FOR OPIOID DEPENDENCE?', DRUG AND ALCOHOL REVIEW, vol. 30, pp. 61 - 61, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297019700187&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Maremmani I; Farrell M; Waal H; Clausen T; Rovai L; Maremmani AG, 2011, 'SYMPOSIUM - EUROPAD HOT TOPICS', DRUG AND ALCOHOL REVIEW, vol. 30, pp. 61 - 61, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297019700186&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Arsov T; Smith KR; Damiano J; Franceschetti S; Canafoglia L; Bromhead CJ; Andermann E; Vears DF; Cossette P; Rajagopalan S; McDougall A; Sofia V; Farrell M; Aguglia U; Zini A; Meletti S; Morbin M; Mullen S; Andermann F; Mole SE; Bahlo M; Berkovic SF, 2011, 'Kufs disease, the major adult form of neuronal ceroid lipofuscinosis, caused by mutations in cln6', American Journal of Human Genetics, vol. 88, pp. 566 - 573, http://dx.doi.org/10.1016/j.ajhg.2011.04.004
Slade T; Teesson M; Carragher N; Farrell M, 2011, 'Commentary on Agrawal et al.: Assessing the impact of changes to diagnostic criteria on the estimated prevalence of alcohol use disorders in general population surveys', Addiction, vol. 106, pp. 1944 - 1945, http://dx.doi.org/10.1111/j.1360-0443.2011.03597.x/full
Hall W; Farrell M, 2011, 'Minimising the misuse of oxycodone and other pharmaceutical opioids in Australia: Simple strategies can reduce harms from misuse of pharmaceutical opioids [Editorial]', Medical Journal of Australia, vol. 195, pp. 248 - 249, http://dx.doi.org/10.5694/mja11.10832
Smith GW; Farrell M; Bunting BP; Houston JE; Shelvin M, 2011, 'Patterns of polydrug use in Great Britain: Findings from a national household population survey', Drug and Alcohol Dependence, vol. 113, pp. 222 - 228, http://dx.doi.org/10.1016/j.drugalcdep.2010.08.010
Amato L; Davoli M; Vecchi S; Ali R; Farrell M; Faggiano F; Foxcroft D; Ling W; Minozzi S; Chengzheng Z, 2011, 'Cochrane systematic reviews in the field of addiction: What's there and what should be', Drug and Alcohol Dependence, vol. 113, pp. 96 - 103, http://dx.doi.org/10.1016/j.drugalcdep.2010.08.003
Gowing L; Farrell M; Bornemann R; Sullivan LE; Ali R, 2011, 'Oral substitution treatment of injecting opioid users for prevention of HIV infection', Cochrane Database of Systematic Reviews, pp. i-ii, 1-115, http://dx.doi.org/10.1002/14651858.CD004145.pub4/pdf
Cooper C; Bebbington P; Farrell M; Brugha T; Mcmanus S; Stewart R; Livingston G, 2011, 'Happiness across age groups: results from the 2007 National Psychiatric Morbidity Survey', International Journal of Geriatric Psychiatry, vol. 26, pp. 608 - 614, http://dx.doi.org/10.1002/gps.2570/pdf
Raza K; Kaliaperumal C; Farrell M; O'Dwyer JA; Pidgeon C, 2011, 'Solitary paraganglioma of the hypoglossal nerve: case report.', Neurosurgery, vol. 68, pp. E1170 - E1174, http://dx.doi.org/10.1227/NEU.0b013e31820a16b5
Cunnea P; Mháille AN; McQuaid S; Farrell M; McMahon J; FitzGerald U, 2011, 'Expression profiles of endoplasmic reticulum stress-related molecules in demyelinating lesions and multiple sclerosis.', Mult Scler, vol. 17, pp. 808 - 818, http://dx.doi.org/10.1177/1352458511399114
Cooper C; Bebbington P; McManus S; Meltzer H; Stewart R; Farrell M; King M; Jenkins R; Livingston G, 2010, 'The treatment of common mental disorders across age groups: Results from the 2007 adult psychiatric morbidity survey', Journal of Affective Disorders, vol. 127, pp. 96 - 101, http://dx.doi.org/10.1016/j.jad.2010.04.020
Farrell M, 2010, 'Classification and confusion', Addiction, vol. 105, pp. 1150, http://dx.doi.org/10.1111/j.1360-0443.2010.02920.x
Farrell M; Strang J; Stöver H, 2010, 'Hepatitis B vaccination in prisons: A much-needed targeted universal intervention', Addiction, vol. 105, pp. 189 - 190, http://dx.doi.org/10.1111/j.1360-0443.2009.02781.x
Marsden J; Eastwood B; Bradbury C; Farrell M; Knight J, 2010, 'Community treatments for heroin and crack cocaine addiction - Authors' reply', The Lancet, vol. 375, pp. 278 - 279, http://dx.doi.org/10.1016/S0140-6736(10)60125-0
Soares B; Lima Reisser AA; Farrell M; Silva de Lima M, 2010, 'WITHDRAWN: Dopamine agonists for cocaine dependence.', Cochrane database of systematic reviews (Online), vol. 2
Silva de Lima M; Farrell M; Lima Reisser AA; Soares B, 2010, 'WITHDRAWN: Antidepressants for cocaine dependence.', Cochrane database of systematic reviews (Online), vol. 2
Merrall EL; Kariminia A; Binswanger IA; Hobbs MS; Farrell M; Marsden J; Hutchinson SJ; Bird SM; Hobbs , 2010, 'Meta-analysis of drug-related deaths soon after release from prison', Addiction, vol. 105, pp. 1545 - 1554, http://dx.doi.org/10.1111/j.1360-0443.2010.02990.x
McHugh JC; Lonergan R; Howley R; O'Rourke K; Taylor RW; Farrell M; Hutchinson M; Connolly S, 2010, 'Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) in a sibling pair with a homozygous p.A467T POLG mutation.', Muscle Nerve, vol. 41, pp. 265 - 269, http://dx.doi.org/10.1002/mus.21494
Owens C; Bradley L; Farrell M; O'Brien D; King MD; Ryan SP, 2010, 'Seizure-induced inflammation in focal cortical dysplasia resulting in imaging progression that simulates neoplasia.', J Neuroimaging, vol. 20, pp. 208 - 210, http://dx.doi.org/10.1111/j.1552-6569.2008.00342.x
Desmond R; Lynch K; Gleeson M; Farrell M; Murphy P, 2010, 'Progressive multifocal leukencephalopathy and cerebral toxoplasmosis in a patient with CLL.', Am J Hematol, vol. 85, pp. 607, http://dx.doi.org/10.1002/ajh.21589
Phelan PJ; Murphy RKJ; Farrell M; O'Toole O; Heffernan J; O'Brien D; Breathnach O; Conlon PJ, 2010, 'EBV-positive B cell cerebral lymphoma 12 years after sex-mismatched kidney transplantation: post-transplant lymphoproliferative disorder or donor-derived lymphoma?', Nephrol Dial Transplant, vol. 25, pp. 2032 - 2035, http://dx.doi.org/10.1093/ndt/gfq170
Dunlea O; Doherty CP; Farrell M; Fitzsimons M; O'Brien D; Murphy K; MacMackin D; Pender N; Staunton H; Phillips J; Delanty N, 2010, 'The Irish epilepsy surgery experience: Long-term follow-up.', Seizure, vol. 19, pp. 247 - 252, http://dx.doi.org/10.1016/j.seizure.2010.03.001
Coid J; Moran P; Bebbington P; Brugha T; Jenkins R; Farrell M; Singleton N; Ullrich S, 2009, 'The co-morbidity of personality disorder and clinical syndromes in prisoners', Criminal Behaviour and Mental Health, vol. 19, pp. 321 - 333, http://dx.doi.org/10.1002/cbm.747
Coid J; Yang M; Bebbington P; Moran P; Brugha T; Jenkins R; Farrell M; Singleton N; Ullrich S, 2009, 'Borderline personality disorder: Health service use and social functioning among a national household population', Psychological Medicine, vol. 39, pp. 1721 - 1731, http://dx.doi.org/10.1017/S0033291708004911
Jenkins R; Meltzer H; Bebbington P; Brugha T; Farrell M; McManus S; Singleton N, 2009, 'The British Mental Health Survey Programme: Achievements and latest findings', Social Psychiatry and Psychiatric Epidemiology, vol. 44, pp. 899 - 904, http://dx.doi.org/10.1007/s00127-009-0112-7
Farrell M, 2009, 'Decline and fall (the speedy way)', BMJ, vol. 339, pp. b3283 - b3283, http://dx.doi.org/10.1136/bmj.b3283
Murphy S; Gorman G; Beetz C; Byrne P; Dytko M; McMonagle P; Kinsella K; Farrell M; Hutchinson M, 2009, 'Dementia in SPG4 hereditary spastic paraplegia: clinical, genetic, and neuropathologic evidence.', Neurology, vol. 73, pp. 378 - 384, http://dx.doi.org/10.1212/WNL.0b013e3181b04c6c
Gowing L; Farrell M; Ali R; White JM, 2009, 'Alpha2-adrenergic agonists for the management of opioid withdrawal.', Cochrane database of systematic reviews (Online)
Forde P; Grant C; Smith E; Farrell M; Brett F; Bolger C; Grogan L; Breathnach O, 2009, 'Primary central nervous system lymphoma: An Irish clinical experience', Journal of Clinical Oncology, vol. 27, pp. e13032 - e13032, http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e13032
Coid J; Yang M; Ullrich S; Roberts A; Moran P; Bebbington P; Brugha T; Jenkins R; Farrell M; Lewis G; Singleton N; Hare R, 2009, 'Psychopathy among prisoners in England and Wales', International Journal of Law and Psychiatry, vol. 32, pp. 134 - 141, http://dx.doi.org/10.1016/j.ijlp.2009.02.008
Farrell M; Beveridge A, 2009, 'Motivational Interviewing in the Treatment of Psychological Problems', BRITISH JOURNAL OF PSYCHIATRY, vol. 194, pp. 471 - 471, http://dx.doi.org/10.1192/bjp.bp.108.049742
Daniel JZ; Hickman M; Macleod J; Wiles N; Lingford-Hughes A; Farrell M; Araya R; Skapinakis P; Haynes J; Lewis G, 2009, 'Is socioeconomic status in early life associated with drug use? A systematic review of the evidence', Drug and Alcohol Review, vol. 28, pp. 142 - 153, http://dx.doi.org/10.1111/j.1465-3362.2008.00042.x
Marsden J; Eastwood B; Bradbury C; Dale-Perera A; Farrell M; Hammond P; Knight J; Randhawa K; Wright C, 2009, 'Effectiveness of community treatments for heroin and crack cocaine addiction in England: a prospective, in-treatment cohort study', The Lancet, vol. 374, pp. 1262 - 1270, http://dx.doi.org/10.1016/S0140-6736(09)61420-3
Gowing L; Farrell M; Ali R; White JM, 2009, 'Alpha
Lima Reisser AARL; Silva de Lima M; Soares BGDO; Farrell M, 2009, 'WITHDRAWN: Carbamazepine for cocaine dependence.', Cochrane database of systematic reviews (Online)
Treacy A; Redmond M; Lynch B; Ryan S; Farrell M; Devaney D, 2009, 'Schwannosis induced medullary compression in VACTERL syndrome.', Clin Neuropathol, vol. 28, pp. 384 - 386, http://dx.doi.org/10.5414/npp28384
O'Rourke K; Buddles MR; Farrell M; Howley R; Sukuraman S; Connolly S; Turnbull DM; Hutchinson M; Taylor RW, 2009, 'Phenotypic diversity associated with the mitochondrial m.8313G>A point mutation.', Muscle Nerve, vol. 40, pp. 648 - 651, http://dx.doi.org/10.1002/mus.21342
Janeczko C; McHugh J; Rawluk D; Farrell M; Brennan P; Delanty N, 2009, 'Hypophysitis secondary to ruptured Rathke's cyst mimicking neurosarcoidosis.', J Clin Neurosci, vol. 16, pp. 599 - 600, http://dx.doi.org/10.1016/j.jocn.2008.04.031
Farrell M, 2008, 'Review: Substance use disorders respond to psychosocial interventions - Commentary', Evidence-Based Mental Health, vol. 11, pp. 123, http://dx.doi.org/10.1136/ebmh.11.4.123
Jenkins R; Bhugra D; Bebbington P; Brugha T; Farrell M; Coid J; Fryers T; Weich S; Singleton N; Meltzer H, 2008, 'Debt, income and mental disorder in the general population', Psychological Medicine, vol. 38, pp. 1485 - 1493, http://dx.doi.org/10.1017/S0033291707002516
Marsden J; Farrell M; Bradbury C; Dale-Perera A; Eastwood B; Roxburgh M; Taylor S, 2008, 'Development of the treatment outcomes profile', Addiction, vol. 103, pp. 1450 - 1460, http://dx.doi.org/10.1111/j.1360-0443.2008.02284.x
Gowing L; Farrell M; Bornemann R; Sullivan L; Ali R, 2008, 'Substitution treatment of injecting opioid users for prevention of HIV infection.', Cochrane database of systematic reviews (Online)
Minozzi S; Amato L; Davoli M; Farrell M; Lima Reisser AA; Pani PP; Silva de Lima M; Soares B; Vecchi S, 2008, 'Anticonvulsants for cocaine dependence.', Cochrane database of systematic reviews (Online)
Humeniuk R; Ali R; Babor TF; Farrell M; Formigoni ML; Jittiwutikarn J; De Lacerda RB; Ling W; Marsden J; Monteiro M; Nhiwatiwa S; Pal H; Poznyak V; Simon S, 2008, 'Validation of the alcohol, smoking and substance involvement screening test (ASSIST)', Addiction, vol. 103, pp. 1039 - 1047, http://dx.doi.org/10.1111/j.1360-0443.2007.02114.x
O'Brien J; Thornton J; Cawley D; Farrell M; Keohane K; Kaar G; McEvoy L; O'Brien DF, 2008, 'Extraskeletal myxoid chondrosarcoma of the cerebellopontine angle presenting during pregnancy', BRITISH JOURNAL OF NEUROSURGERY, vol. 22, pp. 429 - 432, http://dx.doi.org/10.1080/02688690701780127
Haynes JC; Farrell M; Singleton N; Meltzer H; Araya R; Lewis G; Wiles NJ, 2008, 'Alcohol consumption as a risk factor for non-recovery from common mental disorder: Results from the longitudinal follow-up of the National Psychiatric Morbidity Survey', Psychological Medicine, vol. 38, pp. 451 - 455, http://dx.doi.org/10.1017/S0033291707002000
Cooper C; Bebbington PE; Meltzer H; Bhugra D; Brugha T; Jenkins R; Farrell M; King M, 2008, 'Depression and common mental disorders in lone parents: Results of the 2000 National Psychiatric Morbidity Survey', Psychological Medicine, vol. 38, pp. 335 - 342, http://dx.doi.org/10.1017/S0033291707001493
Farrell M; Marsden J, 2008, 'Acute risk of drug-related death among newly released prisoners in England and Wales', Addiction, vol. 103, pp. 251 - 255, http://dx.doi.org/10.1111/j.1360-0443.2007.02081.x
Gowing L; Farrell M; Bornemann R; Sullivan L; Ali R, 2008, 'Substitution treatment of injecting opioid users for prevention of HIV infection', Cochrane Database of Systematic Reviews, http://dx.doi.org/10.1002/14651858.CD004145.pub3
Minozzi S; Amato L; Davoli M; Farrell M; Lima Reisser AARL; Pani PP; Silva De Lima M; Soares B; Vecchi S, 2008, 'Anticonvulsants for cocaine dependence', Cochrane Database of Systematic Reviews, http://dx.doi.org/10.1002/14651858.CD006754.pub2
Cryan LM; Paraoan L; Hiscott P; Damato BE; Grierson I; Gray D; Farrell M; Doherty GA; Fitzgerald DJ; O'Brien C, 2008, 'Expression of COX-2 and prognostic outcome in uveal melanoma.', Curr Eye Res, vol. 33, pp. 177 - 184, http://dx.doi.org/10.1080/02713680701867908
Kelly K; Lynch K; Farrell M; Rawluk D; Kaliaperumal C; Murphy P, 2008, 'Intracranial small lymphocytic lymphoma.', Br J Haematol, vol. 141, pp. 411, http://dx.doi.org/10.1111/j.1365-2141.2008.07047.x
Flannery T; Cawley D; Zulfiger A; Alderazi Y; Heffernan J; Brett F; Farrell M; O'Brien DF, 2008, 'Familial occurrence of oligodendroglial tumours.', Br J Neurosurg, vol. 22, pp. 436 - 438, http://dx.doi.org/10.1080/02688690701818950
Wiles NJ; Lingford-Hughes A; Daniel J; Hickman M; Farrell M; Macleod J; Haynes JC; Skapinakis P; Araya R; Lewis G, 2007, 'Socio-economic status in childhood and later alcohol use: A systematic review', Addiction, vol. 102, pp. 1546 - 1563, http://dx.doi.org/10.1111/j.1360-0443.2007.01930.x
Farrell M, 2007, 'The alcohol industry: taking on the public health critics', BMJ, vol. 335, pp. 671 - 671, http://dx.doi.org/10.1136/bmj.39337.431667.4e
Flannery W; Farrell M, 2007, 'Harm reduction the key to managing problem drug users', Practitioner, vol. 251, pp. 99 - 106
Marshall EJ; Farrell M, 2007, 'Substance use and psychiatric comorbidity', Medicine, vol. 35, pp. 246 - 249, http://dx.doi.org/10.1016/j.mpmed.2007.02.010
Torres AR; Prince MJ; Bebbington PE; Bhugra DK; Brugha TS; Farrell M; Jenkins R; Lewis G; Meltzer H; Singleton N, 2007, 'Treatment seeking by individuals with obsessive-compulsive disorder from the British Psychiatric Morbidity Survey of 2000', Psychiatric Services, vol. 58, pp. 977 - 982, http://dx.doi.org/10.1176/ps.2007.58.7.977
Coid J; Yang M; Roberts A; Ullrich S; Moran P; Bebbington P; Brugha T; Jenkins R; Farrell M; Singleton N, 2007, 'Authors' reply [5]', British Journal of Psychiatry, vol. 190, pp. 177 - 178, http://dx.doi.org/10.1192/bjp.190.2.177b
Hodgson S; Sharifi R; Richardson G; Ashcroft R; Aziz A; Jackson S; Farrell M; Raza T; Khazali S; Gibbs P; Haidari H; Sala M, 2007, 'Emerging concerns abour Iran's scientific and medical future [9]', Clinical Medicine, Journal of the Royal College of Physicians of London, vol. 7, pp. 92 - 93, http://dx.doi.org/10.7861/clinmedicine.7-1-92a
Farrell M; Marshall EJ, 2007, 'Organization and delivery of treatment services for dual diagnosis', Psychiatry, vol. 6, pp. 34 - 36, http://dx.doi.org/10.1053/j.mppsy.2006.10.008
Williams A; Farrell M, 2007, 'Substance use and psychosis', Psychiatry, vol. 6, pp. 19 - 22, http://dx.doi.org/10.1053/j.mppsy.2006.10.005
Marshall EJ; Farrell M, 2007, 'Substance use and psychiatric comorbidity', Psychiatry, vol. 6, pp. 23 - 26, http://dx.doi.org/10.1053/j.mppsy.2006.10.004
McHugh JC; Bradley D; Hutchinson M; Brett F; Heffernan J; Howley R; Farrell M; Tubridy N, 2007, 'Variant Creutzfeldt-Jakob disease: first two indigenous cases in Republic of Ireland. Case report and perspective.', Eur J Neurol, vol. 14, pp. 467 - 469, http://dx.doi.org/10.1111/j.1468-1331.2007.01643.x
O'Brien DF; Farrell M; Delanty N; Traunecker H; Perrin R; Smyth MD; Park TS; Children's Cancer and Leukaemia Group , 2007, 'The Children's Cancer and Leukaemia Group guidelines for the diagnosis and management of dysembryoplastic neuroepithelial tumours.', Br J Neurosurg, vol. 21, pp. 539 - 549, http://dx.doi.org/10.1080/02688690701594817
Zador DA; Farrell M, 2006, 'Beyond the edge of safety [6]', British Medical Journal, vol. 333, pp. 1172 - 1173
Zador DA; Farrell M, 2006, 'Beyond the edge of safety [6]', British Medical Journal, vol. 333, pp. 1172 - 1173, http://dx.doi.org/10.1136/bmj.39045.381991.1F
Farrell M; Marshall EJ, 2006, 'Epidemiology of tobacco, alcohol and drug use', Psychiatry, vol. 5, pp. 427 - 430, http://dx.doi.org/10.1053/j.mppsy.2006.09.003
Farrell M, 2006, 'Rain in my Heart', BMJ, vol. 333, pp. 1127.1 - 1127, http://dx.doi.org/10.1136/bmj.39041.457199.59
Torres AR; Moran P; Bebbington P; Brugha T; Bhugra D; Coid JW; Farrell M; Jenkins R; Lewis G; Meltzer H; Prince M, 2006, 'Obsessive-compulsive disorder and personality disorder', Social Psychiatry and Psychiatric Epidemiology, vol. 41, pp. 862 - 867, http://dx.doi.org/10.1007/s00127-006-0118-3
Barnes GM; Hoffman JH; Welte JW; Farrell MP; Dintcheff BA, 2006, 'Effects of parental monitoring and peer deviance on substance use and delinquency', Journal of Marriage and Family, vol. 68, pp. 1084 - 1104, http://dx.doi.org/10.1111/j.1741-3737.2006.00315.x
Boydell J; Van Os J; Caspi A; Kennedy N; Giouroukou P; Fearon P; Farrell M; Murray RM, 2006, 'Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999', Psychological Medicine, vol. 36, pp. 1441 - 1446, http://dx.doi.org/10.1017/S0033291706008440
Marsden J; Stillwell G; Barlow H; Boys A; Taylor C; Hunt N; Farrell M, 2006, 'An evaluation of a brief motivational intervention among young ecstasy and cocaine users: No effect on substance and alcohol use outcomes', Addiction, vol. 101, pp. 1014 - 1026, http://dx.doi.org/10.1111/j.1360-0443.2006.01290.x
Coid J; Yang M; Roberts A; Ullrich S; Moran P; Bebbington P; Brugha T; Jenkins R; Farrell M; Lewis G; Singleton N, 2006, 'Violence and psychiatric morbidity in the national household population of Britain: Public health implications', British Journal of Psychiatry, vol. 189, pp. 12 - 19, http://dx.doi.org/10.1192/bjp.189.1.12
Farrell M; Boys A; Singleton N; Meltzer H; Brugha T; Bebbington P; Jenkins R; Coid J; Lewis G; Marsden J, 2006, 'Predictors of mental health service utilization in the 12 months before imprisonment: Analysis of results from a national prisons survey', Australian and New Zealand Journal of Psychiatry, vol. 40, pp. 548 - 553, http://dx.doi.org/10.1111/j.1440-1614.2006.01836.x
Gowing LR; Farrell M; Bornemann R; Sullivan LE; Ali RL, 2006, 'Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection', Journal of General Internal Medicine, vol. 21, pp. 193 - 195, http://dx.doi.org/10.1111/j.1525-1497.2005.00287.x
Coid J; Yang M; Roberts A; Ullrich S; Moran P; Bebbington P; Brugha T; Jenkins R; Farrell M; Lewis G; Singleton N, 2006, 'Violence and psychiatric morbidity in a national household population - A report from the British household survey', American Journal of Epidemiology, vol. 164, pp. 1199 - 1208, http://dx.doi.org/10.1093/aje/kwj339
Torres AR; Prince MJ; Bebbington PE; Bhugra D; Brugha TS; Farrell M; Jenkins R; Lewis G; Meltzer H; Singleton N, 2006, 'Obsessive-compulsive disorder: Prevalence, Comorbidity, impact, and help-seeking in the British National Psychiatric Morbidity Survey of 2000', American Journal of Psychiatry, vol. 163, pp. 1978 - 1985, http://dx.doi.org/10.1176/ajp.2006.163.11.1978
Gowing LR; Farrell M; Bornemann R; Sullivan LE; Ali RL, 2006, 'BRIEF REPORT: Methadone Treatment of Injecting Opioid Users for Prevention of HIV Infection', Journal of General Internal Medicine, vol. 21, pp. 193 - 195, http://dx.doi.org/10.1111/j.1525-1497.2005.00287.x
Marshall EJ; Farrell M, 2006, 'Introduction', Psychiatry, vol. 5, pp. 421 - 422, http://dx.doi.org/10.1053/j.mppsy.2006.09.008
Caird J; Napoli C; Taggart C; Farrell M; Bouchier-Hayes D, 2006, 'Matrix metalloproteinases 2 and 9 in human atherosclerotic and non-atherosclerotic cerebral aneurysms.', Eur J Neurol, vol. 13, pp. 1098 - 1105, http://dx.doi.org/10.1111/j.1468-1331.2006.01469.x
Farrell M, 2006, 'Young People and Substance Misuse.', Child Adolesc Ment Health, vol. 11, pp. 61, http://dx.doi.org/10.1111/j.1475-3588.2005.00387_6.x
FARRELL M, 2006, 'Motivational interviewing preparing people for change (2nd edition)', Addiction Biology, vol. 11, pp. 191 - 191, http://dx.doi.org/10.1111/j.1369-1600.2006.00024_3.x
Kelleher MJA; Keown PJ; O'Gara C; Keaney F; Farrell M; Strang J, 2005, 'Dying for heroin: The increasing opioid-related mortality in the Republic of Ireland, 1980-1999', European Journal of Public Health, vol. 15, pp. 589 - 592, http://dx.doi.org/10.1093/eurpub/cki048
Haynes JC; Farrell M; Singleton N; Meltzer H; Araya R; Lewis G; Wiles NJ, 2005, 'Alcohol consumption as a risk factor for anxiety and depression: Results from the longitudinal follow-up of the National Psychiatric Morbidity Survey', British Journal of Psychiatry, vol. 187, pp. 544 - 551, http://dx.doi.org/10.1192/bjp.187.6.544
Farrell M; Taylor C; Welch S; Meltzer H, 2005, 'Co-morbidity in the National Psychiatric Morbidity Surveys', DRUGS-EDUCATION PREVENTION AND POLICY, vol. 12, pp. 77 - 81, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000237742700005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Strang J; Best D; Ridge G; Gossop M; Farrell M, 2005, 'Randomised clinical trial of the effects of time on a waiting list on clinical outcomes in opiate addicts awaiting outpatient treatment', DRUGS-EDUCATION PREVENTION AND POLICY, vol. 12, pp. 115 - 118, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000237742700013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Lima CT; Freire ACC; Silva APB; Teixeira RM; Farrell M; Prince M, 2005, 'Concurrent and construct validity of the audit in an urban Brazillian sample', Alcohol and Alcoholism, vol. 40, pp. 584 - 589, http://dx.doi.org/10.1093/alcalc/agh202
Miller KE; Hoffman JH; Barnes GM; Sabo D; Melnick MJ; Farrell MP, 2005, 'Adolescent anabolic steroid use, gender, physical activity, and other problem behaviors', Substance Use and Misuse, vol. 40, pp. 1637 - 1657, http://dx.doi.org/10.1080/10826080500222727
Marsden J; Boys A; Farrell M; Stillwell G; Hutchings K; Hillebrand J; Griffiths P, 2005, 'Personal and social correlates of alcohol consumption among mid-adolescents', British Journal of Developmental Psychology, vol. 23, pp. 427 - 450, http://dx.doi.org/10.1348/026151005X26020
Brugha T; Singleton N; Meltzer H; Bebbington P; Farrell M; Jenkins R; Coid J; Fryers T; Melzer D; Lewis G, 2005, 'Psychosis in the community and in prisons: A report from the British National Survey of Psychiatric Morbidity', American Journal of Psychiatry, vol. 162, pp. 774 - 780, http://dx.doi.org/10.1176/appi.ajp.162.4.774
Miller KE; Farrell MP; Barnes GM; Melnick MJ; Sabo D, 2005, 'Gender/racial differences in jock identity, dating, and adolescent sexual risk', Journal of Youth and Adolescence, vol. 34, pp. 123 - 136, http://dx.doi.org/10.1007/s10964-005-3211-0
Murphy RT; Mogensen J; McGarry K; Bahl A; Evans A; Osman E; Syrris P; Gorman G; Farrell M; Holton JL; Hanna MG; Hughes S; Elliott PM; Macrae CA; McKenna WJ, 2005, 'Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history.', J Am Coll Cardiol, vol. 45, pp. 922 - 930, http://dx.doi.org/10.1016/j.jacc.2004.11.053
Jenkins R; Bhugra D; Meltzer H; Singleton N; Bebbington P; Brugha T; Coid J; Farrell M; Lewis G; Paton J, 2005, 'Psychiatric and social aspects of suicidal behaviour in prisons', Psychological Medicine, vol. 35, pp. 257 - 269, http://dx.doi.org/10.1017/S0033291704002958
Brugha TS; Morgan Z; Bebbington P; Jenkins R; Lewis G; Farrell M; Meltzer H, 2005, 'Erratum: Social support networks and type of neurotic symptom among adults in British households (Psychological Medicine (2003) vol. 33 (307-318))', Psychological Medicine, vol. 35, pp. 301 - 302, http://dx.doi.org/10.1017/S0033291704004003
Wodak A; Ali R; Farrell M, 2005, 'HIV in injecting drug users in Asian countries: Authors' reply', BMJ, vol. 330, pp. 147, http://dx.doi.org/10.1136/bmj.330.7483.147-a
Wodak A; Ali R; Farrell M, 2005, 'HIV in injecting drug users in Asian countries - Reply', BRITISH MEDICAL JOURNAL, vol. 330, pp. 147 - 147, http://dx.doi.org/10.1136/bmj.330.7483.147-a
Farrell M; Gowing L; Marsden J; Ling W; Ali R, 2005, 'Effectiveness of drug dependence treatment in HIV prevention', International Journal of Drug Policy, vol. 16, pp. 67 - 75, http://dx.doi.org/10.1016/j.drugpo.2005.02.008
Mayet S; Farrell M; Ferri M; Amato L; Davoli M, 2005, 'Psychosocial treatment for opiate abuse and dependence', COCHRANE DATABASE OF SYSTEMATIC REVIEWS, http://dx.doi.org/10.1002/14651858.CD004330.pub2
Miller KE; Melnick MJ; Barnes GM; Farrell MP; Sabo D, 2005, 'Untangling the links among athletic involvement, gender, race, and adolescent academic outcomes', Sociology of Sport Journal, vol. 22, pp. 178 - 193, http://dx.doi.org/10.1123/ssj.22.2.178
Aquilina K; Nanra JS; Allcutt DA; Farrell M, 2005, 'Choroid plexus adenoma: case report and review of the literature.', Childs Nerv Syst, vol. 21, pp. 410 - 415, http://dx.doi.org/10.1007/s00381-004-1038-8
O'Brien D; Aquilina K; Farrell M; Breathnach F; Allcutt D, 2005, 'Cervical lipoblastomatosis producing quadriparesis: case report of surgery with chemotherapy and 10-year follow-up.', Childs Nerv Syst, vol. 21, pp. 165 - 170, http://dx.doi.org/10.1007/s00381-004-0949-8
Sinclair C; Mirakhur M; Kirk J; Farrell M; McQuaid S, 2005, 'Up-regulation of osteopontin and alphaBeta-crystallin in the normal-appearing white matter of multiple sclerosis: an immunohistochemical study utilizing tissue microarrays.', Neuropathol Appl Neurobiol, vol. 31, pp. 292 - 303, http://dx.doi.org/10.1111/j.1365-2990.2004.00638.x
O'Brien DF; Farrell M; Pidgeon CN, 2005, 'Combined nasal and skull base pathology: adjacent nasal schwannoma and olfactory groove meningioma.', Br J Neurosurg, vol. 19, pp. 446 - 448, http://dx.doi.org/10.1080/02688690500390433
Shahwan A; Farrell M; Delanty N, 2005, 'Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects.', Lancet Neurol, vol. 4, pp. 239 - 248, http://dx.doi.org/10.1016/S1474-4422(05)70043-0
Murray B; Lynch T; Farrell M, 2005, 'Clinicopathological features of the tauopathies.', Biochem Soc Trans, vol. 33, pp. 595 - 599, http://dx.doi.org/10.1042/BST0330595
Farrell M; Marshall EJ, 2004, 'Organization and delivery of treatment services for dual diagnosis', Psychiatry, vol. 3, pp. 62 - 64, http://dx.doi.org/10.1383/psyt.3.1.62.30295
Brugha T; Jenkins R; Bebbington P; Meltzer H; Lewis G; Farrell M, 2004, 'Risk factors and the prevalence of neurosis and psychosis in ethnic groups in Great Britain', Social Psychiatry and Psychiatric Epidemiology, vol. 39, pp. 939 - 946, http://dx.doi.org/10.1007/s00127-004-0830-9
Marshall EJ; Farrell M, 2004, 'Substance use and psychiatric comorbidity', Psychiatry, vol. 3, pp. 55 - 58, http://dx.doi.org/10.1383/psyt.3.1.55.30297
Williams A; Farrell M, 2004, 'Substance use and psychosis', Psychiatry, vol. 3, pp. 52 - 54, http://dx.doi.org/10.1383/psyt.3.1.52.30298
Gowing L; Farrell M; Ali R; White J, 2004, 'Alpha2 adrenergic agonists for the management of opioid withdrawal.', Cochrane database of systematic reviews (Online : Update Software)
Brugha TS; Bebbington PE; Singleton N; Melzer D; Jenkins R; Lewis G; Farrell M; Bhugra D; Lee A; Meltzer H, 2004, 'Trends in service use and treatment for mental disorders in adults throughout Great Britain', British Journal of Psychiatry, vol. 185, pp. 378 - 384, http://dx.doi.org/10.1192/bjp.185.5.378
Bebbington PE; Bhugra D; Brugha T; Singleton N; Farrell M; Jenkins R; Lewis G; Meltzer H, 2004, 'Psychosis, victimisation and childhood disadvantage: Evidence from the second British National Survey of Psychiatric Morbidity', British Journal of Psychiatry, vol. 185, pp. 220 - 226, http://dx.doi.org/10.1192/bjp.185.3.220
Ling W; Farrell M; Ali R, 2004, 'Cochrane systematic reviews: Time for an introduction and appraisal', Drug and Alcohol Dependence, vol. 73, pp. 217 - 218, http://dx.doi.org/10.1016/j.drugalcdep.2003.11.003
Johns LC; Cannon M; Singleton N; Murray RM; Farrell M; Brugha T; Bebbington P; Jenkins R; Meltzer H, 2004, 'Prevalence and correlates of self-reported psychotic symptoms in the British population', British Journal of Psychiatry, vol. 185, pp. 298 - 305, http://dx.doi.org/10.1192/bjp.185.4.298
Gowing L; Farrell M; Bornemann R; Ali R, 2004, 'Substitution treatment of injecting opioid users for prevention of HIV infection.', Cochrane database of systematic reviews (Online)
Wodak AD; Ali RL; Farrell M, 2004, 'HIV in injecting drug users in Asian countries', British Medical Journal: Clinical Research, vol. 329, pp. 697 - 698
Horan G; Keohane C; Molloy S; Howley R; Harney M; Heffernan J; McGuigan C; Hutchinson M; Brett F; Farrell M, 2004, 'Creutzfeldt-Jakob disease in Ireland: epidemiological aspects 1980-2002.', Eur Neurol, vol. 51, pp. 132 - 137, http://dx.doi.org/10.1159/000077063
Harney MS; Ghani AC; Donnelly CA; Walsh RM; Walsh M; Howley R; Brett F; Farrell M, 2003, 'vCJD risk in the Republic of Ireland.', BMC Infect Dis, vol. 3, pp. 28, http://dx.doi.org/10.1186/1471-2334-3-28
Boys A; Farrell M; Taylor C; Marsden J; Goodman R; Brugha T; Bebbington P; Jenkins R; Meltzer H, 2003, 'Psychiatric morbidity and substance use in young people aged 13-15 years: Results from the Child and Adolescent Survey of Mental Health', British Journal of Psychiatry, vol. 182, pp. 509 - 517, http://dx.doi.org/10.1192/bjp.182.6.509
Hickman M; Carnwath Z; Madden P; Farrell M; Rooney C; Ashcroft R; Judd A; Stimson G, 2003, 'Drug-Related Mortality and Fatal Overdose Risk: Pilot Cohort Study of Heroin Users Recruited from Specialist Drug Treatment Sites in London', Journal of Urban Health, vol. 80, pp. 274 - 287, http://dx.doi.org/10.1093/jurban/jtg030
Targosz S; Bebbington P; Lewis G; Brugha T; Jenkins R; Farrell M; Meltzer H, 2003, 'Lone mothers, social exclusion and depression', Psychological Medicine, vol. 33, pp. 715 - 722, http://dx.doi.org/10.1017/S0033291703007347
McGuigan C; O'Riordan S; Farrell M; Mitchell B; Hutchinson M, 2003, 'Case report: recurrent temporalis muscle swelling and headache.', Neurology, vol. 60, pp. 724 - 725, http://dx.doi.org/10.1212/01.wnl.0000048664.01003.e2
Lewis G; Bebbington P; Brugha T; Farrell M; Gill B; Jenkins R; Meltzer H, 2003, 'Socio-economic status, standard of living, and neurotic disorder', International Review of Psychiatry, vol. 15, pp. 91 - 96, http://dx.doi.org/10.1080/0954026021000045994
Meltzer H; Bebbington P; Brugha T; Farrell M; Jenkins R; Lewis G, 2003, 'The reluctance to seek treatment for neurotic disorders', International Review of Psychiatry, vol. 15, pp. 123 - 128, http://dx.doi.org/10.1080/0954026021000046038
Singleton N; Farrell M; Meltzer H, 2003, 'Substance misuse among prisoners in England and Wales', International Review of Psychiatry, vol. 15, pp. 150 - 152, http://dx.doi.org/10.1080/0954026021000046092
Farrell M; Howes S; Bebbington P; Brugha T; Jenkins R; Lewis G; Marsden J; Taylor C; Meltzer H, 2003, 'Nicotine, alcohol and drug dependence, and psychiatric comorbidity - Results of a national household survey', International Review of Psychiatry, vol. 15, pp. 50 - 56, http://dx.doi.org/10.1080/0954026021000045949
Jenkins R; Bebbington P; Brugha T; Farrell M; Gill B; Lewis G; Meltzer H; Petticrew M, 2003, 'The National Psychiatric Morbidity Surveys of Great Britain - Strategy and methods', International Review of Psychiatry, vol. 15, pp. 5 - 13, http://dx.doi.org/10.1080/0954026021000045895
Farrell M; Howes S; Taylor C; Lewis G; Jenkins R; Bebbington P; Jarvis M; Brugha T; Gill B; Meltzer H, 2003, 'Substance misuse and psychiatric comorbidity: An overview of the OPCS national psychiatric morbidity survey', International Review of Psychiatry, vol. 15, pp. 43 - 49, http://dx.doi.org/10.1080/0954026021000045930
Jenkins R; Bebbington P; Brugha T; Farrell M; Lewis G; Meltzer H, 2003, 'British Psychiatric Morbidity Survey', International Review of Psychiatry, vol. 15, pp. 14 - 18, http://dx.doi.org/10.1080/0954026021000045903
Jenkins R; Lewis G; Bebbington P; Brugha T; Farrell M; Gill B; Meltzer H, 2003, 'The national psychiatric morbidity surveys of Great Britain - Initial findings from the household survey', International Review of Psychiatry, vol. 15, pp. 29 - 42, http://dx.doi.org/10.1080/0954026021000045921
Brugha TS; Morgan Z; Bebbington P; Jenkins R; Lewis G; Farrell M; Meltzer H, 2003, 'Social support networks and type of neurotic symptom among adults in British households', Psychological Medicine, vol. 33, pp. 307 - 318, http://dx.doi.org/10.1017/S0033291702006505
Bebbington P; Brugha T; Meltzer H; Jenkins R; Ceresa C; Farrell M; Lewis G, 2003, 'Neurotic disorders and the receipt of psychiatric treatment', International Review of Psychiatry, vol. 15, pp. 108 - 114, http://dx.doi.org/10.1080/0954026021000046010
Bebbington P; Dunn G; Jenkins R; Lewis G; Brugha T; Farrell M; Meltzer H, 2003, 'The influence of age and sex on the prevalence of depressive conditions: Report from the National Survey of Psychiatric Morbidity', International Review of Psychiatry, vol. 15, pp. 74 - 83, http://dx.doi.org/10.1080/0954026021000045976
Bebbington P; Meltzer H; Brugha T; Farrell M; Jenkins R; Ceresa C; Lewis G, 2003, 'Unequal access and unmet need: Neurotic disorders and the use of primary care services', International Review of Psychiatry, vol. 15, pp. 115 - 122, http://dx.doi.org/10.1080/0954026021000046029
Coid JW; Petruckevitch A; Bebbington P; Jenkins R; Brugha T; Lewis G; Farrell M; Singleton N, 2003, 'Psychiatric morbidity in prisoners and solitary cellular confinement, I: Disciplinary segregation', Journal of Forensic Psychiatry and Psychology, vol. 14, pp. 298 - 319, http://dx.doi.org/10.1080/1478994031000095510
Coid JW; Petruckevitch A; Bebbington P; Jenkins R; Brugha T; Lewis G; Farrell M; Singleton N, 2003, 'Psychiatric morbidity in prisoners and solitary cellular confinement, II: Special ('strip') cells', Journal of Forensic Psychiatry and Psychology, vol. 14, pp. 320 - 340, http://dx.doi.org/10.1080/1478994031000095501
Boys A; Marsden J; Stillwell G; Hatchings K; Griffiths P; Farrell M, 2003, 'Minimizing respondent attrition in longitudinal research: Practical implications from a cohort study of adolescent drinking', Journal of Adolescence, vol. 26, pp. 363 - 373, http://dx.doi.org/10.1016/S0140-1971(03)00011-3
Gowing L; Farrell M; Ali R; White J, 2003, 'Alpha2 adrenergic agonists for the management of opioid withdrawal.', Cochrane database of systematic reviews (Online)
Gowing L; Farrell M; Ali R; White J, 2003, 'Alpha2 adrenergic agonists for the management of opioid withdrawal.', Cochrane database of systematic reviews (Online)
Lima MS; Reisser AA; Soares BG; Farrell M, 2003, 'Antidepressants for cocaine dependence.', Cochrane database of systematic reviews (Online)
Soares BG; Lima MS; Reisser AA; Farrell M, 2003, 'Dopamine agonists for cocaine dependence.', Cochrane database of systematic reviews (Online)
O'Brien DF; Farrell M; Fraher JP; Bolger C, 2003, 'Schwann cell invasion of the conus medullaris: case report.', Eur Spine J, vol. 12, pp. 328 - 331, http://dx.doi.org/10.1007/s00586-002-0484-9
Nurmi MH; Bishop M; Strain L; Brett F; McGuigan C; Hutchison M; Farrell M; Tilvis R; Erkkilä S; Simell O; Knight R; Haltia M, 2003, 'The normal population distribution of PRNP codon 129 polymorphism.', Acta Neurol Scand, vol. 108, pp. 374 - 378, http://dx.doi.org/10.1034/j.1600-0404.2003.00199.x
Doherty CP; Fitzsimons M; Meredith G; Thornton J; McMackin D; Farrell M; Phillips J; Staunton H, 2003, 'Rapid stereological quantitation of temporal neocortex in TLE.', Magn Reson Imaging, vol. 21, pp. 511 - 518, http://dx.doi.org/10.1016/s0730-725x(03)00078-x
O'Riordan S; McGuigan C; Farrell M; Hutchinson M, 2003, 'Progressive multifocal leucoencephalopathy presenting with Parkinsonism.', J Neurol, vol. 250, pp. 1379 - 1381, http://dx.doi.org/10.1007/s00415-003-0194-1
Caird J; Burke M; Roberts G; Brett F; Phillips J; Usher D; Bouchier-Hayes D; Farrell M, 2003, 'Apolipoprotein(A) expression in intracranial aneurysms.', Neurosurgery, vol. 52, pp. 854 - 858, http://dx.doi.org/10.1227/01.neu.0000054221.41435.0a
Coid J; Petruckevitch A; Bebbington P; Brugha T; Bhugra D; Jenkins R; Farrell M; Lewis G; Singleton N, 2002, 'Ethnic differences in prisoners 1: Criminality and psychiatric morbidity', British Journal of Psychiatry, vol. 181, pp. 473 - 480, http://dx.doi.org/10.1192/bjp.181.6.473
Coid J; Petruckevitch A; Bebbington P; Brugha T; Bhugra D; Jenkins R; Farrell M; Lewis G; Singleton N, 2002, 'Ethnic differences in prisoners 2: Risk factors and psychiatric service use', British Journal of Psychiatry, vol. 181, pp. 481 - 487, http://dx.doi.org/10.1192/bjp.181.6.481
Boys A; Farrell M; Bebbington P; Brugha T; Coid J; Jenkins R; Lewis G; Marsden J; Meltzer H; Singleton N; Taylor C, 2002, 'Drug use and initiation in prison: Results from a national prison survey in England and Wales', Addiction, vol. 97, pp. 1551 - 1560, http://dx.doi.org/10.1046/j.1360-0443.2002.00229.x
Farrell M; Boys A; Bebbington P; Brugha T; Coid J; Jenkins R; Lewis G; Meltzer H; Marsden J; Singleton N; Taylor C, 2002, 'Psychosis and drug dependence: Results from a national survey of prisoners', British Journal of Psychiatry, vol. 181, pp. 393 - 398, http://dx.doi.org/10.1192/bjp.181.5.393
O'Riordan S; McMonagle P; Janssen JC; Fox NC; Farrell M; Collinge J; Rossor MN; Hutchinson M, 2002, 'Presenilin-1 mutation (E280G), spastic paraparesis, and cranial MRI white-matter abnormalities.', Neurology, vol. 59, pp. 1108 - 1110, http://dx.doi.org/10.1212/wnl.59.7.1108
Silva De Lima M; Garcia De Oliveira Soares B; Pereira Reisser AA; Farrell M, 2002, 'Pharmacological treatment of cocaine dependence: A systematic review', Addiction, vol. 97, pp. 931 - 949, http://dx.doi.org/10.1046/j.1360-0443.2002.00209.x
Farrell M; Marsden J; Ali R; Ling W, 2002, 'Methamphetamine: Drug use and psychoses becomes a major public health issue in the Asia Pacific region', Addiction, vol. 97, pp. 771 - 772, http://dx.doi.org/10.1046/j.1360-0443.2002.00195.x
Farrell M, 2002, 'Drug War Heresies: Learning from Other Vices, Times, and Places', BMJ, vol. 325, pp. 108, http://dx.doi.org/10.1136/bmj.325.7355.108/a
Howells C; Allen S; Gupta J; Stillwell G; Marsden J; Farrell M, 2002, 'Prison based detoxification for opioid dependence: A randomised double blind controlled trial of lofexidine and methadone', Drug and Alcohol Dependence, vol. 67, pp. 169 - 176, http://dx.doi.org/10.1016/S0376-8716(02)00024-8
Best D; Noble A; Ridge G; Gossop M; Farrell M; Strang J, 2002, 'The relative impact of waiting time and treatment entry on drug and alcohol use', Addiction Biology, vol. 7, pp. 67 - 74, http://dx.doi.org/10.1080/135562101200100607
Gowing LR; Farrell M; Ali RL; White JM, 2002, 'α
Coid J; Bebbington P; Jenkins R; Brugha T; Lewis G; Farrell M; Singleton N, 2002, 'The national survey of psychiatric morbidity among prisoners and the future of prison healthcare', Medicine, Science and the Law, vol. 42, pp. 245 - 250, http://dx.doi.org/10.1177/002580240204200309
Ali R; Awwad E; Babor TF; Bradley F; Butau T; Farrell M; Formigoni MLOS; Isralowitz R; De Lacerda RB; Marsden J; McRee B; Monteiro M; Pal H; Rubio-Stipec M; Vendetti J, 2002, 'The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): Development, reliability and feasibility', Addiction, vol. 97, pp. 1183 - 1194, http://dx.doi.org/10.1046/j.1360-0443.2002.00185.x
Miller KE; Barnes GM; Melnick MJ; Sabo DF; Farrell MP, 2002, 'Gender and racial/ethnic differences in predicting adolescent sexual risk: Athletic participation versus exercise', Journal of Health and Social Behavior, vol. 43, pp. 436 - 450, http://dx.doi.org/10.2307/3090236
Miller KE; Barnes GM; Sabo DF; Melnick MJ; Farrell MP, 2002, 'Anabolic-androgenic steroid use and other adolescent problem behaviors: Rethinking the male athlete assumption', Sociological Perspectives, vol. 45, pp. 467 - 489+494+497+500, http://dx.doi.org/10.1525/sop.2002.45.4.467
Farrell M; Howes S; Bebbington P; Brugha T; Jenkins R; Lewis G; Marsden J; Taylor C; Meltzer H, 2001, 'Nicotine, alcohol and drug dependence and psychiatric comorbidity: Results of a national household survey', British Journal of Psychiatry, vol. 179, pp. 432 - 437, http://dx.doi.org/10.1192/bjp.179.5.432
Melnick MJ; Miller KE; Sabo DF; Farrell MP; Barnes GM, 2001, 'Tobacco use among high school athletes and nonathletes: Results of the 1997 youth risk behavior survey', Adolescence, vol. 36, pp. 726 - 747
Melnick MJ; Miller KE; Sabo DF; Farrell MP; Barnes GM, 2001, 'Tobacco use among high school athletes and nonatieletes: results of the 1997 youth risk behavior survey.', Adolescence, vol. 36, pp. 727 - 747
Bothwell S; Meredith GE; Phillips J; Staunton H; Doherty C; Grigorenko E; Glazier S; Deadwyler SA; O'Donovan CA; Farrell M, 2001, 'Neuronal hypertrophy in the neocortex of patients with temporal lobe epilepsy.', J Neurosci, vol. 21, pp. 4789 - 4800, https://www.ncbi.nlm.nih.gov/pubmed/11425906
Farrell M; Ritson B, 2001, 'Cannabis and health', British Journal of Psychiatry, vol. 178, pp. 98, http://dx.doi.org/10.1192/bjp.178.2.98
Keaney F; Strang J; Gossop M; Marshall EJ; Farrell M; Welch S; Hahn B; Gonzalez A, 2001, 'A double-blind randomized placebo-controlled trial of lofexidine in alcohol withdrawal: Lofexidine is not a useful adjunct to chlordiazepoxide', Alcohol and Alcoholism, vol. 36, pp. 426 - 430, http://dx.doi.org/10.1093/alcalc/36.5.426
Gowing L; Farrell M; Ali R; White J, 2001, 'Alpha2 adrenergic agonists for the management of opioid withdrawal.', Cochrane database of systematic reviews (Online)
Soares BG; Lima MS; Reisser AA; Farrell M, 2001, 'Dopamine agonists for cocaine dependence.', Cochrane database of systematic reviews (Online)
Mattick RP; Ali RL; Auriacombe M; Davoli M; Faggiano F; Farrell M; Ferri M; Ling W, 2001, 'Cochrane drugs and alcohol group: The development of systematic reviews of treatment outcomes', Alcohol and Alcoholism, vol. 36, pp. 109 - 111
McDonald D; Farrell ; McMenamin J, 2001, 'Rasmussen's syndrome associated with chronic brain stem encephalitis.', Eur J Paediatr Neurol, vol. 5, pp. 203 - 206, http://dx.doi.org/10.1053/ejpn.2000.0512
Little MA; O'Riordan A; Lucey B; Farrell M; Lee M; Conlon PJ; Walshe JJ, 2001, 'A prospective study of complications associated with cuffed, tunnelled haemodialysis catheters.', Nephrol Dial Transplant, vol. 16, pp. 2194 - 2200, http://dx.doi.org/10.1093/ndt/16.11.2194
Farrell M, 2001, 'Drugs: Dilemmas and Choices By a Working Party of the Royal College of Psychiatrists and the Royal College of Physicians. London: Gaskell. 2000. 304 pp. £9.50 (pb). ISBN 1 901242 447', British Journal of Psychiatry, vol. 178, pp. 484 - 484, http://dx.doi.org/10.1192/bjp.178.5.484
Anderson J; Baum M; Bero LA; Chalmers I; Chapman S; Deary IJ; Ebrahim S; Evans M; Farrell M; Greaves D; Higginson I; Hippisley-Cox J; James B; McKenzie H; Macaulay AC; Rabow M; Smyth RL; Stores G; Wolpert L, 2000, 'Music to be born to, music to die to.', BMJ, vol. 321, pp. 1577 - 1579, http://dx.doi.org/10.1136/bmj.321.7276.1577
Bebbington PE; Brugha TS; Meltzer H; Jenkins R; Ceresa C; Farrell M; Lewis G, 2000, 'Neurotic disorders and the receipt of psychiatric treatment', Psychological Medicine, vol. 30, pp. 1369 - 1376, http://dx.doi.org/10.1017/S0033291799002974
Bebbington PE; Meltzer H; Brugha TS; Farrell M; Jenkins R; Ceresa C; Lewis G, 2000, 'Unequal access and unmet need: Neurotic disorders and the use of primary care services', Psychological Medicine, vol. 30, pp. 1359 - 1367, http://dx.doi.org/10.1017/S0033291799002950
Lima AR; Lima MS; Soares BG; Churchill R; Farrell M, 2000, 'Carbamazepine for cocaine dependence.', Cochrane database of systematic reviews (Online : Update Software)
Keaney F; Farrell M, 2000, 'Safe approaches to treating drug addiction', Practitioner, vol. 244, pp. 410 - 425
Marsden J; Gossop M; Stewart D; Rolfe A; Farrell M, 2000, 'Psychiatric symptoms among clients seeking treatment for drug dependence: Intake data from the National Treatment Outcome Research Study', British Journal of Psychiatry, vol. 176, pp. 285 - 289, http://dx.doi.org/10.1192/bjp.176.3.285
Winstock AJ; Sheridan J; Lovell S; Farrell M; Strang J, 2000, 'National survey of hepatitis testing and vaccination services provided by drug services in England and Wales', European Journal of Clinical Microbiology and Infectious Diseases, vol. 19, pp. 823 - 828, http://dx.doi.org/10.1007/s100960000377
Bebbington P; Brugha T; Meltzer H; Farrell M; Ceresa C; Jenkins R; Lewis G, 2000, 'Psychiatric disorder and dysfunction in the UK National Survey of Psychiatric Morbidity', Social Psychiatry and Psychiatric Epidemiology, vol. 35, pp. 191 - 197, http://dx.doi.org/10.1007/s001270050227
Meltzer H; Bebbington P; Brugha T; Farrell M; Jenkins R; Lewis G, 2000, 'The reluctance to seek treatment for neurotic disorders', Journal of Mental Health, vol. 9, pp. 319 - 327, http://dx.doi.org/10.1080/713680243
Lima AR; Lima MS; Soares BG; Churchill R; Farrell M, 2000, 'Carbamazepine for cocaine dependence.', Cochrane database of systematic reviews (Online)
Strang J; Marsden J; Cummins M; Farrell M; Finch E; Gossop M; Stewart D; Welch S, 2000, 'Randomized trial of supervised injectable versus oral methadone maintenance: Report of feasibility and 6-month outcome', Addiction, vol. 95, pp. 1631 - 1645, http://dx.doi.org/10.1046/j.1360-0443.2000.951116314.x
Lima AR; Lima MS; Soares BG; Churchill R; Farrell M, 2000, 'Carbamazepine for cocaine dependence.', Cochrane database of systematic reviews (Online)
Fountain J; Strang J; Gossop M; Farrell M; Griffiths P, 2000, 'Diversion of prescribed drugs by drug users in treatment: Analysis of the UK market and new data from London', Addiction, vol. 95, pp. 393 - 406, http://dx.doi.org/10.1046/j.1360-0443.2000.95339310.x
Lima AR; Lima MS; Soares BG; Churchill R; Farrell M, 2000, 'Carbamazepine for cocaine dependence.', Cochrane database of systematic reviews (Online)
Best D; Harris J; Gossop M; Farrell M; Finch E; Noble A; Strang J, 2000, 'Use of non-prescribed methadone and other illicit drugs during methadone maintenance treatment', Drug and Alcohol Review, vol. 19, pp. 9 - 16, http://dx.doi.org/10.1080/09595230096093
Molloy S; O'Laoide R; Brett F; Farrell M, 2000, 'The "Pulvinar" sign in variant Creutzfeldt-Jakob disease.', AJR Am J Roentgenol, vol. 175, pp. 555 - 556, http://dx.doi.org/10.2214/ajr.175.2.1750555
Doherty CP; Fitzsimons M; Holohan T; Mohamed HB; Farrell M; Meredith GE; Staunton H, 2000, 'Accuracy and validity of stereology as a quantitative method for assessment of human temporal lobe volumes acquired by magnetic resonance imaging.', Magn Reson Imaging, vol. 18, pp. 1017 - 1025, http://dx.doi.org/10.1016/s0730-725x(00)00185-5
Caird J; Roberts G; Farrell M; Allcutt D, 2000, 'Self-inflicted head trauma using a captive bolt pistol: report of three cases.', Br J Neurosurg, vol. 14, pp. 349 - 351, http://dx.doi.org/10.1080/026886900417360
Caird J; McDermott M; Farrell M, 2000, 'March 2000: 5 month old boy with occipital bone mass.', Brain Pathol, vol. 10, pp. 317 - 319, http://dx.doi.org/10.1111/j.1750-3639.2000.tb00206.x
Ali R; Auriacombe M; Casas M; Cottler L; Farrell M; Kleiber D; Kreuzer A; Ogborne A; Rehm J; Ward P, 1999, 'Report of the external panel on the evaluation of the Swiss scientific studies of medically prescribed narcotics to drug addicts', Sucht, vol. 45, pp. 160 - 170
Bacchus L; Marsden J; Griffiths P; Gossop M; Farrell M; Clarke K; Strang J, 1999, 'Client Perceptions of Inpatient Treatment: A qualitative account with implications for service delivery', Drugs: Education, Prevention and Policy, vol. 6, pp. 87 - 97, http://dx.doi.org/10.1080/09687639997313
Fountain J; Griffiths P; Farrell M; Gossop M; Strang J, 1999, 'Benzodiazepines in Polydrug-using Repertoires: The impact of the decreased availability of temazepam gel-filled capsules', Drugs: Education, Prevention and Policy, vol. 6, pp. 60 - 69
Farrell M, 1999, 'Addicted', BMJ, vol. 318, pp. 404, http://dx.doi.org/10.1136/bmj.318.7180.404
Wolff K; Farrell M; Marsden J; Monteiro MG; Ali R; Welch S; Strang J, 1999, 'A review of biological indicators of illicit drug use, practical considerations and clinical usefulness', Addiction, vol. 94, pp. 1279 - 1298, http://dx.doi.org/10.1046/j.1360-0443.1999.94912792.x
Hickman M; Cox S; Harvey J; Howes S; Farrell M; Frischer M; Stimson G; Taylor C; Tilling K, 1999, 'Estimating the prevalence of problem drug use in inner London: A discussion of three capture-recapture studies', Addiction, vol. 94, pp. 1653 - 1662, http://dx.doi.org/10.1046/j.1360-0443.1999.941116534.x
Farrell M, 1999, 'Cannabis dependence and withdrawal', Addiction, vol. 94, pp. 1277 - 1278, http://dx.doi.org/10.1046/j.1360-0443.1999.94912771.x
Vingoe L; Welch S; Farrell M; Strang J, 1999, 'Heroin overdose among a treatment sample of injecting drug misusers: Accident or suicidal behaviour?', Journal of Substance Use, vol. 4, pp. 88 - 91, http://dx.doi.org/10.3109/14659899909053019
Fountain J; Griffiths P; Farrell M; Gossop M; Strang J, 1999, 'Benzodiazepinesin Polydrug-using Repertoires: The impact of the decreased availability of temazepam gel-filled capsules', Drugs: Education, Prevention and Policy, vol. 6, pp. 61 - 69, http://dx.doi.org/10.1080/09687639997296
Doherty CP; Meredith GE; Farrell M; Toland J; Staunton H, 1999, 'Radiological determination of the posterior limits of the temporal lobe for volumetric analysis.', Brain Res Brain Res Protoc, vol. 4, pp. 1 - 10, http://dx.doi.org/10.1016/s1385-299x(98)00053-1
Farrell M; Howes S; Taylor C; Lewis G; Jenkins R; Bebbington P; Jarvis M; Brugha T; Gill B; Meltzer H, 1998, 'Substance misuse and psychiatric comorbidity: An overview of the OPCS national psychiatric morbidity survey', Addictive Behaviors, vol. 23, pp. 909 - 918, http://dx.doi.org/10.1016/S0306-4603(98)00075-6
Venning GR; Wodak A; Hall W; Farrell M, 1998, 'The Swiss heroin trials (multiple letters) [1]', British Medical Journal, vol. 317, pp. 1011 - 1012
Venning GR; Wodak A; Hall W; Farrell M, 1998, 'The Swiss heroin trials', BMJ, vol. 317, pp. 1011, http://dx.doi.org/10.1136/bmj.317.7164.1011
Venning GR, 1998, 'The Swiss heroin trials - Trial is needed comparing decriminalisation of heroin with existing policy of prohibition', BRITISH MEDICAL JOURNAL, vol. 317, pp. 1011 - 1011, http://dx.doi.org/10.1136/bmj.317.7164.1011
Lewis G; Bebbington P; Brugha T; Farrell M; Gill B; Jenkins R; Meltzer H, 1998, 'Socioeconomic status, standard of living, and neurotic disorder', Lancet, vol. 352, pp. 605 - 609, http://dx.doi.org/10.1016/S0140-6736(98)04494-8
Farrell M; Strang J, 1998, 'Review: Family or couples therapy is more effective than non-family therapy for drug abuse: Commentary', Evidence-Based Mental Health, vol. 1, pp. 81, http://dx.doi.org/10.1136/ebmh.1.3.81
Fountain J; Griffiths P; Farrell M; Gossop M; Strang J, 1998, 'Diversion tactics: How a sample of drug misusers in treatment obtained surplus drugs to sell on the illicit market', International Journal of Drug Policy, vol. 9, pp. 159 - 167, http://dx.doi.org/10.1016/S0955-3959(98)00013-9
McManus C; Berman JW; Brett FM; Staunton H; Farrell M; Brosnan CF, 1998, 'MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study.', J Neuroimmunol, vol. 86, pp. 20 - 29, http://dx.doi.org/10.1016/s0165-5728(98)00002-2
Farrell M; Strang J, 1998, 'Britain's new strategy for tackling drugs misuse', British Medical Journal, vol. 316, pp. 1399 - 1400
Farrell M; Churchill R; Strang J, 1998, 'A programme of methadone maintenance plus moderate counselling services was cost effective: Commentary', Evidence-Based Mental Health, vol. 1, pp. 63, http://dx.doi.org/10.1136/ebmh.1.2.63
Marsden J; Gossop M; Farrell M; Strang J, 1998, 'Opioid substitution: Critical issues and future directions', JOURNAL OF DRUG ISSUES, vol. 28, pp. 243 - 263, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000074912000001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Farrell M; Hall W, 1998, 'The Swiss heroin trials: Testing alternative approaches', British Medical Journal, vol. 316, pp. 639, http://dx.doi.org/10.1136/bmj.316.7132.639
Farrell M, 1998, 'Therapeutic uses of cannabis; Marijuana myths and marijuana facts: A review of the scientific evidence', BMJ, vol. 316, pp. 239, http://dx.doi.org/10.1136/bmj.316.7126.239
Marsden J; Gossop M; Stewart D; Best D; Farrell M; Lehmann P; Edwards C; Strang J, 1998, 'The Maudsley Addiction Profile (MAP): A brief instrument for assessing treatment outcome', Addiction, vol. 93, pp. 1857 - 1867, http://dx.doi.org/10.1046/j.1360-0443.1998.9312185711.x
Marsden J; Griffiths P; Farrell M; Gossop M; Strang J, 1998, 'Cocaine in Britain: Prevalence, problems, and treatment responses', Journal of Drug Issues, vol. 28, pp. 225 - 242, http://dx.doi.org/10.1177/002204269802800113
Jenkins R; Bebbington P; Brugha TS; Farrell M; Lewis G; Meltzer H, 1998, 'British psychiatric morbidity survey', British Journal of Psychiatry, vol. 173, pp. 4 - 7, http://dx.doi.org/10.1192/bjp.173.1.4
Strang J; Bearn J; Farrell M; Finch E; Gossop M; Griffiths P; Marsden J; Wolff K, 1998, 'Route of drug use and its implications for drug effect, risk of dependence and health consequences', Drug and Alcohol Review, vol. 17, pp. 197 - 211, http://dx.doi.org/10.1080/09595239800187001
Marsden J; Gossop M; Farrell M; Strang J, 1998, 'Opioid substitution: Critical issues and future directions', Journal of Drug Issues, vol. 28, pp. 243 - 264, http://dx.doi.org/10.1177/002204269802800114
Bebbington PE; Dunn G; Jenkins R; Lewis G; Brugha T; Farrell M; Meltzer H, 1998, 'The influence of age and sex on the prevalence of depressive conditions: Report from the National Survey of Psychiatric Morbidity', Psychological Medicine, vol. 28, pp. 9 - 19, http://dx.doi.org/10.1017/S0033291797006077
Wodak A, 1998, 'The Swiss heroin trials. Further studies of heroin treatment are needed.', BMJ (Clinical research ed.), vol. 317
Reifman A; Barnes GM; Dintcheff BA; Farrell MP; Uhteg L, 1998, 'Parental and peer influences on the onset of heavier drinking among adolescents', Journal of Studies on Alcohol, vol. 59, pp. 311 - 317, http://dx.doi.org/10.15288/jsa.1998.59.311
Roberts G; Allcutt D; Farrell M, 1998, 'Embolic bacterial aneurysm of the basilar artery: case report.', Br J Neurosurg, vol. 12, pp. 440 - 444, http://dx.doi.org/10.1080/02688699844664
Brett FM; Costigan D; Farrell MA; Heaphy P; Thornton J; King MD, 1998, 'Merosin-deficient congenital muscular dystrophy and cortical dysplasia.', Eur J Paediatr Neurol, vol. 2, pp. 77 - 82, http://dx.doi.org/10.1016/s1090-3798(98)80045-7
Finch E; Griffiths P; Farrell M, 1998, 'HCV policies—where do we go?', International Journal of Drug Policy, vol. 9, pp. 1 - 2, http://dx.doi.org/10.1016/s0955-3959(97)00010-8
Farrell M; Marsden J; Finch E; Gossop M; Strang J, 1998, 'Opiate substitution treatment combining opiate agonist treatment with appropriate psychosocial interventions and maintaining quality of care', European Neuropsychopharmacology, vol. 8, pp. S70 - S71, http://dx.doi.org/10.1016/s0924-977x(98)80030-8
Best D; Gossop M; Marsden J; Farrell M; Strang J, 1997, 'Time of day of methadone consumption and illicit heroin use', Drug and Alcohol Dependence, vol. 49, pp. 49 - 54, http://dx.doi.org/10.1016/S0376-8716(97)00138-5
Farrel M; Gerada C, 1997, 'Drug misusers: Whose business is it?: Shared care can work well, but drug misusers still need specialist services', BMJ, vol. 315, pp. 559 - 560, http://dx.doi.org/10.1136/bmj.315.7108.559
Polkinghorne J; Strang J; Farrell M, 1997, 'Mistake in report: Hepatitis B vaccination for drug misusers is recommended [11]', British Medical Journal, vol. 315, pp. 61
Jenkins R; Lewis G; Bebbington P; Brugha T; Farrell M; Gill B; Meltzer H, 1997, 'The National Psychiatric Morbidity Surveys of Great Britain - initial findings from the Household Survey', Psychological Medicine, vol. 27, pp. 775 - 789, http://dx.doi.org/10.1017/S0033291797005308
Jenkins R; Bebbington P; Brugha T; Farrell M; Gill B; Lewis G; Meltzer H; Petticrew M, 1997, 'The national psychiatric morbidity surveys of great britain - strategy and methods', Psychological Medicine, vol. 27, pp. 765 - 774, http://dx.doi.org/10.1017/S003329179700531X
Farrell M, 1997, 'R & D for LSD?', BMJ, vol. 314, pp. 614, http://dx.doi.org/10.1136/bmj.314.7080.614
Strang J; Finch E; Hankinson L; Farrell M; Taylor C; Gossop M, 1997, 'Methadone treatment for opiate addiction: Benefits in the first month', Addiction Research and Theory, vol. 5, pp. 71 - 76, http://dx.doi.org/10.3109/16066359709005583
Neeleman J; Farrell M, 1997, 'Fatal methadone and heroin overdoses: Time trends in England and Wales', Journal of Epidemiology and Community Health, vol. 51, pp. 435 - 437, http://dx.doi.org/10.1136/jech.51.4.435
Neeleman J; Farrell M, 1997, 'Suicide and substance misuse', British Journal of Psychiatry, vol. 171, pp. 303 - 304, http://dx.doi.org/10.1192/bjp.171.4.303
Sell L; Farrell M; Robson P, 1997, 'Prescription of diamorphine, dipipanone and cocaine in England and Wales', Drug and Alcohol Review, vol. 16, pp. 221 - 226, http://dx.doi.org/10.1080/09595239800187401
Hall WD; Farrell MP, 1997, 'Comorbidity of mental disorders with substance misuse', British Journal of Psychiatry, vol. 171, pp. 4 - 5, http://dx.doi.org/10.1192/bjp.171.1.4
McEntagart M; Droogan O; Burke M; Brett F; Murphy S; Farrell M, 1997, 'Mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) in a Donegal kindred--clinical features and molecular genetic analysis.', Ir Med J, vol. 90, pp. 144 - 145, https://www.ncbi.nlm.nih.gov/pubmed/9267093
Hardiman O; Molloy F; Brett F; Farrell M, 1997, 'Inflammatory myopathy in thyrotoxicosis.', Neurology, vol. 48, pp. 339 - 341, http://dx.doi.org/10.1212/wnl.48.2.339
Phillips J; Roberts G; Bolger C; el Baghdady A; Bouchier-Hayes D; Farrell M; Collins P, 1997, 'Lipoprotein (a): a potential biological marker for unruptured intracranial aneurysms.', Neurosurgery, vol. 40, pp. 1112 - 1115, http://dx.doi.org/10.1097/00006123-199705000-00067
Farrell M; OʼConnell S; Burke M; Droogan O; Brett F, 1997, 'COMBINED CYTOCHROME OXIDASE (COX) AND SUCCINIC DEHYDROGENASE (SDH) MUSCLE HISTOCHEMISTRY IN THE EVALUATION OF SUSPECTED MITOCHONDRIAL DISEASE', Journal of Neuropathology and Experimental Neurology, vol. 56, pp. 619 - 619, http://dx.doi.org/10.1097/00005072-199705000-00205
Sell L; Finch E; Farrell M; Sheridan J; Strang J, 1996, 'Directly observed treatment for tuberculosis', BMJ, vol. 313, pp. 45, http://dx.doi.org/10.1136/bmj.313.7048.45a
Sell L; Finch E; Farrell M; Sheridan J; Strang J, 1996, 'Directly observed treatment for tuberculosis. Could be provided by community pharmacists supervising consumption of methadone.', BMJ (Clinical research ed.), vol. 313, pp. 45
Strang J; Darke S; Hall W; Farrell M; Ali R, 1996, 'Heroin overdose: The case for take-home naloxone - Home based supplies of naloxone would save lives', BRITISH MEDICAL JOURNAL, vol. 312, pp. 1435 - 1436, http://dx.doi.org/10.1136/bmj.312.7044.1435
Strang J; Darke S; Hall W; Farrell M; Ali R, 1996, 'Heroin overdose: The case for take-home naloxone', British Medical Journal, vol. 312, pp. 1435 - 1436, http://dx.doi.org/10.1136/bmj.312.7044.1435
Farrell M; Neeleman J; Griffiths P; Strang J, 1996, 'Suicide and overdose among opiate addicts.', Addiction (Abingdon, England), vol. 91, pp. 321 - 323, http://dx.doi.org/10.1111/j.1360-0443.1996.tb02282.x
Thomas G; Farrell MP; Barnes GM, 1996, 'The effects of single-mother families and nonresident fathers on delinquency and substance abuse in black and white adolescents', Journal of Marriage and Family, vol. 58, pp. 884 - 894, http://dx.doi.org/10.2307/353977
Finch EJL; Strang J; Hankinson L; Gossop M; Farrell M; Taylor C, 1996, 'Methadone maintenance or withdrawal: How realistic is it to conduct a controlled trial?', European Psychiatry, vol. 11, pp. 234s - 235s, http://dx.doi.org/10.1016/0924-9338(96)88701-3
Farrell M; Neeleman J; Gossop M; Griffiths P; Finch E; Strang J, 1996, 'Delivery of methadone maintenance in the European union', European Psychiatry, vol. 11, pp. 234s - 234s, http://dx.doi.org/10.1016/0924-9338(96)88700-1
Cotter D; Takei N; Farrell M; Sham P; Quinn P; Larkin C; Oxford J; Murray RM; O'Callaghan E, 1995, 'Does prenatal exposure to influenza in mice induce pyramidal cell disarray in the dorsal hippocampus?', Schizophrenia Research, vol. 16, pp. 233 - 241, http://dx.doi.org/10.1016/0920-9964(94)E0082-I
Mattick R; Hall W; Ward J; Farrell M; Gossop M; Strang J; Stimson G, 1995, 'Methadone maintenance treatment', BMJ, vol. 310, pp. 1408, http://dx.doi.org/10.1136/bmj.310.6991.1408
Alagona P; Altus P; Carrubba C; Duplis R; Langdon J; Marriott HJ; Rosenberg D; Farrell M, 1995, 'Prehospital actions by health-care providers and physicians.', The Journal of the Florida Medical Association, vol. 82, pp. 100 - 107
Farrell M; Strang J, 1995, 'Compressed opiate withdrawal syndrome and naltrexone', Journal of Psychopharmacology, vol. 9, pp. 383 - 385, http://dx.doi.org/10.1177/026988119500900414
Bolger C; Phillips J; Gilligan S; Zourob T; Farrell M; Croake D; Collins P; Bouchier-Hayes D, 1995, 'Elevated levels of lipoprotein (a) in association with cerebrovascular saccular aneurysmal disease.', Neurosurgery, vol. 37, pp. 241 - 245, http://dx.doi.org/10.1227/00006123-199508000-00008
Bolger C; Phillips J; Gilligan S; Zourob T; Farrell M; Croake D; Collins P; Bouchier-Hayes D, 1995, 'Elevated Levels of Lipoprotein (a) in Association with Cerebrovascular Saccular Aneurysmal Disease', Neurosurgery, vol. 37, pp. 241???245 - 241???245, http://dx.doi.org/10.1097/00006123-199508000-00008
Farrell M; Ward J; Mattick R; Hall W; Stimson GV; Des Jarlais D; Gossop M; Strang J, 1994, 'Fortnightly Review: Methadone maintenance treatment in opiate dependence: A review', BMJ, vol. 309, pp. 997, http://dx.doi.org/10.1136/bmj.309.6960.997
Barer D; Finch E; Gossop M; Hankinson L; Taylor C; Farrell M; Strang J; Thornton H, 1994, 'Patients' preferences and randomised trials', The Lancet, vol. 344, pp. 688 - 689, http://dx.doi.org/10.1016/S0140-6736(94)92124-5
Barer D, 1994, 'Patients' preferences and randomised trials.', Lancet, vol. 344, pp. 688, https://www.ncbi.nlm.nih.gov/pubmed/7915376
Farrell M; Strang J, 1994, 'Drug users in prison', BMJ, vol. 309, pp. 271, http://dx.doi.org/10.1136/bmj.309.6949.271b
NEELEMAN J; UNWIN C; FARREL M, 1994, 'HEPATITIS-C VIRUS-INFECTION - PSYCHOSOCIAL IMPACT SIMILAR TO THAT OF HIV-INFECTION', BRITISH MEDICAL JOURNAL, vol. 308, pp. 1710 - 1710, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994NU48300051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Strang J; Farrell M, 1994, 'Treatment of heroin users', BMJ, vol. 308, pp. 718, http://dx.doi.org/10.1136/bmj.308.6930.718c
Farrell M; Strang J; Neeleman J; Reuter P, 1994, 'Policy on drug misuse in Europe', BMJ, vol. 308, pp. 609, http://dx.doi.org/10.1136/bmj.308.6929.609
Neeleman J; Beaseley R; Farrell M, 1994, 'Healthy alliances with drug dealers', BMJ, vol. 308, pp. 417, http://dx.doi.org/10.1136/bmj.308.6925.417a
Farrell M, 1994, 'Methadone treatment programmes in the United Kingdom', Annales de Medecine Interne, vol. 145, pp. 34 - 35
Farrell M; Strang J, 1994, 'Drug users in prison [12]', British Medical Journal, vol. 309, pp. 271 - 272
Wodak A, 1994, 'Olympian ideas or pragmatism?', Addiction, vol. 89, pp. 803 - 814, http://dx.doi.org/10.1111/j.1360-0443.1994.tb00975.x
FARRELL M, 1994, 'Opiate withdrawal', Addiction, vol. 89, pp. 1471 - 1475, http://dx.doi.org/10.1111/j.1360-0443.1994.tb03745.x
Finch E; Strang J; Farrell M, 1994, 'Methadone‐maintenance and the prognosis paradox', Addiction, vol. 89, pp. 812 - 813, http://dx.doi.org/10.1111/j.1360-0443.1994.tb00982.x
Farrell M, 1994, 'Cocaine: Physiological and Physiopathological Effects. Edited by Alfonso Paredes and David A. Gorelick. New York: Haworth. 1992. 130 pp. US $26.95 (hb) or $23.95 (pb).', British Journal of Psychiatry, vol. 165, pp. 708 - 709, http://dx.doi.org/10.1192/s0007125000073530
Beigi B; Loaan P; Eustace P; Farrell M, 1994, 'Clinical research: Ragged-red fibres in the orbicularis oculi muscle and their significance', Orbit, vol. 13, pp. 113 - 117, http://dx.doi.org/10.3109/01676839409031145
Coleman K; Baak JP; Dorman A; Mullaney J; Curran B; Tiernan D; Farrell M; Fenton M; Leader M, 1993, 'Deoxyribonucleic acid ploidy studies in choroidal melanomas.', Am J Ophthalmol, vol. 115, pp. 376 - 383, http://dx.doi.org/10.1016/s0002-9394(14)73592-5
Strang J; Farrell M, 1993, 'Drug regimens that break a country's drug laws [31]', British Medical Journal, vol. 307, pp. 1010
Cotter D; Takei N; Larkin C; Sham P; Murray RM; Farrell M; Oxford J; O'Callaghan E, 1993, 'Does prenatal exposure to influenza induce pyramidal cell disarray in mice?', Schizophrenia Research, vol. 9, pp. 147 - 147, http://dx.doi.org/10.1016/0920-9964(93)90257-j
Coleman K; Baak JP; Van Diest P; Mullaney J; Farrell M; Fenton M, 1993, 'Prognostic factors following enucleation of 111 uveal melanomas.', Br J Ophthalmol, vol. 77, pp. 688 - 692, http://dx.doi.org/10.1136/bjo.77.11.688
Power WJ; Mullaney P; Farrell M; Collum LM, 1993, 'Effect of topical cyclosporin A on conjunctival T cells in patients with secondary Sjögren's syndrome.', Cornea, vol. 12, pp. 507 - 511, http://dx.doi.org/10.1097/00003226-199311000-00008
Farrell M, 1992, 'Smoke free flying', British Journal of Addiction, vol. 87, pp. 137
FARRELL M; STRANG J, 1992, 'MEDICINE IN EUROPE .11. ALCOHOL AND DRUGS', BRITISH MEDICAL JOURNAL, vol. 304, pp. 489 - 491, http://dx.doi.org/10.1136/bmj.304.6825.489
Farrell M; Strang J, 1992, 'Alcohol and drugs', British Medical Journal, vol. 304, pp. 489 - 491, http://dx.doi.org/10.1136/bmj.304.6825.489
Unnithan S; Farrell M, 1992, 'Substance misusers attending a psychiatric emergency clinic', Journal of Mental Health, vol. 1, pp. 163 - 168, http://dx.doi.org/10.3109/09638239209034528
Strang J; Farrell M, 1992, 'Maintenance treatment with methadone [12]', British Medical Journal, vol. 305, pp. 182
Farrell M, 1992, 'NIDA notes', British Journal of Addiction, vol. 87, pp. 138
Farrell M, 1992, 'Sensible drinking, UK', British Journal of Addiction, vol. 87, pp. 139 - 140
Strang J; Seivewright N; Farrell M, 1992, 'Intravenous and other novel abuses of benzodiazepines: the opening of Pandora's box?', British Journal of Addiction, vol. 87, pp. 1373 - 1375, http://dx.doi.org/10.1111/j.1360-0443.1992.tb01916.x
Farrell M, 1992, 'ACMD training report', British Journal of Addiction, vol. 87, pp. 140
Farrell M, 1992, 'Research centres reorganize', British Journal of Addiction, vol. 87, pp. 137 - 138
Campion P; Farrell M, 1992, 'Opening up addictions training', British Journal of Addiction, vol. 87, pp. 1237 - 1240, http://dx.doi.org/10.1111/j.1360-0443.1992.tb02732.x
Farrell M, 1992, 'HIV outreach', British Journal of Addiction, vol. 87, pp. 140
Strang J; Farrell M, 1992, 'Harm minimisation for drug misusers', British Medical Journal, vol. 304, pp. 1127 - 1128, http://dx.doi.org/10.1136/bmj.304.6835.1127
Battersby M; Farrell M; Gossop M; Robson P; Strang J, 1992, '‘Horse trading’: prescribing injectable opiates to opiate addicts. A descriptive study', Drug and Alcohol Review, vol. 11, pp. 35 - 42, http://dx.doi.org/10.1080/09595239200185061
Keogan M; McMackin D; Peng S; Phillips J; Burke T; Murphy S; Farrell M; Staunton H, 1992, 'Temporal neocorticectomy in management of intractable epilepsy: long-term outcome and predictive factors.', Epilepsia, vol. 33, pp. 852 - 861, http://dx.doi.org/10.1111/j.1528-1157.1992.tb02193.x
Farrell M, 1992, 'Crack cocaine: A practical treatment approach for the chemically dependent', Journal of Psychosomatic Research, vol. 36, pp. 291 - 292, http://dx.doi.org/10.1016/0022-3999(92)90101-7
Farrell M, 1991, 'Cocaine and HIV.', BMJ (Clinical research ed.), vol. 303, pp. 330
BURNS A; FARRELL M; CHRISTIEBROWN J, 1991, 'GENDER-IDENTITY CLINIC PATIENTS - REPLY', BRITISH JOURNAL OF PSYCHIATRY, vol. 158, pp. 715 - 715, http://dx.doi.org/10.1192/S0007125000023904
Farrell M; Strang J, 1991, 'Substance Use and Misuse in Childhood and Adolescence', Journal of Child Psychology and Psychiatry, vol. 32, pp. 109 - 128, http://dx.doi.org/10.1111/j.1469-7610.1991.tb00005.x
Farrell M; Strang J, 1991, 'Drugs, HIV, and prisons', British Medical Journal, vol. 302, pp. 1477 - 1478, http://dx.doi.org/10.1136/bmj.302.6791.1477
Farrell M; Strang J; Patel R; Kinghorn GR; Kudesia G, 1991, 'Failure to deliver hepatitis B vaccine [5]', British Medical Journal, vol. 303, pp. 309 - 310
Cranfield S; Dixon A, 1991, 'Training issues', British Journal of Addiction, vol. 86, pp. 917 - 917, http://dx.doi.org/10.1111/j.1360-0443.1991.tb01848.x
Farrell M, 1991, 'British AIDS funding: unfair distribution.', British journal of addiction, vol. 86, pp. 113
Farrell M, 1991, 'A Reply', British Journal of Addiction, vol. 86, pp. 917 - 917, http://dx.doi.org/10.1111/j.1360-0443.1991.tb01849.x
Collum LM; Power WJ; Mullaney J; Farrell M, 1991, 'Limbal xanthogranuloma.', J Pediatr Ophthalmol Strabismus, vol. 28, pp. 157 - 159, http://dx.doi.org/10.3928/0191-3913-19910501-10
O'Connor G; Dinn J; Farrell M; Phillips J; Stack J; Eustace P, 1991, 'Pituitary apoplexy in an ectopic pituitary tumour.', Eur J Ophthalmol, vol. 1, pp. 33 - 38, http://dx.doi.org/10.1177/112067219100100107
Noonan C; Farrell M; Mullaney J; Cassidy H; Asghar MA; Young BJ; Hickey-Dwyer M; Patterson A; Power W; Hillery M; Benedict-Smith A; Collum LMT; Fitzsimon S; O’Donoghue E; Hitchings R; Arden GB; O’Mahony A; Murray A; Whyte A; Shehata M; O’Donoghue H; Robinson R; Toland J; Eustace P, 1991, 'Royal Academy of Medicine in Ireland Section of Ophthalmology Proceedings of meeeting of the Section of Ophthalmology, April 1990', Irish Journal of Medical Science, vol. 160, pp. 322 - 324, http://dx.doi.org/10.1007/bf02957864
Farrell M, 1991, 'Relapse Prevention for Addictive Behaviours: A Manual for Therapists. By Shamil Wanigaratne, Wendy Wallace, Jane Pullin, Francis Keaney and Roger Farmer. Oxford: Blackwell Scientific Publications. 1990. 205 pp. £12.95.', British Journal of Psychiatry, vol. 158, pp. 875 - 875, http://dx.doi.org/10.1192/s0007125000141819
Farrell M, 1990, 'HIV and AIDS in European prisons.', British journal of addiction, vol. 85, pp. 1669 - 1670
Farrell M, 1990, 'UK Home Office notification statistics for 1989.', British journal of addiction, vol. 85, pp. 971 - 972
Farrell M, 1990, 'Thailand and AIDS.', British journal of addiction, vol. 85, pp. 817
Farrell M, 1990, 'Beyond Platitudes: Problem Drug Use: a review of training', British Journal of Addiction, vol. 85, pp. 1559 - 1562, http://dx.doi.org/10.1111/j.1360-0443.1990.tb01642.x
Farrell M, 1990, 'Hepatitis B vaccination', British Journal of Addiction, vol. 85, pp. 428
Farrell M, 1990, 'Hair analysis', British Journal of Addiction, vol. 85, pp. 428
Farrell M, 1990, 'Acid house parties in UK', British Journal of Addiction, vol. 85, pp. 427 - 428
Burns A; Farrell M; Brown JC, 1990, 'Clinical features of patients attending a gender-identity clinic', British Journal of Psychiatry, vol. 157, pp. 265 - 268, http://dx.doi.org/10.1192/bjp.157.2.265
Farrell M, 1990, 'Russia's alcohol policy U turn', British Journal of Addiction, vol. 85, pp. 427
FARRELL M; STRANG J, 1990, 'The lure of masterstrokes: drug legalization', British Journal of Addiction, vol. 85, pp. 5 - 7, http://dx.doi.org/10.1111/j.1360-0443.1990.tb00617.x
Strang J; Farrell M; Meadows G, 1990, 'Misuse of dihydrocodeine tartrate (DF 118) among opiate addicts (II)', British Medical Journal, vol. 301, pp. 119
FARRELL M; LEWIS G, 1990, 'Discrimination on the grounds of diagnosis', British Journal of Addiction, vol. 85, pp. 883 - 890, http://dx.doi.org/10.1111/j.1360-0443.1990.tb03718.x
FARRELL M; BATTERSBY M; STRANG J, 1990, 'Screening for hepatitis B and vaccination of injecting drug users in NHS drug treatment services', British Journal of Addiction, vol. 85, pp. 1657 - 1659, http://dx.doi.org/10.1111/j.1360-0443.1990.tb01656.x
Gerada C; Farrell M; Dawe S, 1990, 'Management of the pregnant opiate user', British Journal of Hospital Medicine, vol. 43, pp. 138 - 141
Farrell M; Herrod J; Smith B; Strang J, 1990, 'Detection of intravenous drug use', British Medical Journal, vol. 300, pp. 612 - 613, http://dx.doi.org/10.1136/bmj.300.6724.612-d
Farrell M; Strang J, 1990, 'Confusion between the drug legalization and the drug prescribing debate', Drug and Alcohol Review, vol. 9, pp. 364 - 368, http://dx.doi.org/10.1080/09595239000185521
Battersby M; Farrell M; Strang J, 1990, 'Pharmaceutical heroin and ‘chasing the dragon’From Malcolm Battersby, Michael Farrell & John Strong', British Journal of Addiction, vol. 85, pp. 151 - 151, http://dx.doi.org/10.1111/j.1360-0443.1990.tb00637.x
Farrell M, 1990, 'Alcoholism. A guide to diagnosis, intervention and treatment', Journal of Psychosomatic Research, vol. 34, pp. 597 - 597, http://dx.doi.org/10.1016/0022-3999(90)90041-2
Farrell M, 1989, 'US heterosexual HIV.', British journal of addiction, vol. 84, pp. 1553
MCINTYRE K; FARRELL M; DAVID A, 1989, 'INPATIENT PSYCHIATRIC-CARE - THE PATIENTS VIEW', BRITISH JOURNAL OF MEDICAL PSYCHOLOGY, vol. 62, pp. 249 - 255, http://dx.doi.org/10.1111/j.2044-8341.1989.tb02833.x
FARRELL M; DAWE S; STRANG J, 1989, 'OBSTETRIC LIAISON', BRITISH JOURNAL OF PSYCHIATRY, vol. 155, pp. 264 - 265, http://dx.doi.org/10.1192/bjp.155.2.264b
Strang J; Farrell M; Battersby M; Gossop M, 1989, 'Decriminalising possession of drugs.', BMJ (Clinical research ed.), vol. 299, pp. 320, http://dx.doi.org/10.1136/bmj.299.6694.320
Herrod J; Farrell M; Strang J, 1989, 'Cleaning injecting equipment: A message gone wrong?', British Medical Journal, vol. 299, pp. 601, http://dx.doi.org/10.1136/bmj.299.6699.601
Farrell M, 1989, 'Addictions and the Media', British Journal of Addiction, vol. 84, pp. 841 - 841, http://dx.doi.org/10.1111/j.1360-0443.1989.tb00751.x
Strong J; Gossop M; Griffiths P; Farrell M, 1989, 'The Technology of Dragon Chasing', British Journal of Addiction, vol. 84, pp. 699 - 699, http://dx.doi.org/10.1111/j.1360-0443.1989.tb03490.x
McIntyre K; Farrell M; David AS, 1989, 'What do psychiatric inpatients really want?', British Medical Journal, vol. 298, pp. 159 - 160, http://dx.doi.org/10.1136/bmj.298.6667.159
McIntyre K; Farrell M; David A, 1989, 'In‐patient psychiatric care: The patient's view', British Journal of Medical Psychology, vol. 62, pp. 249 - 255, http://dx.doi.org/10.1111/j.2044-8341.1989.tb02833.x
Farrell M, 1989, 'Ecstasy and the Oxygen of Publicity', British Journal of Addiction, vol. 84, pp. 943 - 943, http://dx.doi.org/10.1111/j.1360-0443.1989.tb00768.x
Strang J; Orgel M; Farrell M, 1989, 'Well users clinic for illicit drug users.', BMJ (Clinical research ed.), vol. 298, pp. 1310, http://dx.doi.org/10.1136/bmj.298.6683.1310
Strang J; Farrell M, 1989, 'HIV and drug misuse: Forcing the process of change', Current Opinion in Psychiatry, vol. 2, pp. 402 - 407, http://dx.doi.org/10.1097/00001504-198906000-00011
Appleby L; Lewis G; Cawley RH; Marks I; Taylor P; Levy R; Bergmann K; Temple N; Toone B; Wolkind S; Joyce E; Gill M; Guinness E; Farrell M; Nimgaonkar VL; Chee D; Mynors-Wallis L; Jones P; Thompson P; Brown R; Ring H; Gerada C; Bearn J; Potts SG; Beats BC; Pilowsky L; Jackson J; Searle GF; Lloyd K; Fox H; Moodley P; Maden T; Lewis SW; Orrell MW; Murphy D; Levy WJ; Green B; Buchanan A; Perkins MJ; Misch P; Mezey G; Murphy M; David A; Kerwin R; Pezeshgi S; Abas M; Silverstone P; Stone JH; O.'Sullivan G; Araya R; Ball R; Palazidou E; Milton J; Pelosi AJ; Carrick J; Bhugra D; Hollis C; Berelowitz M; Fisher NR; Brooke D; Hindler C; Battersby M; Seltzer A, 1988, 'An open letter to the President', Psychiatric Bulletin, vol. 12, pp. 554 - 554, http://dx.doi.org/10.1192/pb.12.12.554-a
Farrell M, 1988, 'Young People and Alcohol', British Journal of Addiction, vol. 83, pp. 1137 - 1138, http://dx.doi.org/10.1111/j.1360-0443.1988.tb03019.x
Farrell MP; David AS, 1988, 'Do psychiatric registrars take a proper drinking history?', British Medical Journal (Clinical research ed.), vol. 296, pp. 395 - 396, http://dx.doi.org/10.1136/bmj.296.6619.395
Farrell M; Strang J; Drake J; Ballard R, 1988, 'Misuse of temazepam', British Medical Journal, vol. 297, pp. 1402
Appleby L; Lewis G; Cawley RH; Marks I; Taylor P; Levy R; Bergmann K; Temple N; Toone B; Wolkind S; Joyce E; Gill M; Guinness E; Farrell M; Nimgaonkar VL; Chee D; Mynors-Wallis L; Jones P; Thompson P; Brown R; Ring H; Gerada C; Bearn J; Potts SG; Beats BC; Pilowsky L; Jackson J; Searle GF; Lloyd K; Fox H; Moodley P; Maden T; Lewis SW; Orrell MW; Murphy D; Levy WJ; Green B; Buchanan A; Perkins MJ; Misch P; Mezey G; Murphy M; David A; Kerwin R; Pezeshgi S; Abas M; Silverstone P; Stone JH; 'Sullivan GO; Araya R; Ball R; Palazidou E; Milton J; Pelosi AJ; Carrick J; Bhugra D; Hollis C; Berelowitz M; Fisher NR; Brooke D; Hindler C; Battersby M; Seltzer A, 1988, 'An open letter to the President', Psychiatric Bulletin, vol. 12, pp. 554 - 554, http://dx.doi.org/10.1192/pb.12.12.554
DAVID AS; FARRELL M, 1987, 'SUFFOCATION AND VIDEOS', BRITISH MEDICAL JOURNAL, vol. 295, pp. 116 - 116, http://dx.doi.org/10.1136/bmj.295.6590.116
Appleby L; Farrell M, 1987, 'Prescription charges', Psychiatric Bulletin, vol. 11, pp. 102 - 102, http://dx.doi.org/10.1192/pb.11.3.102-a
Hardiman O; Farrell M; McElvaney G; Tipton K; Staunton H, 1987, 'Hyperuricemia in type V glycogenosis.', Neurology, vol. 37, pp. 728 - 729, http://dx.doi.org/10.1212/wnl.37.4.728-b
Appleby L; Farrell M, 1987, 'Prescription charges', Bulletin of the Royal College of Psychiatrists, vol. 11, pp. 102 - 102, http://dx.doi.org/10.1192/s0140078900024615
Johnson PB; Kidd MN; Kervick G; Cleary PE; Collum LMT; McGettrick PM; Hillery M; Blake J; O’Connor G; Philips J; Farrell M; Eustace P; Condon PI; de Jesus V; Hillery M; Curtin D; Mooney D, 1986, 'Section of ophthalmology', Irish Journal of Medical Science, vol. 155, pp. 32 - 34, http://dx.doi.org/10.1007/bf02939949
Deary IJ; Wessely S; Farrell M, 1985, 'Dementia and Mrs Thatcher.', Br Med J (Clin Res Ed), vol. 291, pp. 1768, http://dx.doi.org/10.1136/bmj.291.6511.1768
O'Connell K; Looby S; Gou P; Flavin R; Farrell M; Cryan JB; Beausang A; Brett FM, 'CNS lymphoma, the Irish experience: A retrospective review of neuropathologically confirmed cases over 10 years.', Clin Neuropathol, vol. 39, pp. 212 - 220, http://dx.doi.org/10.5414/NP301252
Farrell M; Aherne S; O'Riordan S; O'Keeffe E; Greene C; Campbell M, 'Blood-brain barrier dysfunction in a boxer with chronic traumatic encephalopathy and schizophrenia.', Clin Neuropathol, vol. 38, pp. 51 - 58, http://dx.doi.org/10.5414/NP301130
Doherty CP; O'Keeffe E; Keaney J; Lawlor B; Coen RF; Farrell M; Campbell M, 'Neuropolypathology as a result of severe traumatic brain injury?', Clin Neuropathol, vol. 38, pp. 14 - 22, http://dx.doi.org/10.5414/NP301131
Loftus T; Chen D; Looby S; Chalissery A; Howley R; Heaney C; Heffernan J; Farrell M; Brett F, 'CJD surveillance in the Republic of Ireland from 2005 to 2015: a suggested algorithm for referrals.', Clin Neuropathol, vol. 36, pp. 188 - 194, http://dx.doi.org/10.5414/NP301016
Conference Papers
Acheson LS; Gordon C; Ezard N; Lintzeris N; Dunlop AJ; Brett J; Rodgers C; Gill A; Christmass M; McKetin R; Farrell M; Shoptaw S; Siefried KJ, 2022, 'An exploratory analysis of actigraphy and sleep diaries in a methamphetamine withdrawal clinical trial', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S23 - S24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Acheson LS; Ezard N; Lintzeris N; Dunlop AJ; Brett J; Rodgers C; Gill A; Christmass M; McKetin R; Farrell M; Shoptaw S; Siefried KJ, 2022, 'Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot safety and feasibility trial', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S22 - S23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700041&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Clay S; Treloar C; Degenhardt L; Grebely J; Farrell M; Marshall AD, 2022, 'Options: Exploring patients' experiences with depot buprenorphine and their motivations to discontinue', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S43 - S43, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700076&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Howard BC; McRobbie H; Petrie D; Barker D; Mendelsohn C; Anderson J; Borland R; Naughton F; Tutka P; Zwar N; Shakeshaft A; Gartner C; Richmond R; Hall W; Mattick RP; Farrell M; Courtney RJ, 2022, 'Effectiveness, safety and cost-effectiveness of vaporised nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: A study protocol for a randomised controlled trial', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S75 - S76, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700130&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Colledge-Frisby S; Jones N; Degenhardt L; Farrell M; Kwa J; Padmanathan P; Santo T; Hickman M; Gisev N, 2022, 'Suicide and self-harm among people prescribed opioid agonist treatment in New South Wales: A retrospective data linkage study', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S47 - S48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700083&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Mills L; Mammen K; Deacon RM; Black E; Montebello M; Bruno R; Dunlop AJ; Ezard N; Shakeshaft A; Farrell M; Holmes J; Reid D; Childs S; Siefried KJ; Lintzeris N, 2022, 'Outcomes for clients in opioid treatment programs who use amphetamine type substances: Results from a retrospective analysis of routinely-collected clinical data', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S96 - S97, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700167&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Black E; Mammen K; Deacon RM; Mills L; Montebello M; Bruno R; Dunlop AJ; Ezard N; Shakeshaft A; Farrell M; Holmes J; Reid D; Childs S; Siefried KJ; Lintzeris N, 2022, 'Clients entering New South Wales alcohol and other drug treatment services: Characteristics by principal drug of concern, July 2016-June 2019', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S31 - S32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Gates P; Sabioni P; Copeland J; Le Foll B; Gowing L, 2016, 'PSYCHOSOCIAL INTERVENTIONS FOR CANNABIS USE DISORDER', in DRUG AND ALCOHOL REVIEW, WILEY, pp. 37 - 37, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500101&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Farrell M; Van Brussel G; Skauge L; Burke M; Auriacombe M; Sayka M; Fischer G; Haemmig R; Kokkoris C; Ulug B; Reisinger M; Pani PP; Granstrom V; Johnsen J; Ball A, 1999, 'Clinical guidelines - Europe', in Research and Clinical Forums, pp. 55 - 67
Scott J; Gilvarry E; Farrell M, 1998, 'Managing anxiety and depression in alcohol and drug dependence', in Addictive Behaviors, pp. 919 - 931, http://dx.doi.org/10.1016/S0306-4603(98)00074-4
Conference Posters
Acheson L; Ezard N; Lintzeris N; Dunlop A; Brett J; Rodgers C; Gill A; Christmass M; McKetin R; Farrell M; Shoptaw S; Siefried K, 2022, 'The Safety and Feasibility of Lisdexamfetamine for the Treatment of Acute Methamphetamine Withdrawal: Preliminary Results of an Open Label Pilot Study', Minneapolis, USA, presented at The College on Problems of Drug Dependence 84th Annual Scientific Meeting, Minneapolis, USA, 11 June 2022 - 15 June 2022, https://d2p55c5k0gw6a2.cloudfront.net/wp-content/uploads/2022/07/2022-CPDD-Abstract-Book.pdf
Acheson L; Williams BHM; Farrell M; McKetin R; Ezard N; Siefried K, 2021, 'Pharmacological treatment for methamphetamine withdrawal: a systematic review and meta-analysis of randomised controlled trials', Virtual, presented at The APSAD Scientific Drug and Alcohol Conference, Virtual, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384
Black E; Deacon RM; Mills L; Mammen K; Dunlop A; Ezard N; Montebello M; Bruno R; Shakeshaft A; Farrell M; Holmes J; Reid D; Childs S; Siefried K; Cretikos M; Lintzeris N, 2021, 'Starting treatment in public drug and alcohol services in New South Wales: What can electronic medical records tell us about amphetamine type stimulant use?', Virtual, presented at The APSAD Scientific Drug and Alcohol Conference, Virtual, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384
Chrzanowska A; Man N; Sutherland R; Darke S; Degenhardt L; Farrell M; Moran L; Peacock A, 2021, 'Unintentional and intentional drug poisoning deaths in Australia in 2012-2016', Sydney, presented at 2021 NDARC Annual Research Symposium, Sydney, 20 October 2021 - 22 October 2021, https://ndarc.med.unsw.edu.au/resource/agata-chryzanowska-ndarc-symposium-2021-poster-presentation
Conference Presentations
Siefried K; Acheson L; Williams B; Farrell M; McKetin R; Ezard N, 2022, 'OUTCOMES AND MEASURES USED IN RANDOMISED CONTROLLED TRIALS EXAMINING PHARMACOTHERAPIES FOR THE TREATMENT OF METHAMPHETAMINE WITHDRAWAL: RESULTS OF A SYSTEMATIC REVIEW', Minneapolis, USA, presented at The College on Problems of Drug Dependence 84th Annual Scientific Meeting, Minneapolis, USA, 11 June 2022 - 15 July 2022, https://d2p55c5k0gw6a2.cloudfront.net/wp-content/uploads/2022/07/2022-CPDD-Abstract-Book.pdf
Siefried K; Arunogiri S; Brett J; McKetin R; Acheson LS; Knock E; Farrell M; Dunlop A; Lintzeris N; Ezard N, 2021, 'The future of pharmacotherapy clinical trials in Australia: the OLAM trial; the MOXY trial; the PSIMA trial; the TINA trial', Virtual, presented at The APSAD Scientific Drug and Alcohol Conference, Virtual, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384
Larance B; Nielsen S; Hordern A; Lintzeris N; Burns L; Mattick R; Campbell G; Farrell M; Cohen M; Bruno R; Brown A; Johnson J; Degenhardt L, 2014, 'PHARMACEUTICAL OPIOID USE AND PAIN AMONG PEOPLE WHO INJECT DRUGS: BASELINE FINDINGS FROM A PROSPECTIVE COHORT STUDY', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 33, pp. 6 - 6, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Larance B; Peacock A; Campbell G; Freckleton S; Smith K; Mattick R; Bruno R; Nielsen S; Cohen M; Lintzeris N; Shand F; Hall WD; Farrell M; Degenhardt L, 2014, 'ALCOHOL USE DISORDERS, RISKY ALCOHOL CONSUMPTION AND ADVERSE EVENTS AMONG CHRONIC NON-CANCER PAIN PATIENTS RECEIVING OPIOID THERAPY', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 33, pp. 39 - 40, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800113&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Nielsen S; Larance B; Lintzeris N; Holliday S; Vanderhaven M; Hordern A; Dunlop A; Haber P; Murnion B; Silsbury C; Johnson J; Demirkol A; Sadler C; Phung N; Burns L; Mattick R; Campbell G; Farrell M; Cohen M; Bruno R; Hardy M; Brown A; Houseman J; Degenhardt L, 2014, 'SEEKING TREATMENT FOR PHARMACEUTICAL OPIOID DEPENDENCE: BASELINE CHARACTERISTICS FROM AN IN-TREATMENT COHORT', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 33, pp. 7 - 7, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800021&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Campbell G; Mattick R; Bruno R; Larance B; Nielsen S; Cohen M; Lintzeris N; Shand F; Hall WD; Farrell M; Degenhardt L, 2014, 'CHARACTERISTICS OF A NATIONAL SAMPLE OF PEOPLE WITH CHRONIC NON-CANCER PAIN PRESCRIBED PRESCRIPTION OPIOIDS', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 33, pp. 6 - 6, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800019&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Conference Abstracts
Williams BH; Acheson LS; Farrell M; McKetin R; Ezard N; Siefried KJ, 2022, 'PHARMACOLOGICAL TREATMENT FOR METHAMPHETAMINE WITHDRAWAL: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS', in AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, SAGE PUBLICATIONS LTD, Vol. 56, pp. 208 - 209, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000792769900489&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Peacock A; Gisev N; Memedovic S; Larance B; Brown J; Cairns R; Buckley N; Farrell M; Degenhardt L, 2020, 'Opioid use and harms associated with a sustained-release tapentadol formulation: A post-marketing surveillance study', in Drug and Alcohol Dependence, WILEY, Vol. 206, pp. S57 - S57, http://dx.doi.org/10.1016/j.drugalcdep.2019.107697
Black E; Deacon RM; Mills L; Dunlop A; Ezard N; Bruno R; Shakeshaft A; Farrell M; Holmes J; Cretikos MA; Montebello M; Reid D; Childs S; Siefried KJ; Mammen K; Lintzeris N, 2019, 'Characteristics and treatment outcomes of the drug treatment population in New South Wales: Focus on amphetamine type stimulants', in Drug and Alcohol Review, Wiley, Hobart, Australia, Vol. 38, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference, Hobart, Australia, 10 November 2019 - 13 November 2019, http://dx.doi.org/10.1111/dar.12991
Karlsson A; Gibbs D; Kelly G; Uporova J; Dietze PM; Bruno R; Lenton S; Salom C; Degenhardt L; Farrell M; Peacock A, 2019, 'TRENDS IN METHAMPHETAMINE FORMS AND ROUTES OF ADMINISTRATION AMONG PEOPLE WHO REGULARLY CONSUME DRUGS IN AUSTRALIA', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S59 - S59, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100149&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Farnbach S; Foley C; Sara G; Shakeshaft A; Lappin J; Allan J; Courtney RJ; Farrell M; Dobbins T, 2019, 'WHO IS ACCESSING BOTH MENTAL HEALTH AND DRUG AND ALCOHOL SERVICES? MAPPING THE OVERLAP TO IDENTIFY OPPORTUNITIES FOR IMPROVING SPECIALISED CARE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S45 - S45, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100115&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Kelly G; Bruno R; Gibbs D; Karlsson A; Uporova J; Sutherland R; Dietze PM; Salom C; Lenton S; Degenhardt L; Farrell M; Peacock A, 2019, 'RECENT USE OF 'CAPSULES CONTENTS UNKNOWN' AMONG A SAMPLE OF PEOPLE WHO FREQUENTLY USE ECSTASY AND OTHER ILLICIT STIMULANTS IN AUSTRALIA', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S60 - S61, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100152&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Mammen K; Deacon RM; Holmes J; Dunlop AJ; Bruno R; Ryan A; Gardner L; Shakeshaft A; Farrell M; Phung N; Lintzeris N, 2017, 'THE CLINICAL UTILITY OF THE AUSTRALIAN TREATMENT OUTCOMES PROFILE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 36, pp. 50 - 50, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424000500129&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Larance B; Cama E; Bruno R; Farrell M; Ali R; Lintzeris N; Peacock A; Kihas I; Hordern T; White N; Degenhardt L, 2014, 'PATTERNS OF OPIOID CONSUMPTION IN A COHORT OF PEOPLE WHO TAMPER WITH PHARMACEUTICAL OPIOIDS: BASELINE FINDINGS FROM THE NATIONAL OPIOID MEDICATION ABUSE DETERRENCE (NOMAD) STUDY', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 33, pp. 38 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800111&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Farrell M, 1992, 'Making the science and policy connection', in British Journal of Addiction, Vol. 87, pp. 138 - 139
Reports
Sutherland R; Uporova J; Peacock A; Udesha C; Price O; Karlsson A; Gibbs D; Swanton R; Lenton S; Woods E; Farrell M; Bruno R; Dietze P; Salom C; Thomas N; Daly C; Juckel J; Agramunt S; Wilson Y; Degenhardt L; Moon C, 2021, Australian Drug Trends 2021: Key Findings from the National Illicit Drug Reporting System (IDRS) Interviews, NDARC, Sydney, http://dx.doi.org/10.26190/4p6r-jq88
Sutherland R; Uporova J; Karlsson A; Price O; Chandrasena U; Swanton R; Gibbs D; Dietze P; Lenton S; Salom C; Grigg J; Wilson Y; Eddy S; Hall C; Daly C; Thomas N; Juckel J; Degenhardt L; Farrell M; Peacock A, 2021, Australian Drug Trends 2021: Key Findings from the National Ecstasy and related Drug Reporting System (EDRS) Interviews, NDARC, Sydney, http://dx.doi.org/10.26190/t6sh-g213
Peacock A; Price O; Dietze P; Bruno R; Salom C; Lenton S; Uporova J; Karlsson A; Chan R; Gibbs D; Grigg J; Daly C; Hall C; Wilson T; Degenhardt L; Farrell M, 2020, Impacts of COVID-19 and associated restrictions on people who use illicit stimulants in Australia: Findings from the Ecstasy and Related Drugs Reporting System 2020, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5f74257af29e4
Chrzanowska A; Gisev N; Price O; Sutherland R; Memedovic S; Degenhardt L; Farrell M; Peacock A, 2020, Tapentadol use and harms in Australia: Analysis of opioid sales data and sentinel survey data from people who inject drugs, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5ef15b883c0ac
Peacock A; Price O; Dietze P; Bruno R; Salom C; Lenton S; Swanton R; Uporova J; Karlsson A; Chan R; Gibbs D; Grigg J; Daly C; Hall C; Wilson T; Degenhardt L; Farrell M, 2020, Impacts of COVID-19 and associated restrictions on people who use illicit stimulants in Australia: Preliminary findings from the Ecstasy and Related Drugs Reporting System 2020, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5ef1628d8e50c
Peacock A; Farrell M; Muscat C; Degenhardt L, 2020, Viability of an Early Warning System (ViEWS) study: Final report, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5e586c51e3059
Peacock A; Karlsson T; Uporova J; Gibbs D; Swanton R; Kelly G; Price O; Bruno R; Dietze P; Lenton S; Salom C; Degenhardt L; Farrell M, 2019, Australian Drug Trends 2019: Key findings from the National Ecstasy and Related Drugs Reporting System (EDRS) Interviews, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5da51c1740a16
Peacock A; Uporova J; Karlsson T; Gibbs D; Swanton R; Kelly G; Price O; Bruno R; Dietze P; Lenton S; Salom C; Degenhardt L; Farrell M, 2019, Australian Drug Trends 2019: Key findings from the National Illicit Drug Reporting System (IDRS) Interviews, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5da521d347daf
Gibbs D; Grebely J; Larney S; Butler K; Sutherland R; Starr M; Karlsson A; Uporova J; Degenhardt L; Farrell M; Peacock A, 2019, Self-report and serological HCV status amongst people who inject drugs in NSW and ACT, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Drug Trends Bulletin August 2019, http://dx.doi.org/10.26190/5d788a487ac61, https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/4.%20DBS%20and%20HCV%20self%20report%20bulletin.pdf
Sutherland R; Memedovic S; Degenhardt L; Farrell M; Peacock A, 2019, Tapentadol use among people who regularly inject drugs in Australia, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, https://ndarc.med.unsw.edu.au/resource/tapentadol-use-among-people-who-regularly-inject-drugs-australia
Peacock A; Gibbs D; Sutherland R; Uporova J; Karlsson A; Bruno R; Dietze P; Lenton S; Alati R; Degenhardt L; Farrell M, 2018, Illicit Drug Reporting System (IDRS) Interviews: Background and Methods, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, https://ndarc.med.unsw.edu.au/sites/default/files/National%20IDRS%20Interviews%20Background%20and%20Methods%202018.pdf
Peacock A; Gibbs D; Karlsson A; Uporova J; Sutherland R; Bruno R; Dietze P; Lenton S; Alati R; Degenhardt L; Farrell M, 2018, Ecstasy and Related Drugs Reporting System (EDRS) Interviews: Background and Methods, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, https://ndarc.med.unsw.edu.au/sites/default/files/National%20EDRS%20Interviews%20Method%20and%20Background.pdf
Peacock A; Gibbs D; Sutherland R; Uporova J; Karlsson T; Bruno R; Dietze P; Lenton S; Alati R; Degenhardt L; Farrell M, 2018, Australian Drug Trends 2018: Key findings from the National Illicit Drug Reporting System (IDRS) Interviews, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, https://ndarc.med.unsw.edu.au/resource/australian-drug-trends-2018-key-findings-national-illicit-drug-reporting-system-idrs
Preprints
Saxby K; Ireland A; Ghijben P; Sweeney R; Sia K-L; Chen E; Farrell M; McRobbie H; Courtney R; Petrie D, 2022, Household composition, smoking cessation and relapse: results from a prospective longitudinal Australian cohort, http://dx.doi.org/10.1101/2022.01.03.22268695
Other
Campbell G; Hall W; Degenhardt L; Dobbins T; Farrell M, 2018, Cannabis use and non-cancer chronic pain – Authors' reply, http://dx.doi.org/10.1016/S2468-2667(18)30182-8